≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Follicular lymphoma, hilmo

Endpoint Browser PheWeb

C3_FOLLICULAR_LYMPHOMA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C82
  • Hospital discharge: ICD-9 — 2000A
  • Cause of death: ICD-10 — C82
  • Cause of death: ICD-9 — 2000A

2 out of 7 registries used, show all original rules.

1612

4. Check minimum number of events

None

1612

5. Include endpoints

None

1612

6. Filter based on genotype QC (FinnGen only)

1555

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
C81-C96
Name in latin
Lymphoma non-Hodgkin nodulare (folliculare)

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1555 792 763
Unadjusted period prevalence (%) 0.31 0.28 0.35
Median age at first event (years) 64.99 64.25 65.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1612
Matched controls
16120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
48.8
307.7
286
71
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
36.4
307.7
486
189
L03AA02
ATC
filgrastim; parenteral
20.9
307.7
392
244
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
58.8
307.7
329
70
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
307.7
394
*
M04AA01
ATC
allopurinol; systemic
7.6
307.7
712
1517
C82.1
ICD-10 Finland
Follicular lymphoma grade II
16384.0
307.7
914
*
JN4BD
NOMESCO Finland
Extensive body CT
8.7
307.7
650
1156
JN6AD
NOMESCO Finland
CT of torso and neck
33.0
307.7
324
122
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
40.9
307.7
304
91
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
31.6
307.7
279
106
PJA10
NOMESCO Finland
Exploration of lymph nodes
44.2
307.7
294
81
XW000
NOMESCO Finland
Bone marrow biopsy
24.3
307.7
593
377
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
37.9
307.7
502
190
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
307.7
336
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
76.3
307.7
1061
397
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
307.7
363
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
5292.0
307.7
412
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
62.7
307.7
208
38
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
65.0
305.6
169
29
L03AA13
ATC
pegfilgrastim; parenteral
11.2
291.5
342
378
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.4
280.7
351
422
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
280.4
840
2497
1XC02, ,
NOMESCO Finland
48.2
260.6
153
35
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
232.0
217
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
27.8
226.3
156
62
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
96.1
222.5
116
13
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
32.3
200.7
131
44
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.0
200.5
271
354
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
34.1
196.3
126
40
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
90.7
194.2
102
12
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
32.3
184.1
120
40
JN4AD
NOMESCO Finland
Body CT examination
5.0
180.1
509
1369
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
58.5
176.1
99
18
A04AA01
ATC
ondansetron; systemic, rectal
5.7
172.8
380
822
A04AA02
ATC
granisetron; systemic, transdermal
6.2
168.4
330
640
ZX120
NOMESCO Finland
Intravenous
5.2
154.4
384
919
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.6
150.9
269
473
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
11.7
133.9
142
132
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.3
131.1
207
319
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.5
129.1
119
88
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.6
127.5
272
564
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
29.4
120.9
81
29
D70.82
ICD-10 Finland
Drug-induced neutropenia
12.2
120.2
123
108
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
61.5
116.6
65
11
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.7
115.2
115
97
WF002
NOMESCO Finland
Radical radiotherapy
5.2
108.2
251
557
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
106.4
101
*
ZX112
NOMESCO Finland
Subcutaneous
9.0
106.3
136
163
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.0
106.0
252
571
C83.00
ICD-10 Finland
Lymphocytic lymphoma
55.6
103.9
59
11
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
103.6
421
1419
WW500
NOMESCO Finland
Blood transfusion
6.0
99.2
187
343
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
52.7
97.5
56
11
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.1
96.4
180
327
L01AA02
ATC
chlorambucil; oral
36.0
93.8
59
17
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
92.6
88
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
91.3
837
4446
H02AB02
ATC
dexamethasone; systemic
3.5
90.5
375
1270
L03AA14
ATC
lipegfilgrastim; parenteral
9.2
89.6
112
130
WF004
NOMESCO Finland
Palliative radiotherapy
7.9
88.7
126
171
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
8.8
86.4
112
136
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
43.9
85.3
51
12
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
85.2
81
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
30.5
84.8
56
19
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
14.4
84.0
77
56
H02AB06
ATC
prednisolone; systemic
2.8
83.8
1019
6159
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
12.9
82.6
81
66
R50.9
ICD-10 Finland
Fever, unspecified
3.2
82.2
409
1542
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
74.6
71
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.5
71.5
94
116
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
18.9
69.3
55
30
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
26.9
68.2
47
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
67.7
337
1258
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
13.1
65.2
63
50
WW300
NOMESCO Finland
Transfer of autologic stem cells
21.0
64.7
49
24
212
Kela drug reimbursment
Gout
6.9
60.8
97
149
9691/3-C42.1
ICD-O-3
Follicular lymphoma, grade 2 of bone marrow
+∞
60.8
58
*
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
60.8
58
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
9.7
59.3
70
75
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
9.2
57.9
71
80
J05AB11
ATC
valaciclovir; oral
2.8
57.8
356
1484
H02AB07
ATC
prednisone; oral
2.8
56.3
343
1419
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
50.3
48
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
19.0
49.3
39
21
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.0
48.7
67
87
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
47.1
45
*
B72
ICPC
Hodgkin Lymphoma
76.8
46.2
52
7
D70.89
ICD-10 Finland
Neutropenic splenomegaly
8.0
45.7
63
82
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
45.5
289
1211
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.5
43.4
110
258
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
42.5
978
6889
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
40.4
174
588
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.5
40.0
52
63
C82
ICD-10 Finland
Follicular lymphoma
+∞
39.7
38
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.5
38.8
76
143
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.7
37
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.8
38.5
71
126
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.4
37.7
97
230
N02AA05
ATC
oxycodone; systemic
2.1
37.4
438
2385
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.4
36.8
95
226
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
36.0
101
256
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
35.5
34
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
14.2
34.8
32
23
WZC30
NOMESCO Finland
Teaching
2.2
34.0
365
1912
ZX108
NOMESCO Finland
Inhalation
9.3
33.1
40
44
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
6.7
32.5
52
80
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
32.4
31
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.8
32.1
103
287
JN4CD
NOMESCO Finland
Very extensive body CT
3.5
32.0
116
351
TGC00
NOMESCO Finland
Bronchial lavation
4.2
32.0
86
211
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
73.7
32.0
36
5
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
73.7
32.0
36
5
1AA09, ,
NOMESCO Finland
115.7
31.8
34
*
J01MA12
ATC
levofloxacin; systemic
2.1
31.2
396
2204
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
8.5
30.9
40
48
A02BC02
ATC
pantoprazole; systemic
2.0
30.7
1209
9697
YNB10
NOMESCO Finland
Collection of stem cells for transplant
52.5
30.4
36
7
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
6.4
29.6
49
78
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
29.3
28
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.8
29.2
90
244
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
65.2
28.0
32
5
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
147.6
27.7
29
*
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
7.7
27.7
39
52
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
8.7
27.6
35
41
A41.9
ICD-10 Finland
Sepsis, unspecified
3.4
27.5
102
313
A07AA02
ATC
nystatin; oral
2.8
27.5
144
541
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.3
27.4
36
44
Z51.5
ICD-10 Finland
Palliative care
2.3
27.1
225
1053
R06AE07
ATC
cetirizine; oral
1.8
27.0
701
4870
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
26.6
515
3274
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
26.1
25
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
25.9
439
2673
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
22.2
25.7
37
17
JAH01
NOMESCO Finland
Laparoscopy
3.3
25.3
100
319
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
23.0
25.3
36
16
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.5
25.2
41
64
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
24.9
149
599
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.9
24.1
43
74
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4.6
24.0
58
131
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
7.5
23.8
34
46
J05AB01
ATC
aciclovir; systemic
1.9
23.8
396
2389
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
31.6
23.7
31
10
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
23.7
204
967
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
23.5
104
355
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.4
23.4
171
755
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
+∞
23.0
22
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
84.7
22.7
25
*
JAH00
NOMESCO Finland
Laparotomy
3.6
22.5
77
224
B01AB05
ATC
enoxaparin; parenteral
1.7
22.4
589
4050
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
22.0
130
519
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
81.3
21.7
24
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
81.3
21.7
24
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
21.0
21.3
31
15
B02
ICPC
Lymph gland(s) enlarged/painful
6.4
21.0
35
56
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
20.9
20
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.2
20.7
199
985
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
111.5
20.6
22
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
42.2
20.5
25
6
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
20.4
200
997
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
20.1
452
2959
XX9CD
NOMESCO Finland
Very extensive complementary CT
58.3
19.9
23
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
58.3
19.9
23
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.4
19.7
49
113
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
74.4
19.7
22
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.0
19.7
57
148
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
19.5
173
828
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.7
19.3
62
173
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
15.0
18.9
31
21
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
101.2
18.6
20
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
101.2
18.6
20
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
18.4
218
1166
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
7.9
18.3
25
32
JAH21
NOMESCO Finland
Staging laparoscopy
53.1
18.0
21
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
17.9
809
6267
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
18.3
17.8
27
15
JAH20
NOMESCO Finland
Staging laparotomy
67.4
17.7
20
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
14.7
17.6
29
20
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
37.1
17.6
22
6
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
96.1
17.6
19
*
ZXE00
NOMESCO Finland
One hour or less
1.6
17.3
624
4576
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
12.7
17.1
30
24
WW409
NOMESCO Finland
Other aferesis
17.6
16.9
26
15
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.6
16.8
55
156
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
91.0
16.6
18
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
16.5
446
3040
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
16.5
142
671
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.3
16.4
63
198
B01AB10
ATC
tinzaparin; parenteral
1.9
16.2
215
1193
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.1
16.1
68
226
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
48.0
16.0
19
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
48.0
16.0
19
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
5.2
16.0
33
65
WX402
NOMESCO Finland
General anaesthesia
1.7
15.8
376
2479
J01MA14
ATC
moxifloxacin; systemic
2.0
15.6
172
895
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
28.9
15.2
20
7
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
15.1
246
1455
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.6
15.1
49
138
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
15.1
550
4012
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
45.4
15.1
18
*
ELB30
NOMESCO Finland
Excision of submandibular gland
6.6
14.9
24
37
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.4
14.8
37
86
ELB40
NOMESCO Finland
Partial parotidectomy
4.5
14.8
36
82
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
14.6
14
*
WW200
NOMESCO Finland
Immunization
3.3
14.6
56
176
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
14.3
14.5
24
17
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.9
14.4
68
241
N02BE01
ATC
paracetamol; systemic, rectal
1.9
14.4
1450
13248
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
14.4
112
507
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
5.7
14.2
26
46
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
14.0
376
2546
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
13.9
442
3113
Z51.0
ICD-10 Finland
Radiotherapy session
4.0
13.9
39
99
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
53.8
13.8
16
*
TPX15
NOMESCO Finland
Removal of vascular injection port
11.5
13.8
25
22
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
13.6
13
*
EP1AE, ,
SPAT
4.0
13.2
37
94
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.7
13.1
71
272
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
13.0
1088
9333
372
Kela drug reimbursment
Idelalisib
50.4
12.8
15
*
B02.9
ICD-10 Finland
Zoster without complication
2.0
12.7
139
720
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
17.5
12.5
19
11
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
12.5
12
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
12.5
12
*
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
12.5
12
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
12.4
212
1270
FM1FN
NOMESCO Finland
Heart function isotope examination
9.1
12.2
25
28
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
9.1
12.2
25
28
J35.1
ICD-10 Finland
Hypertrophy of tonsils
5.7
12.0
22
39
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
47.0
11.9
14
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
11.8
130
675
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
14.8
11.8
19
13
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
10.6
11.8
22
21
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
9.0
11.8
24
27
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.5
11.7
40
117
OAA41
NOMESCO Finland
Health check based on individual needs
10.1
11.5
22
22
9698/3-C42.1
ICD-O-3
Follicular lymphoma, grade 3 of bone marrow
+∞
11.5
11
*
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
9695/3-C42.1
ICD-O-3
Follicular lymphoma, grade 1 of bone marrow
+∞
11.5
11
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
35.3
11.3
14
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
9.0
11.3
23
26
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.1
11.2
45
146
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.3
11.1
41
126
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.2
11.1
29
70
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
10.1
11.0
21
21
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
43.6
10.9
13
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
43.6
10.9
13
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.9
10.9
31
80
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
10.7
301
2047
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
21.6
10.7
15
7
L01CB01
ATC
etoposide; systemic
5.3
10.6
21
40
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.4
10.5
73
315
R59
ICD-10 Finland
Enlarged lymph nodes
110.7
10.4
11
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
10.4
10
*
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
10.4
10
*
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
10.4
10
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.5
10.4
20
37
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
16.2
10.4
16
10
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.2
10.3
41
132
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
8.9
10.3
21
24
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.9
10.2
30
79
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
10.2
168
994
J01DB01
ATC
cefalexin; oral
1.5
10.1
1264
11397
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
9.9
157
917
4701
FHL
Neck lymph node removal
16.8
9.9
15
9
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.9
9.8
46
163
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
20.2
9.8
14
7
YX9AW, ,
NOMESCO Finland
4.9
9.8
21
43
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.7
9.7
50
187
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
9.7
316
2218
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.7
9.6
52
199
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
9.6
199
1253
120
Kela drug reimbursment
Hypogammaglobulinaemia
15.1
9.5
15
10
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.7
9.4
29
79
A02BC01
ATC
omeprazole; systemic
1.5
9.4
428
3209
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
9.4
9
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
9.2
52
204
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.4
9.1
22
50
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
15.7
9.0
14
9
L01BB05
ATC
fludarabine; systemic
15.7
9.0
14
9
D11.70
ICD-10 Finland
Gland sublingual
10.1
9.0
17
17
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
36.9
9.0
11
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.6
9.0
50
195
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
8.9
489
3790
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.2
8.8
69
315
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
9.5
8.8
17
18
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
8.8
595
4779
J01MA02
ATC
ciprofloxacin; systemic
1.4
8.7
615
4968
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
50.3
8.7
10
*
L01EM01
ATC
idelalisib; oral
50.3
8.7
10
*
J01CA04
ATC
amoxicillin; systemic
1.4
8.7
1214
10965
XX1AD
NOMESCO Finland
Other CT-examination
4.3
8.7
22
52
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.5
8.6
51
205
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
8.6
91
467
JFB00
NOMESCO Finland
Partial resection of small intestine
3.1
8.6
35
115
WW402
NOMESCO Finland
Leucoferesis
20.1
8.5
12
6
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
7.9
8.4
18
23
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
8.3
8
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
8.3
8
*
N03AX16
ATC
[U] pregabalin
1.4
8.3
362
2685
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.2
8.2
31
97
A07AA09
ATC
vancomycin; oral
3.3
8.2
30
92
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
8.2
97
517
S04
ICPC
Lump/swelling localized
1.6
8.1
173
1097
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
4.8
8.1
18
38
C85.0
ICD-10 Finland
Lymphosarcoma
33.5
8.1
10
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
11.8
8.1
14
12
A79
ICPC
Malignancy NOS
2.9
8.0
37
131
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.6
7.9
46
183
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
4.5
7.9
19
43
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
6.6
7.9
19
29
C03CA01
ATC
furosemide; systemic
1.4
7.9
524
4178
XX2RW, ,
NOMESCO Finland
3.1
7.9
32
105
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.6
7.9
221
1497
JAL00
NOMESCO Finland
Biopsy of peritoneum
7.0
7.8
18
26
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
15.1
7.7
12
8
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
11.9
7.6
13
11
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
25.1
7.6
10
*
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
8.9
7.5
15
17
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
7.5
95
518
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.5
601
4929
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.4
7.4
18
41
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
80.5
7.4
8
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.2
7.3
57
260
WZC15, ,
NOMESCO Finland
3.6
7.3
23
64
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
7.3
547
4433
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
7.3
7
*
9597/3-C44.9
ICD-O-3
Primary cutaneous follicle center lymphoma of skin, NOS
+∞
7.3
7
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.7
7.3
131
795
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.3
7.2
18
42
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.1
7.2
67
329
WE100
NOMESCO Finland
Profylactic cytostatic therapy
30.1
7.1
9
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
12.1
7.1
12
10
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
6.1
7.1
18
30
J02AC01
ATC
fluconazole; systemic
1.4
7.0
504
4056
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
5.5
6.9
19
35
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
7.6
6.9
15
20
GEA00
NOMESCO Finland
Mediastinoscopy
7.6
6.9
15
20
D69.5
ICD-10 Finland
Secondary thrombocytopenia
8.3
6.8
14
17
J02AC03
ATC
voriconazole; systemic
8.3
6.8
14
17
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.2
6.8
55
255
ZX080
NOMESCO Finland
Image guided radiotherapy
2.5
6.8
42
173
SPAT1153
SPAT
Removal of sutures
1.3
6.8
506
4089
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
6.8
126
772
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
40.2
6.8
8
*
E83.50
ICD-10 Finland
Hypercalcemia
2.9
6.8
30
104
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
4.3
6.8
17
40
EMB10
NOMESCO Finland
Tonsillectomy
2.3
6.7
47
205
Z3231
NOMESCO Finland
Registered nurse
1.4
6.7
398
3105
WF099
NOMESCO Finland
Other radiotherapy
5.5
6.6
18
33
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.6
186
1260
J94.8
ICD-10 Finland
Other specified pleural conditions
2.8
6.6
31
111
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
8.7
6.6
13
15
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
8.7
6.6
13
15
CFA20
NOMESCO Finland
Biopsy of conjunctiva
10.1
6.5
12
12
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
6.5
555
4567
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
70.1
6.4
7
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
70.1
6.4
7
*
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
14.4
6.4
10
7
H02AB09
ATC
hydrocortisone; systemic
2.5
6.4
39
160
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
11.1
6.3
11
10
L03AA04, ,
ATC
9.3
6.3
12
13
9691/3-C17.9
ICD-O-3
Follicular lymphoma, grade 2 of small intestine, NOS
+∞
6.3
6
*
9691/3-C77.3
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of axilla or arm
+∞
6.3
6
*
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
6.3
6
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
26.8
6.2
8
*
UJF32
NOMESCO Finland
Coloscopy
1.3
6.2
422
3357
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.6
6.1
34
133
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.1
227
1627
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.0
6.1
61
308
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
6.0
205
1445
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
3.3
6.0
22
68

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Medical Oncology
90 [38004507]
9.8e-01
1.5e+00
2.8e+00
7.1e+00
4.7e+00
4.5e+00
4.0e+00
cases:10.63%
controls:4.26%
cases:13.31%
controls:3.18%
cases:15.49%
controls:1.11%
cases:55.04%
controls:0.10%
cases:56.03%
controls:1.16%
cases:75.64%
controls:3.25%
cases:73.81%
controls:5.12%
171
685
1437
15393
214
511
1394
15567
249
178
1359
15900
885
16
723
16062
897
187
704
15865
1158
509
373
15144
958
705
340
13053
Diffuse lymphoma with large B cells
C83.31 [2000501224]
2.8e+00
3.3e+00
4.2e+00
—
4.6e+00
4.3e+00
4.2e+00
cases:2.43%
controls:0.15%
cases:3.36%
controls:0.12%
cases:3.30%
controls:0.05%
—
—
cases:4.25%
controls:0.04%
cases:8.16%
controls:0.11%
cases:11.02%
controls:0.18%
39
24
1569
16054
54
20
1554
16058
53
8
1555
16070
—
68
7
1533
16045
125
18
1406
15635
143
25
1155
13733
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
1.9e+00
1.6e+00
2.4e+00
1.0e+50
5.0e+00
5.0e+00
4.8e+00
cases:0.81%
controls:0.12%
cases:0.56%
controls:0.11%
cases:0.62%
controls:0.06%
cases:1.31%
controls:0.00%
cases:8.68%
controls:0.06%
cases:17.70%
controls:0.15%
cases:13.41%
controls:0.12%
13
19
1595
16059
9
18
1599
16060
10
9
1598
16069
21
0
1587
16078
139
10
1462
16042
271
23
1260
15630
174
17
1124
13741
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
8.9e-01
2.0e+00
6.4e+00
—
5.0e+00
2.2e+00
1.8e+00
cases:2.11%
controls:0.88%
cases:2.74%
controls:0.39%
cases:19.15%
controls:0.04%
—
—
cases:7.18%
controls:0.05%
cases:2.87%
controls:0.33%
cases:7.16%
controls:1.21%
34
141
1574
15937
44
63
1564
16015
308
6
1300
16072
—
115
8
1486
16044
44
51
1487
15602
93
166
1205
13592
pegfilgrastim; parenteral
L03AA13 [21603856]
1.4e+00
1.6e+00
3.2e+00
—
4.9e+00
4.7e+00
2.6e+00
cases:1.18%
controls:0.30%
cases:1.12%
controls:0.24%
cases:0.75%
controls:0.03%
—
—
cases:4.93%
controls:0.04%
cases:11.89%
controls:0.12%
cases:5.55%
controls:0.43%
19
48
1589
16030
18
38
1590
16040
12
5
1596
16073
—
79
6
1522
16046
182
19
1349
15634
72
59
1226
13699
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
8.1e-01
2.0e+00
5.2e+00
—
4.3e+00
3.1e+00
2.6e+00
cases:4.42%
controls:2.02%
cases:8.77%
controls:1.34%
cases:25.37%
controls:0.19%
—
—
cases:16.11%
controls:0.26%
cases:20.51%
controls:1.16%
cases:31.51%
controls:3.18%
71
324
1537
15754
141
215
1467
15863
408
30
1200
16048
—
258
41
1343
16011
314
181
1217
15472
409
437
889
13321
filgrastim; parenteral
L03AA02 [21603851]
2.3e+00
2.3e+00
—
—
4.5e+00
5.0e+00
3.7e+00
cases:1.93%
controls:0.21%
cases:1.31%
controls:0.14%
—
—
—
—
cases:4.37%
controls:0.05%
cases:11.37%
controls:0.08%
cases:9.63%
controls:0.28%
31
33
1577
16045
21
22
1587
16056
—
—
70
8
1531
16044
174
13
1357
15640
125
38
1173
13720
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.2e+00
1.6e+00
2.9e+00
1.0e+50
4.6e+00
4.2e+00
3.0e+00
cases:1.80%
controls:0.53%
cases:1.31%
controls:0.28%
cases:0.93%
controls:0.05%
cases:0.75%
controls:0.00%
cases:6.93%
controls:0.07%
cases:14.24%
controls:0.25%
cases:13.79%
controls:0.76%
29
86
1579
15992
21
45
1587
16033
15
8
1593
16070
12
0
1596
16078
111
12
1490
16040
218
39
1313
15614
179
104
1119
13654
Hematology
82 [38004501]
1.2e+00
2.1e+00
3.6e+00
—
4.1e+00
3.4e+00
3.1e+00
cases:4.10%
controls:1.26%
cases:6.84%
controls:0.92%
cases:7.65%
controls:0.22%
—
—
cases:15.24%
controls:0.30%
cases:22.73%
controls:0.95%
cases:26.50%
controls:1.55%
66
202
1542
15876
110
148
1498
15930
123
36
1485
16042
—
244
48
1357
16004
348
148
1183
15505
344
213
954
13545
Extensive body CT
JN4BD [2001310899]
6.5e-01
2.2e+00
3.5e+00
1.0e+50
3.2e+00
4.1e+00
3.5e+00
cases:2.99%
controls:1.58%
cases:5.41%
controls:0.63%
cases:3.54%
controls:0.11%
cases:6.72%
controls:0.00%
cases:2.81%
controls:0.11%
cases:19.46%
controls:0.39%
cases:23.81%
controls:0.97%
48
254
1560
15824
87
101
1521
15977
57
18
1551
16060
108
0
1500
16078
45
18
1556
16034
298
61
1233
15592
309
133
989
13625
Immunohistochemistry procedure
117617002 [4035726]
7.0e-01
2.6e+00
5.4e+00
1.0e+50
3.5e+00
2.1e+00
1.9e+00
cases:2.74%
controls:1.38%
cases:9.14%
controls:0.71%
cases:13.18%
controls:0.07%
cases:0.50%
controls:0.00%
cases:2.31%
controls:0.07%
cases:3.33%
controls:0.42%
cases:9.63%
controls:1.50%
44
222
1564
15856
147
114
1461
15964
212
11
1396
16067
8
0
1600
16078
37
12
1564
16040
51
65
1480
15588
125
207
1173
13551
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5.6e-01
1.7e+00
5.7e+00
—
4.8e+00
1.8e+00
1.4e+00
cases:2.67%
controls:1.54%
cases:3.61%
controls:0.65%
cases:20.34%
controls:0.09%
—
—
cases:8.00%
controls:0.07%
cases:3.59%
controls:0.59%
cases:8.78%
controls:2.22%
43
248
1565
15830
58
105
1550
15973
327
14
1281
16064
—
128
11
1473
16041
55
92
1476
15561
114
306
1184
13452
Lymph node Pathology biopsy report
66112-4 [40768795]
2.5e+00
4.4e+00
1.0e+50
1.0e+50
—
4.4e+00
4.6e+00
cases:1.43%
controls:0.12%
cases:5.97%
controls:0.07%
cases:13.12%
controls:0.00%
cases:0.50%
controls:0.00%
—
—
cases:3.07%
controls:0.04%
cases:9.48%
controls:0.11%
23
20
1585
16058
96
12
1512
16066
211
0
1397
16078
8
0
1600
16078
—
47
6
1484
15647
123
15
1175
13743
Oncology Clinic/Center
261QX0200X [38004268]
7.6e-01
3.4e+00
5.6e+00
—
3.7e+00
1.3e+00
6.9e-01
cases:12.75%
controls:6.38%
cases:37.75%
controls:1.90%
cases:39.86%
controls:0.24%
—
—
cases:6.12%
controls:0.16%
cases:4.96%
controls:1.42%
cases:11.94%
controls:6.36%
205
1026
1403
15052
607
306
1001
15772
641
39
967
16039
—
98
26
1503
16026
76
222
1455
15431
155
875
1143
12883
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
1.3e+00
1.1e+00
2.1e+00
1.0e+50
4.3e+00
4.0e+00
2.6e+00
cases:1.06%
controls:0.30%
cases:0.81%
controls:0.27%
cases:0.93%
controls:0.12%
cases:1.49%
controls:0.00%
cases:6.75%
controls:0.09%
cases:11.43%
controls:0.23%
cases:6.09%
controls:0.47%
17
48
1591
16030
13
43
1595
16035
15
19
1593
16059
24
0
1584
16078
108
15
1493
16037
175
36
1356
15617
79
64
1219
13694
Outpatient Visit
OP [9202]
9.0e-02
1.0e+00
2.1e+00
5.4e+00
2.3e+00
2.2e+00
2.4e+00
cases:72.82%
controls:71.00%
cases:74.88%
controls:52.09%
cases:50.06%
controls:10.85%
cases:52.30%
controls:0.49%
cases:54.28%
controls:11.00%
cases:90.79%
controls:52.55%
cases:97.77%
controls:79.84%
1171
11415
437
4663
1204
8375
404
7703
805
1744
803
14334
841
78
767
16000
869
1766
732
14286
1390
8226
141
7427
1269
10984
29
2774
Localized enlarged lymph nodes
R59.0 [45534459]
2.3e+00
5.8e+00
—
1.0e+50
—
4.0e+00
3.2e+00
cases:2.05%
controls:0.22%
cases:15.36%
controls:0.06%
—
—
cases:3.17%
controls:0.00%
—
—
cases:3.00%
controls:0.06%
cases:4.47%
controls:0.18%
33
35
1575
16043
247
9
1361
16069
—
51
0
1557
16078
—
46
9
1485
15644
58
25
1240
13733
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
5.0e-01
1.9e+00
5.4e+00
—
4.9e+00
1.5e+00
1.5e+00
cases:2.86%
controls:1.75%
cases:4.60%
controls:0.73%
cases:20.52%
controls:0.11%
—
—
cases:9.12%
controls:0.07%
cases:3.53%
controls:0.77%
cases:9.71%
controls:2.35%
46
281
1562
15797
74
117
1534
15961
330
18
1278
16060
—
146
12
1455
16040
54
121
1477
15532
126
323
1172
13435
Monocytes [#/volume] in Blood
26484-6 [3001604]
2.0e-01
1.1e+00
3.3e+00
4.8e+00
2.8e+00
1.8e+00
1.3e+00
cases:12.19%
controls:10.20%
cases:18.03%
controls:6.58%
cases:25.50%
controls:1.26%
cases:3.79%
controls:0.03%
cases:17.86%
controls:1.31%
cases:28.87%
controls:6.54%
cases:41.99%
controls:16.07%
196
1640
1412
14438
290
1058
1318
15020
410
203
1198
15875
61
5
1547
16073
286
211
1315
15841
442
1024
1089
14629
545
2211
753
11547
Basophils [#/volume] in Blood
26444-0 [3006315]
2.0e-01
1.1e+00
3.3e+00
4.8e+00
2.8e+00
1.8e+00
1.3e+00
cases:12.25%
controls:10.24%
cases:18.10%
controls:6.61%
cases:25.56%
controls:1.28%
cases:3.79%
controls:0.03%
cases:17.86%
controls:1.31%
cases:28.94%
controls:6.57%
cases:42.06%
controls:16.15%
197
1646
1411
14432
291
1062
1317
15016
411
205
1197
15873
61
5
1547
16073
286
211
1315
15841
443
1029
1088
14624
546
2222
752
11536
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
5.2e-01
1.7e+00
5.4e+00
—
4.9e+00
1.8e+00
1.4e+00
cases:2.36%
controls:1.42%
cases:3.23%
controls:0.63%
cases:19.03%
controls:0.11%
—
—
cases:7.75%
controls:0.06%
cases:3.27%
controls:0.58%
cases:7.47%
controls:1.97%
38
228
1570
15850
52
101
1556
15977
306
17
1302
16061
—
124
10
1477
16042
50
91
1481
15562
97
271
1201
13487
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
6.2e-02
1.0e+00
3.4e+00
4.0e+00
3.1e+00
2.1e+00
1.5e+00
cases:10.88%
controls:10.30%
cases:15.24%
controls:5.97%
cases:27.24%
controls:1.26%
cases:3.54%
controls:0.07%
cases:22.74%
controls:1.33%
cases:34.10%
controls:6.15%
cases:44.99%
controls:15.74%
175
1656
1433
14422
245
960
1363
15118
438
202
1170
15876
57
11
1551
16067
364
213
1237
15839
522
962
1009
14691
584
2166
714
11592
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.7e-01
1.1e+00
3.2e+00
4.9e+00
2.8e+00
1.7e+00
1.3e+00
cases:12.38%
controls:10.67%
cases:18.28%
controls:6.82%
cases:25.68%
controls:1.33%
cases:3.92%
controls:0.03%
cases:17.93%
controls:1.35%
cases:29.00%
controls:6.76%
cases:42.14%
controls:16.67%
199
1716
1409
14362
294
1096
1314
14982
413
214
1195
15864
63
5
1545
16073
287
216
1314
15836
444
1058
1087
14595
547
2293
751
11465
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.0e-01
1.1e+00
3.2e+00
4.9e+00
2.8e+00
1.7e+00
1.3e+00
cases:12.87%
controls:10.83%
cases:18.59%
controls:6.84%
cases:25.87%
controls:1.35%
cases:3.86%
controls:0.03%
cases:18.24%
controls:1.40%
cases:29.52%
controls:6.84%
cases:42.30%
controls:16.71%
207
1742
1401
14336
299
1099
1309
14979
416
217
1192
15861
62
5
1546
16073
292
224
1309
15828
452
1070
1079
14583
549
2299
749
11459
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.2e-01
1.1e+00
3.3e+00
4.7e+00
2.8e+00
1.7e+00
1.3e+00
cases:11.63%
controls:9.57%
cases:17.10%
controls:6.13%
cases:23.76%
controls:1.11%
cases:3.92%
controls:0.04%
cases:16.74%
controls:1.24%
cases:27.24%
controls:6.15%
cases:38.75%
controls:14.70%
187
1539
1421
14539
275
986
1333
15092
382
178
1226
15900
63
6
1545
16072
268
199
1333
15853
417
963
1114
14690
503
2022
795
11736
Monocytes/Leukocytes in Blood
26485-3 [3019069]
2.2e-01
1.1e+00
3.3e+00
4.7e+00
2.8e+00
1.7e+00
1.3e+00
cases:11.69%
controls:9.60%
cases:17.10%
controls:6.16%
cases:23.76%
controls:1.12%
cases:3.92%
controls:0.04%
cases:16.80%
controls:1.23%
cases:27.17%
controls:6.18%
cases:38.98%
controls:14.73%
188
1544
1420
14534
275
990
1333
15088
382
180
1226
15898
63
6
1545
16072
269
198
1332
15854
416
968
1115
14685
506
2026
792
11732
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
2.2e-01
1.1e+00
3.3e+00
4.7e+00
2.8e+00
1.7e+00
1.3e+00
cases:11.69%
controls:9.61%
cases:16.98%
controls:6.18%
cases:23.69%
controls:1.11%
cases:3.86%
controls:0.04%
cases:16.61%
controls:1.25%
cases:26.98%
controls:6.17%
cases:38.98%
controls:14.69%
188
1545
1420
14533
273
993
1335
15085
381
179
1227
15899
62
6
1546
16072
266
200
1335
15852
413
966
1118
14687
506
2021
792
11737
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
2.2e-01
1.1e+00
3.3e+00
4.7e+00
2.8e+00
1.7e+00
1.3e+00
cases:11.94%
controls:9.83%
cases:16.92%
controls:6.23%
cases:23.76%
controls:1.14%
cases:3.86%
controls:0.04%
cases:16.80%
controls:1.25%
cases:27.24%
controls:6.27%
cases:38.91%
controls:15.21%
192
1580
1416
14498
272
1001
1336
15077
382
183
1226
15895
62
6
1546
16072
269
201
1332
15851
417
982
1114
14671
505
2093
793
11665
Outpatient Hospital
22 [8756]
1.6e-01
1.3e+00
3.1e+00
5.0e+00
3.0e+00
1.5e+00
7.4e-01
cases:29.42%
controls:26.24%
cases:24.13%
controls:7.74%
cases:19.15%
controls:1.01%
cases:8.02%
controls:0.06%
cases:14.49%
controls:0.82%
cases:24.43%
controls:6.64%
cases:31.51%
controls:17.99%
473
4219
1135
11859
388
1245
1220
14833
308
163
1300
15915
129
9
1479
16069
232
132
1369
15920
374
1039
1157
14614
409
2475
889
11283
Inpatient Hospital
21 [8717]
1.6e-01
1.1e+00
2.8e+00
5.3e+00
3.1e+00
1.6e+00
8.0e-01
cases:35.45%
controls:31.88%
cases:26.06%
controls:10.55%
cases:20.58%
controls:1.55%
cases:15.49%
controls:0.09%
cases:24.17%
controls:1.43%
cases:34.49%
controls:9.68%
cases:40.22%
controls:23.24%
570
5125
1038
10953
419
1696
1189
14382
331
250
1277
15828
249
14
1359
16064
387
229
1214
15823
528
1515
1003
14138
522
3198
776
10560
Otolaryngology
4 [38004449]
4.4e-01
1.9e+00
3.5e+00
5.1e+00
1.7e+00
1.2e+00
8.3e-01
cases:17.10%
controls:11.76%
cases:22.45%
controls:4.30%
cases:18.84%
controls:0.69%
cases:4.73%
controls:0.03%
cases:4.00%
controls:0.72%
cases:12.61%
controls:4.29%
cases:25.35%
controls:12.88%
275
1890
1333
14188
361
692
1247
15386
303
111
1305
15967
76
5
1532
16073
64
116
1537
15936
193
671
1338
14982
329
1772
969
11986
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
7.2e-01
1.3e+00
4.5e+00
1.0e+50
3.7e+00
2.3e+00
2.1e+00
cases:2.24%
controls:1.11%
cases:2.61%
controls:0.70%
cases:7.28%
controls:0.09%
cases:1.37%
controls:0.00%
cases:4.50%
controls:0.12%
cases:5.62%
controls:0.61%
cases:11.86%
controls:1.66%
36
178
1572
15900
42
113
1566
15965
117
14
1491
16064
22
0
1586
16078
72
19
1529
16033
86
96
1445
15557
154
229
1144
13529
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.9e-01
1.2e+00
3.2e+00
4.5e+00
2.7e+00
1.7e+00
1.2e+00
cases:11.38%
controls:9.57%
cases:16.98%
controls:6.08%
cases:22.39%
controls:1.13%
cases:3.30%
controls:0.04%
cases:15.55%
controls:1.21%
cases:26.13%
controls:6.14%
cases:37.75%
controls:14.90%
183
1539
1425
14539
273
977
1335
15101
360
182
1248
15896
53
6
1555
16072
249
194
1352
15858
400
961
1131
14692
490
2050
808
11708
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
2.6e+00
4.0e+00
—
1.0e+50
—
4.7e+00
3.0e+00
cases:5.60%
controls:0.46%
cases:5.04%
controls:0.10%
—
—
cases:1.99%
controls:0.00%
—
—
cases:9.86%
controls:0.10%
cases:7.86%
controls:0.41%
90
74
1518
16004
81
16
1527
16062
—
32
0
1576
16078
—
151
16
1380
15637
102
56
1196
13702
CT of torso and neck
JN6AD [2001310938]
2.1e+00
2.9e+00
—
1.0e+50
—
5.1e+00
4.1e+00
cases:0.44%
controls:0.06%
cases:0.81%
controls:0.04%
—
—
cases:1.99%
controls:0.00%
—
—
cases:6.79%
controls:0.04%
cases:9.48%
controls:0.17%
7
9
1601
16069
13
7
1595
16071
—
32
0
1576
16078
—
104
7
1427
15646
123
24
1175
13734
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.7e-01
1.1e+00
2.9e+00
3.8e+00
2.8e+00
2.1e+00
1.6e+00
cases:13.99%
controls:12.07%
cases:20.90%
controls:8.28%
cases:26.99%
controls:2.03%
cases:4.79%
controls:0.11%
cases:24.86%
controls:2.02%
cases:40.82%
controls:8.15%
cases:51.85%
controls:18.32%
225
1940
1383
14138
336
1331
1272
14747
434
326
1174
15752
77
18
1531
16060
398
324
1203
15728
625
1276
906
14377
673
2521
625
11237
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
6.5e-01
1.5e+00
4.9e+00
1.0e+50
4.2e+00
1.7e+00
1.9e+00
cases:1.55%
controls:0.81%
cases:2.11%
controls:0.50%
cases:5.72%
controls:0.04%
cases:0.56%
controls:0.00%
cases:3.12%
controls:0.05%
cases:2.16%
controls:0.40%
cases:6.86%
controls:1.13%
25
131
1583
15947
34
81
1574
15997
92
7
1516
16071
9
0
1599
16078
50
8
1551
16044
33
62
1498
15591
89
156
1209
13602
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
9.4e-02
9.9e-01
3.6e+00
4.1e+00
2.9e+00
1.4e+00
8.9e-01
cases:9.45%
controls:8.68%
cases:12.62%
controls:5.10%
cases:24.25%
controls:0.89%
cases:2.30%
controls:0.04%
cases:13.43%
controls:0.88%
cases:17.96%
controls:5.01%
cases:28.04%
controls:13.85%
152
1395
1456
14683
203
820
1405
15258
390
143
1218
15935
37
6
1571
16072
215
142
1386
15910
275
784
1256
14869
364
1906
934
11852
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
1.9e+00
2.1e+00
—
1.0e+50
—
5.6e+00
4.0e+00
cases:0.68%
controls:0.11%
cases:0.44%
controls:0.06%
—
—
cases:1.18%
controls:0.00%
—
—
cases:9.54%
controls:0.04%
cases:6.24%
controls:0.12%
11
17
1597
16061
7
9
1601
16069
—
19
0
1589
16078
—
146
6
1385
15647
81
16
1217
13742
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
7.3e-01
1.3e+00
2.5e+00
—
4.8e+00
2.6e+00
1.7e+00
cases:6.59%
controls:3.30%
cases:4.66%
controls:1.37%
cases:2.92%
controls:0.25%
—
—
cases:18.80%
controls:0.20%
cases:15.22%
controls:1.30%
cases:17.41%
controls:3.60%
106
530
1502
15548
75
221
1533
15857
47
40
1561
16038
—
301
32
1300
16020
233
204
1298
15449
226
495
1072
13263
Internal Medicine
11 [38004456]
8.8e-02
9.9e-01
2.3e+00
5.4e+00
2.2e+00
1.5e+00
9.2e-01
cases:25.00%
controls:23.38%
cases:21.02%
controls:9.00%
cases:12.75%
controls:1.47%
cases:10.88%
controls:0.06%
cases:12.18%
controls:1.48%
cases:30.37%
controls:8.77%
cases:39.75%
controls:20.85%
402
3759
1206
12319
338
1447
1270
14631
205
237
1403
15841
175
9
1433
16069
195
238
1406
15814
465
1373
1066
14280
516
2868
782
10890
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
1.0e+00
7.7e-01
2.2e+00
—
4.2e+00
3.6e+00
2.3e+00
cases:1.37%
controls:0.50%
cases:0.75%
controls:0.35%
cases:0.87%
controls:0.10%
—
—
cases:5.31%
controls:0.09%
cases:8.03%
controls:0.23%
cases:5.16%
controls:0.56%
22
80
1586
15998
12
56
1596
16022
14
16
1594
16062
—
85
14
1516
16038
123
36
1408
15617
67
77
1231
13681
Body CT examination
JN4AD [2001310897]
1.0e+00
1.6e+00
3.1e+00
1.0e+50
3.0e+00
2.5e+00
2.0e+00
cases:1.68%
controls:0.62%
cases:2.80%
controls:0.59%
cases:1.93%
controls:0.09%
cases:2.30%
controls:0.00%
cases:1.31%
controls:0.07%
cases:7.71%
controls:0.66%
cases:12.40%
controls:1.81%
27
100
1581
15978
45
95
1563
15983
31
14
1577
16064
37
0
1571
16078
21
11
1580
16041
118
103
1413
15550
161
249
1137
13509
Intravenous
ZX120 [2001311495]
5.6e-01
1.1e+00
1.8e+00
—
4.4e+00
3.4e+00
2.4e+00
cases:2.05%
controls:1.19%
cases:1.62%
controls:0.55%
cases:0.75%
controls:0.12%
—
—
cases:4.87%
controls:0.06%
cases:10.97%
controls:0.43%
cases:10.94%
controls:1.10%
33
191
1575
15887
26
88
1582
15990
12
20
1596
16058
—
78
10
1523
16042
168
67
1363
15586
142
152
1156
13606
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.1e-02
7.1e-01
3.4e+00
3.4e+00
2.9e+00
1.7e+00
9.5e-01
cases:6.78%
controls:6.46%
cases:6.53%
controls:3.33%
cases:12.62%
controls:0.49%
cases:0.93%
controls:0.03%
cases:9.12%
controls:0.57%
cases:14.11%
controls:3.04%
cases:21.80%
controls:9.74%
109
1039
1499
15039
105
535
1503
15543
203
78
1405
16000
15
5
1593
16073
146
92
1455
15960
216
476
1315
15177
283
1340
1015
12418
Upper gastrointestinal surgery
106 [44777669]
2.1e-01
1.4e+00
3.2e+00
4.8e+00
1.9e+00
9.0e-01
6.3e-01
cases:11.50%
controls:9.52%
cases:14.43%
controls:3.99%
cases:13.31%
controls:0.65%
cases:3.67%
controls:0.03%
cases:3.37%
controls:0.54%
cases:8.69%
controls:3.73%
cases:18.49%
controls:10.79%
185
1530
1423
14548
232
642
1376
15436
214
104
1394
15974
59
5
1549
16073
54
87
1547
15965
133
584
1398
15069
240
1485
1058
12273
Bone marrow biopsy
XW000 [2001310618]
1.6e+00
2.9e+00
—
1.0e+50
—
5.0e+00
3.3e+00
cases:1.93%
controls:0.41%
cases:2.99%
controls:0.17%
—
—
cases:5.85%
controls:0.00%
—
—
cases:8.36%
controls:0.06%
cases:8.71%
controls:0.36%
31
66
1577
16012
48
27
1560
16051
—
94
0
1514
16078
—
128
10
1403
15643
113
49
1185
13709
Mantle cell lymphoma
C83.1 [45542646]
2.5e+00
3.3e+00
—
—
—
3.2e+00
3.7e+00
cases:0.87%
controls:0.07%
cases:1.18%
controls:0.04%
—
—
—
—
—
—
cases:1.57%
controls:0.06%
cases:2.00%
controls:0.05%
14
12
1594
16066
19
7
1589
16071
—
—
—
24
10
1507
15643
26
7
1272
13751
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
-3.8e-03
7.9e-01
2.9e+00
3.5e+00
2.6e+00
1.7e+00
1.2e+00
cases:19.15%
controls:19.21%
cases:23.76%
controls:12.36%
cases:29.98%
controls:2.36%
cases:3.92%
controls:0.12%
cases:24.55%
controls:2.39%
cases:44.28%
controls:12.77%
cases:55.78%
controls:28.03%
308
3089
1300
12989
382
1988
1226
14090
482
379
1126
15699
63
20
1545
16058
393
384
1208
15668
678
1999
853
13654
724
3856
574
9902
Bone marrow Pathology biopsy report
33721-2 [3045142]
1.6e+00
2.8e+00
—
1.0e+50
—
4.9e+00
3.2e+00
cases:1.12%
controls:0.22%
cases:1.12%
controls:0.07%
—
—
cases:1.12%
controls:0.00%
—
—
cases:4.90%
controls:0.04%
cases:5.55%
controls:0.23%
18
35
1590
16043
18
11
1590
16067
—
18
0
1590
16078
—
75
6
1456
15647
72
32
1226
13726
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
7.3e-02
1.0e+00
3.1e+00
4.1e+00
2.2e+00
1.2e+00
8.4e-01
cases:19.40%
controls:18.29%
cases:23.51%
controls:10.08%
cases:24.56%
controls:1.39%
cases:2.67%
controls:0.04%
cases:11.31%
controls:1.36%
cases:26.06%
controls:9.67%
cases:44.61%
controls:25.75%
312
2940
1296
13138
378
1621
1230
14457
395
224
1213
15854
43
7
1565
16071
181
218
1420
15834
399
1514
1132
14139
579
3542
719
10216
Localized swelling, mass and lump, neck
R22.1 [45592412]
1.6e+00
4.5e+00
—
1.0e+50
2.5e+00
2.1e+00
1.6e+00
cases:1.68%
controls:0.33%
cases:5.97%
controls:0.07%
—
—
cases:0.75%
controls:0.00%
cases:0.44%
controls:0.04%
cases:0.91%
controls:0.11%
cases:1.54%
controls:0.33%
27
53
1581
16025
96
11
1512
16067
—
12
0
1596
16078
7
6
1594
16046
14
17
1517
15636
20
45
1278
13713
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.1e-01
9.8e-01
4.4e+00
1.0e+50
3.9e+00
1.5e+00
1.2e+00
cases:6.53%
controls:5.34%
cases:6.72%
controls:2.62%
cases:21.27%
controls:0.33%
cases:2.86%
controls:0.00%
cases:13.87%
controls:0.32%
cases:10.91%
controls:2.66%
cases:22.50%
controls:7.69%
105
858
1503
15220
108
421
1500
15657
342
53
1266
16025
46
0
1562
16078
222
51
1379
16001
167
416
1364
15237
292
1058
1006
12700
Drug-induced neutropenia
D70.82 [2000501376]
2.2e+00
1.8e+00
—
—
1.0e+50
4.5e+00
3.5e+00
cases:0.68%
controls:0.07%
cases:0.44%
controls:0.07%
—
—
—
—
cases:0.87%
controls:0.00%
cases:2.87%
controls:0.03%
cases:2.93%
controls:0.09%
11
12
1597
16066
7
12
1601
16066
—
—
14
0
1587
16052
44
5
1487
15648
38
12
1260
13746
Fever, unspecified
R50.9 [45582716]
6.3e-01
1.2e+00
2.9e+00
—
3.1e+00
2.6e+00
1.5e+00
cases:2.49%
controls:1.34%
cases:1.68%
controls:0.52%
cases:1.06%
controls:0.06%
—
—
cases:1.56%
controls:0.07%
cases:6.53%
controls:0.52%
cases:7.86%
controls:1.87%
40
215
1568
15863
27
83
1581
15995
17
9
1591
16069
—
25
12
1576
16040
100
82
1431
15571
102
257
1196
13501
Short blood count panel - Blood
55429-5 [40758558]
1.2e-01
7.0e-01
2.5e+00
3.4e+00
2.4e+00
1.6e+00
1.2e+00
cases:5.97%
controls:5.32%
cases:6.16%
controls:3.17%
cases:7.21%
controls:0.63%
cases:1.12%
controls:0.04%
cases:6.18%
controls:0.61%
cases:12.87%
controls:3.02%
cases:21.80%
controls:7.65%
96
855
1512
15223
99
509
1509
15569
116
101
1492
15977
18
6
1590
16072
99
98
1502
15954
197
472
1334
15181
283
1052
1015
12706
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.0e+00
7.9e-01
3.1e+00
—
3.1e+00
3.0e+00
2.4e+00
cases:0.75%
controls:0.27%
cases:0.44%
controls:0.20%
cases:0.68%
controls:0.03%
—
—
cases:0.94%
controls:0.04%
cases:3.46%
controls:0.17%
cases:4.93%
controls:0.49%
12
44
1596
16034
7
32
1601
16046
11
5
1597
16073
—
15
7
1586
16045
53
27
1478
15626
64
67
1234
13691
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-6.7e-02
7.2e-01
2.8e+00
3.7e+00
2.5e+00
1.1e+00
6.8e-01
cases:9.64%
controls:10.24%
cases:11.50%
controls:5.97%
cases:14.18%
controls:1.04%
cases:1.80%
controls:0.04%
cases:10.56%
controls:0.95%
cases:17.05%
controls:6.39%
cases:28.51%
controls:16.86%
155
1646
1453
14432
185
960
1423
15118
228
168
1380
15910
29
7
1579
16071
169
153
1432
15899
261
1000
1270
14653
370
2319
928
11439
General Surgery
2 [38004447]
7.4e-02
1.3e+00
3.1e+00
4.7e+00
1.5e+00
5.0e-01
3.7e-01
cases:20.09%
controls:18.93%
cases:17.54%
controls:5.68%
cases:14.80%
controls:0.78%
cases:3.30%
controls:0.03%
cases:3.56%
controls:0.79%
cases:8.36%
controls:5.24%
cases:20.11%
controls:14.84%
323
3044
1285
13034
282
914
1326
15164
238
125
1370
15953
53
5
1555
16073
57
127
1544
15925
128
820
1403
14833
261
2041
1037
11717
Chemotherapy session for neoplasm
Z51.1 [45595526]
2.1e+00
2.3e+00
—
—
—
4.3e+00
2.7e+00
cases:0.62%
controls:0.07%
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:2.81%
controls:0.04%
cases:2.16%
controls:0.15%
10
12
1598
16066
6
6
1602
16072
—
—
—
43
6
1488
15647
28
21
1270
13737
pH of Serum or Plasma
2753-2 [3018418]
-4.3e-02
7.2e-01
2.5e+00
3.4e+00
2.5e+00
1.3e+00
8.9e-01
cases:5.41%
controls:5.64%
cases:6.53%
controls:3.29%
cases:7.40%
controls:0.63%
cases:1.24%
controls:0.04%
cases:6.00%
controls:0.53%
cases:11.43%
controls:3.55%
cases:19.95%
controls:9.32%
87
906
1521
15172
105
529
1503
15549
119
102
1489
15976
20
7
1588
16071
96
85
1505
15967
175
555
1356
15098
259
1282
1039
12476
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
8.9e-01
1.8e+00
3.8e+00
—
—
3.1e+00
2.4e+00
cases:0.50%
controls:0.21%
cases:0.68%
controls:0.12%
cases:1.43%
controls:0.03%
—
—
—
—
cases:2.29%
controls:0.10%
cases:3.47%
controls:0.32%
8
33
1600
16045
11
19
1597
16059
23
5
1585
16073
—
—
35
16
1496
15637
45
44
1253
13714
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-1.5e-01
7.0e-01
2.7e+00
3.3e+00
2.5e+00
1.1e+00
7.4e-01
cases:8.08%
controls:9.30%
cases:10.07%
controls:5.28%
cases:12.94%
controls:0.95%
cases:1.55%
controls:0.06%
cases:8.93%
controls:0.82%
cases:14.96%
controls:5.61%
cases:26.04%
controls:14.41%
130
1496
1478
14582
162
849
1446
15229
208
152
1400
15926
25
9
1583
16069
143
131
1458
15921
229
878
1302
14775
338
1983
960
11775
prednisone; oral
H02AB07 [21602735]
6.6e-01
1.2e+00
1.9e+00
—
3.6e+00
2.3e+00
1.4e+00
cases:3.79%
controls:2.00%
cases:2.05%
controls:0.64%
cases:0.75%
controls:0.11%
—
—
cases:5.06%
controls:0.15%
cases:5.88%
controls:0.59%
cases:5.32%
controls:1.37%
61
322
1547
15756
33
103
1575
15975
12
18
1596
16060
—
81
24
1520
16028
90
93
1441
15560
69
188
1229
13570
prednisone
A07EA03 [21600655]
6.6e-01
1.2e+00
1.9e+00
—
3.6e+00
2.3e+00
1.4e+00
cases:3.79%
controls:2.00%
cases:2.05%
controls:0.64%
cases:0.75%
controls:0.11%
—
—
cases:5.06%
controls:0.15%
cases:5.88%
controls:0.59%
cases:5.32%
controls:1.37%
61
322
1547
15756
33
103
1575
15975
12
18
1596
16060
—
81
24
1520
16028
90
93
1441
15560
69
188
1229
13570
Blasts/Leukocytes in Blood
26446-5 [3025159]
8.1e-01
1.1e+00
3.0e+00
—
2.7e+00
2.1e+00
1.4e+00
cases:1.62%
controls:0.73%
cases:2.24%
controls:0.75%
cases:3.17%
controls:0.16%
—
—
cases:2.87%
controls:0.21%
cases:6.34%
controls:0.82%
cases:10.02%
controls:2.78%
26
117
1582
15961
36
120
1572
15958
51
26
1557
16052
—
46
33
1555
16019
97
129
1434
15524
130
382
1168
13376
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.6e-01
1.4e+00
3.2e+00
—
3.6e+00
1.8e+00
1.1e+00
cases:1.49%
controls:1.27%
cases:2.80%
controls:0.70%
cases:2.18%
controls:0.09%
—
—
cases:3.75%
controls:0.11%
cases:3.59%
controls:0.63%
cases:7.24%
controls:2.61%
24
204
1584
15874
45
113
1563
15965
35
15
1573
16063
—
60
17
1541
16035
55
99
1476
15554
94
359
1204
13399
Bacterial infection, unspecified
A49.9 [45590816]
2.8e-01
1.2e+00
2.2e+00
—
3.5e+00
2.7e+00
1.4e+00
cases:1.37%
controls:1.04%
cases:1.49%
controls:0.46%
cases:0.50%
controls:0.06%
—
—
cases:1.87%
controls:0.06%
cases:6.07%
controls:0.44%
cases:6.32%
controls:1.67%
22
167
1586
15911
24
74
1584
16004
8
9
1600
16069
—
30
9
1571
16043
93
69
1438
15584
82
230
1216
13528
CD3 cells [#/volume] in Blood
8122-4 [3011412]
1.1e+00
2.4e+00
—
1.0e+50
1.0e+50
4.8e+00
3.7e+00
cases:0.44%
controls:0.15%
cases:0.50%
controls:0.04%
—
—
cases:0.93%
controls:0.00%
cases:1.12%
controls:0.00%
cases:4.44%
controls:0.04%
cases:6.55%
controls:0.18%
7
24
1601
16054
8
7
1600
16071
—
15
0
1593
16078
18
0
1583
16052
68
6
1463
15647
85
25
1213
13733
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
8.3e-02
1.9e+00
2.6e+00
—
2.7e+00
2.5e+00
1.1e+00
cases:0.31%
controls:0.29%
cases:1.06%
controls:0.16%
cases:0.56%
controls:0.04%
—
—
cases:0.56%
controls:0.04%
cases:1.11%
controls:0.09%
cases:1.00%
controls:0.32%
5
46
1603
16032
17
25
1591
16053
9
7
1599
16071
—
9
6
1592
16046
17
14
1514
15639
13
44
1285
13714
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
1.1e-01
8.2e-01
4.0e+00
—
3.1e+00
1.8e+00
1.0e+00
cases:3.79%
controls:3.42%
cases:3.92%
controls:1.77%
cases:11.38%
controls:0.22%
—
—
cases:6.25%
controls:0.29%
cases:9.01%
controls:1.55%
cases:14.02%
controls:5.64%
61
550
1547
15528
63
284
1545
15794
183
36
1425
16042
—
100
46
1501
16006
138
242
1393
15411
182
776
1116
12982
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
3.3e-01
1.1e+00
3.3e+00
—
3.6e+00
1.8e+00
1.0e+00
cases:1.93%
controls:1.40%
cases:2.11%
controls:0.70%
cases:4.23%
controls:0.16%
—
—
cases:3.44%
controls:0.10%
cases:4.51%
controls:0.77%
cases:6.16%
controls:2.30%
31
225
1577
15853
34
112
1574
15966
68
26
1540
16052
—
55
16
1546
16036
69
121
1462
15532
80
317
1218
13441
Neck ultrasound examination
EP1AE [2001302284]
7.8e-01
3.1e+00
—
1.0e+50
2.5e+00
2.7e+00
2.5e+00
cases:1.12%
controls:0.52%
cases:3.79%
controls:0.17%
—
—
cases:0.37%
controls:0.00%
cases:0.37%
controls:0.03%
cases:2.22%
controls:0.15%
cases:7.09%
controls:0.63%
18
83
1590
15995
61
28
1547
16050
—
6
0
1602
16078
6
5
1595
16047
34
24
1497
15629
92
87
1206
13671
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
—
2.5e+00
—
1.0e+50
1.0e+50
4.7e+00
3.6e+00
—
—
cases:0.44%
controls:0.04%
—
—
cases:0.81%
controls:0.00%
cases:0.87%
controls:0.00%
cases:3.46%
controls:0.03%
cases:5.55%
controls:0.16%
—
7
6
1601
16072
—
13
0
1595
16078
14
0
1587
16052
53
5
1478
15648
72
22
1226
13736
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
8.4e-01
1.3e+00
3.0e+00
1.0e+50
—
3.5e+00
2.1e+00
cases:1.49%
controls:0.65%
cases:1.24%
controls:0.33%
cases:1.00%
controls:0.05%
cases:0.31%
controls:0.00%
—
—
cases:8.36%
controls:0.29%
cases:7.63%
controls:0.96%
24
105
1584
15973
20
53
1588
16025
16
8
1592
16070
5
0
1603
16078
—
128
45
1403
15608
99
132
1199
13626
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2.4e-01
1.1e+00
4.1e+00
1.0e+50
3.6e+00
8.0e-01
9.6e-01
cases:3.36%
controls:2.66%
cases:3.48%
controls:1.13%
cases:5.72%
controls:0.10%
cases:0.50%
controls:0.00%
cases:3.19%
controls:0.09%
cases:2.42%
controls:1.11%
cases:9.32%
controls:3.78%
54
428
1554
15650
56
182
1552
15896
92
16
1516
16062
8
0
1600
16078
51
14
1550
16038
37
173
1494
15480
121
520
1177
13238
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.9e-01
8.0e-01
2.6e+00
3.2e+00
2.1e+00
1.1e+00
8.3e-01
cases:9.14%
controls:7.70%
cases:13.68%
controls:6.62%
cases:17.79%
controls:1.53%
cases:2.11%
controls:0.09%
cases:12.43%
controls:1.69%
cases:18.68%
controls:7.40%
cases:29.35%
controls:15.35%
147
1238
1461
14840
220
1064
1388
15014
286
246
1322
15832
34
14
1574
16064
199
271
1402
15781
286
1159
1245
14494
381
2112
917
11646
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
4.2e-01
1.3e+00
3.1e+00
—
2.8e+00
1.8e+00
1.2e+00
cases:5.35%
controls:3.56%
cases:7.71%
controls:2.33%
cases:8.58%
controls:0.44%
—
—
cases:7.12%
controls:0.46%
cases:12.15%
controls:2.31%
cases:18.80%
controls:6.43%
86
573
1522
15505
124
375
1484
15703
138
70
1470
16008
—
114
74
1487
15978
186
362
1345
15291
244
884
1054
12874
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
6.7e-01
1.1e+00
3.0e+00
—
2.8e+00
2.2e+00
1.4e+00
cases:1.80%
controls:0.93%
cases:2.43%
controls:0.82%
cases:3.05%
controls:0.16%
—
—
cases:3.31%
controls:0.21%
cases:7.18%
controls:0.89%
cases:10.79%
controls:2.86%
29
150
1579
15928
39
132
1569
15946
49
25
1559
16053
—
53
33
1548
16019
110
139
1421
15514
140
393
1158
13365
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
48674-6 [3049539]
2.4e+00
4.1e+00
—
—
—
—
4.0e+00
cases:0.93%
controls:0.09%
cases:2.92%
controls:0.05%
—
—
—
—
—
—
—
—
cases:4.47%
controls:0.09%
15
14
1593
16064
47
8
1561
16070
—
—
—
—
58
12
1240
13746
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
—
2.3e+00
—
1.0e+50
1.0e+50
4.6e+00
3.6e+00
—
—
cases:0.44%
controls:0.04%
—
—
cases:0.87%
controls:0.00%
cases:1.00%
controls:0.00%
cases:3.53%
controls:0.04%
cases:5.70%
controls:0.17%
—
7
7
1601
16071
—
14
0
1594
16078
16
0
1585
16052
54
6
1477
15647
74
23
1224
13735
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.5e-01
1.1e+00
3.4e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:8.21%
controls:6.49%
cases:12.19%
controls:4.35%
cases:18.47%
controls:0.78%
—
—
cases:12.80%
controls:0.91%
cases:21.10%
controls:4.19%
cases:29.58%
controls:9.80%
132
1044
1476
15034
196
700
1412
15378
297
126
1311
15952
—
205
146
1396
15906
323
656
1208
14997
384
1348
914
12410
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
6.9e-01
1.1e+00
3.0e+00
—
2.8e+00
2.1e+00
1.4e+00
cases:1.74%
controls:0.88%
cases:2.36%
controls:0.78%
cases:2.99%
controls:0.16%
—
—
cases:3.12%
controls:0.21%
cases:6.53%
controls:0.85%
cases:10.55%
controls:2.76%
28
142
1580
15936
38
126
1570
15952
48
25
1560
16053
—
50
33
1551
16019
100
133
1431
15520
137
380
1161
13378
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
1.1e+00
2.5e+00
—
1.0e+50
1.0e+50
4.3e+00
3.6e+00
cases:0.31%
controls:0.11%
cases:0.44%
controls:0.04%
—
—
cases:0.87%
controls:0.00%
cases:1.19%
controls:0.00%
cases:3.59%
controls:0.05%
cases:5.78%
controls:0.17%
5
17
1603
16061
7
6
1601
16072
—
14
0
1594
16078
19
0
1582
16052
55
8
1476
15645
75
23
1223
13735
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4.0e-02
1.2e+00
3.0e+00
—
3.4e+00
1.6e+00
1.1e+00
cases:2.11%
controls:2.03%
cases:3.42%
controls:1.07%
cases:2.86%
controls:0.14%
—
—
cases:4.56%
controls:0.16%
cases:4.70%
controls:0.95%
cases:9.63%
controls:3.38%
34
327
1574
15751
55
172
1553
15906
46
23
1562
16055
—
73
26
1528
16026
72
149
1459
15504
125
465
1173
13293
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-1.0e-02
7.5e-01
2.5e+00
3.0e+00
2.2e+00
1.2e+00
6.5e-01
cases:28.05%
controls:28.26%
cases:32.34%
controls:18.47%
cases:32.03%
controls:3.86%
cases:5.41%
controls:0.29%
cases:26.61%
controls:3.73%
cases:45.07%
controls:19.22%
cases:56.93%
controls:40.73%
451
4543
1157
11535
520
2970
1088
13108
515
621
1093
15457
87
47
1521
16031
426
599
1175
15453
690
3009
841
12644
739
5604
559
8154
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
7.9e-01
8.4e-01
1.6e+00
—
4.3e+00
3.5e+00
2.5e+00
cases:0.44%
controls:0.20%
cases:0.37%
controls:0.16%
cases:0.31%
controls:0.06%
—
—
cases:3.50%
controls:0.05%
cases:7.64%
controls:0.26%
cases:4.55%
controls:0.37%
7
32
1601
16046
6
26
1602
16052
5
10
1603
16068
—
56
8
1545
16044
117
41
1414
15612
59
51
1239
13707
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
9.7e-02
8.7e-01
3.4e+00
—
3.0e+00
1.8e+00
1.0e+00
cases:3.05%
controls:2.77%
cases:3.05%
controls:1.29%
cases:6.09%
controls:0.22%
—
—
cases:5.25%
controls:0.26%
cases:7.12%
controls:1.23%
cases:10.63%
controls:4.19%
49
446
1559
15632
49
208
1559
15870
98
36
1510
16042
—
84
42
1517
16010
109
192
1422
15461
138
577
1160
13181
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
6.8e-01
9.9e-01
2.9e+00
—
2.6e+00
2.1e+00
1.4e+00
cases:1.62%
controls:0.83%
cases:1.93%
controls:0.73%
cases:2.74%
controls:0.15%
—
—
cases:2.62%
controls:0.19%
cases:6.07%
controls:0.81%
cases:10.17%
controls:2.59%
26
133
1582
15945
31
117
1577
15961
44
24
1564
16054
—
42
31
1559
16021
93
127
1438
15526
132
357
1166
13401
Lymphocytic lymphoma
C83.00 [2000501222]
2.1e+00
3.2e+00
—
—
—
3.3e+00
3.4e+00
cases:0.31%
controls:0.04%
cases:0.93%
controls:0.04%
—
—
—
—
—
—
cases:1.37%
controls:0.05%
cases:1.54%
controls:0.05%
5
6
1603
16072
15
6
1593
16072
—
—
—
21
8
1510
15645
20
7
1278
13751
Emergency Room Visit
ER [9203]
5.4e-02
7.1e-01
2.0e+00
3.8e+00
1.8e+00
1.1e+00
5.9e-01
cases:34.39%
controls:33.18%
cases:20.71%
controls:11.35%
cases:11.01%
controls:1.64%
cases:3.36%
controls:0.08%
cases:8.31%
controls:1.53%
cases:27.50%
controls:11.03%
cases:43.61%
controls:29.98%
553
5335
1055
10743
333
1825
1275
14253
177
263
1431
15815
54
13
1554
16065
133
246
1468
15806
421
1726
1110
13927
566
4125
732
9633
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-1.8e-01
6.2e-01
2.6e+00
3.3e+00
2.3e+00
8.1e-01
3.9e-01
cases:10.20%
controls:11.97%
cases:11.19%
controls:6.34%
cases:11.01%
controls:0.93%
cases:1.00%
controls:0.04%
cases:7.62%
controls:0.86%
cases:13.19%
controls:6.36%
cases:25.27%
controls:18.67%
164
1925
1444
14153
180
1019
1428
15059
177
149
1431
15929
16
6
1592
16072
122
138
1479
15914
202
995
1329
14658
328
2568
970
11190
ABO and Rh group [Type] in Blood
882-1 [3003694]
-1.3e-04
1.4e+00
4.2e+00
—
3.6e+00
7.7e-01
1.4e-01
cases:3.92%
controls:3.92%
cases:5.16%
controls:1.36%
cases:8.15%
controls:0.14%
—
—
cases:3.25%
controls:0.09%
cases:2.29%
controls:1.07%
cases:6.16%
controls:5.38%
63
630
1545
15448
83
219
1525
15859
131
22
1477
16056
—
52
15
1549
16037
35
168
1496
15485
80
740
1218
13018
Bacteria identified in Blood by Culture
600-7 [3023368]
-2.5e-01
3.8e-01
2.1e+00
2.3e+00
2.7e+00
1.7e+00
8.1e-01
cases:3.54%
controls:4.49%
cases:3.30%
controls:2.27%
cases:2.61%
controls:0.32%
cases:0.37%
controls:0.04%
cases:3.87%
controls:0.28%
cases:10.78%
controls:2.16%
cases:15.72%
controls:7.63%
57
722
1551
15356
53
365
1555
15713
42
52
1566
16026
6
6
1602
16072
62
45
1539
16007
165
338
1366
15315
204
1050
1094
12708
PET-CT of upper body metabolism
JN5DR [2001310926]
9.2e-01
2.3e+00
—
1.0e+50
1.0e+50
3.8e+00
3.4e+00
cases:0.31%
controls:0.12%
cases:0.50%
controls:0.05%
—
—
cases:1.37%
controls:0.00%
cases:1.00%
controls:0.00%
cases:1.63%
controls:0.04%
cases:1.77%
controls:0.06%
5
20
1603
16058
8
8
1600
16070
—
22
0
1586
16078
16
0
1585
16052
25
6
1506
15647
23
8
1275
13750
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.8e-01
1.8e+00
3.6e+00
1.0e+50
3.2e+00
3.2e-02
7.3e-01
cases:1.49%
controls:1.24%
cases:2.86%
controls:0.50%
cases:5.41%
controls:0.15%
cases:0.68%
controls:0.00%
cases:2.12%
controls:0.09%
cases:0.65%
controls:0.63%
cases:3.62%
controls:1.77%
24
200
1584
15878
46
81
1562
15997
87
24
1521
16054
11
0
1597
16078
34
14
1567
16038
10
99
1521
15554
47
244
1251
13514
Treatment plan or consultation
WZC00 [2001310885]
9.7e-02
5.0e-01
2.1e+00
—
3.4e+00
2.1e+00
1.2e+00
cases:5.66%
controls:5.16%
cases:3.42%
controls:2.11%
cases:2.55%
controls:0.31%
—
—
cases:8.68%
controls:0.31%
cases:13.65%
controls:1.97%
cases:17.80%
controls:6.19%
91
830
1517
15248
55
339
1553
15739
41
50
1567
16028
—
139
49
1462
16003
209
309
1322
15344
231
852
1067
12906
tinzaparin; parenteral
B01AB10 [21600981]
1.8e-01
9.5e-01
2.3e+00
—
3.1e+00
2.0e+00
9.4e-01
cases:0.93%
controls:0.78%
cases:1.12%
controls:0.44%
cases:1.18%
controls:0.12%
—
—
cases:1.44%
controls:0.07%
cases:3.27%
controls:0.46%
cases:3.85%
controls:1.55%
15
126
1593
15952
18
70
1590
16008
19
19
1589
16059
—
23
11
1578
16041
50
72
1481
15581
50
213
1248
13545
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
1.2e+00
2.4e+00
—
1.0e+50
—
4.0e+00
2.8e+00
cases:0.75%
controls:0.24%
cases:1.18%
controls:0.11%
—
—
cases:2.36%
controls:0.00%
—
—
cases:3.53%
controls:0.06%
cases:4.62%
controls:0.31%
12
38
1596
16040
19
17
1589
16061
—
38
0
1570
16078
—
54
10
1477
15643
60
42
1238
13716
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 [3013201]
9.2e-01
2.8e+00
—
1.0e+50
—
3.2e+00
3.3e+00
cases:0.31%
controls:0.12%
cases:0.81%
controls:0.05%
—
—
cases:0.68%
controls:0.00%
—
—
cases:1.50%
controls:0.06%
cases:3.31%
controls:0.13%
5
20
1603
16058
13
8
1595
16070
—
11
0
1597
16078
—
23
10
1508
15643
43
18
1255
13740
Thymidine kinase [Enzymatic activity/volume] in Serum
44934-8 [3045066]
—
2.9e+00
—
1.0e+50
—
3.1e+00
3.2e+00
—
—
cases:0.56%
controls:0.03%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.72%
controls:0.03%
cases:1.93%
controls:0.08%
—
9
5
1599
16073
—
5
0
1603
16078
—
11
5
1520
15648
25
11
1273
13747
Emergency Room and Inpatient Visit
ERIP [262]
-5.3e-02
5.6e-01
2.1e+00
3.7e+00
1.9e+00
9.8e-01
2.7e-01
cases:3.92%
controls:4.12%
cases:4.42%
controls:2.57%
cases:3.48%
controls:0.44%
cases:1.43%
controls:0.04%
cases:2.56%
controls:0.40%
cases:7.84%
controls:3.09%
cases:13.94%
controls:11.03%
63
663
1545
15415
71
414
1537
15664
56
70
1552
16008
23
6
1585
16072
41
65
1560
15987
120
483
1411
15170
181
1517
1117
12241
General anesthesia, balanced
WX408 [2001310808]
9.2e-02
1.6e+00
4.4e+00
—
1.7e+00
7.9e-01
6.7e-01
cases:4.66%
controls:4.27%
cases:5.16%
controls:1.11%
cases:5.53%
controls:0.07%
—
—
cases:0.50%
controls:0.09%
cases:1.70%
controls:0.78%
cases:4.16%
controls:2.17%
75
687
1533
15391
83
178
1525
15900
89
12
1519
16066
—
8
14
1593
16038
26
122
1505
15531
54
299
1244
13459
allopurinol; oral, parenteral
M04AA01 [21604131]
4.9e-01
7.4e-01
1.4e+00
—
3.4e+00
1.7e+00
1.4e+00
cases:5.29%
controls:3.31%
cases:4.91%
controls:2.41%
cases:2.86%
controls:0.73%
—
—
cases:16.49%
controls:0.62%
cases:11.50%
controls:2.43%
cases:13.64%
controls:3.73%
85
532
1523
15546
79
388
1529
15690
46
118
1562
15960
—
264
100
1337
15952
176
380
1355
15273
177
513
1121
13245
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
1.9e-02
1.2e+00
2.8e+00
—
2.7e+00
1.5e+00
9.0e-01
cases:2.05%
controls:2.02%
cases:2.80%
controls:0.89%
cases:1.99%
controls:0.12%
—
—
cases:1.94%
controls:0.13%
cases:3.98%
controls:0.89%
cases:5.86%
controls:2.46%
33
324
1575
15754
45
143
1563
15935
32
20
1576
16058
—
31
21
1570
16031
61
139
1470
15514
76
338
1222
13420
Medical doctor
Z2221 [2001311556]
3.1e-01
1.0e+00
2.2e+00
—
3.2e+00
1.4e+00
1.1e+00
cases:6.03%
controls:4.52%
cases:3.98%
controls:1.46%
cases:1.68%
controls:0.18%
—
—
cases:4.31%
controls:0.18%
cases:4.70%
controls:1.16%
cases:7.55%
controls:2.73%
97
726
1511
15352
64
234
1544
15844
27
29
1581
16049
—
69
29
1532
16023
72
181
1459
15472
98
376
1200
13382
Radiotherapy with large shaped fields - isocentric therapy
ZX012 [2001311468]
2.0e-01
—
—
—
3.1e+00
3.6e+00
2.3e+00
cases:0.75%
controls:0.61%
—
—
—
—
—
—
cases:0.94%
controls:0.04%
cases:4.51%
controls:0.13%
cases:3.00%
controls:0.31%
12
98
1596
15980
—
—
—
15
7
1586
16045
69
21
1462
15632
39
43
1259
13715
rituximab
L01FA01 [955167]
1.4e+00
1.7e+00
—
1.0e+50
—
4.7e+00
4.1e+00
cases:0.62%
controls:0.16%
cases:0.44%
controls:0.08%
—
—
cases:0.37%
controls:0.00%
—
—
cases:8.62%
controls:0.08%
cases:8.40%
controls:0.15%
10
26
1598
16052
7
13
1601
16065
—
6
0
1602
16078
—
132
13
1399
15640
109
20
1189
13738
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.9e-01
1.3e+00
2.2e+00
—
2.8e+00
1.6e+00
9.6e-01
cases:1.62%
controls:1.34%
cases:1.18%
controls:0.34%
cases:0.50%
controls:0.06%
—
—
cases:0.69%
controls:0.04%
cases:1.89%
controls:0.37%
cases:3.78%
controls:1.48%
26
215
1582
15863
19
54
1589
16024
8
9
1600
16069
—
11
7
1590
16045
29
58
1502
15595
49
203
1249
13555
Blood transfusion
WW500 [2001310603]
1.3e+00
1.8e+00
—
—
—
3.5e+00
2.2e+00
cases:0.81%
controls:0.22%
cases:0.68%
controls:0.12%
—
—
—
—
—
—
cases:3.53%
controls:0.11%
cases:3.31%
controls:0.38%
13
35
1595
16043
11
19
1597
16059
—
—
—
54
17
1477
15636
43
52
1255
13706
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-8.5e-03
4.7e-01
2.1e+00
3.1e+00
1.8e+00
7.9e-01
4.6e-01
cases:21.83%
controls:21.97%
cases:27.11%
controls:18.91%
cases:27.61%
controls:4.60%
cases:6.22%
controls:0.30%
cases:22.61%
controls:4.40%
cases:35.60%
controls:20.00%
cases:47.38%
controls:36.24%
351
3533
1257
12545
436
3041
1172
13037
444
740
1164
15338
100
48
1508
16030
362
706
1239
15346
545
3130
986
12523
615
4986
683
8772
Cathetrisation of vein
TPH04 [2001309597]
8.0e-02
1.1e+00
2.6e+00
—
2.5e+00
1.6e+00
9.5e-01
cases:3.17%
controls:2.94%
cases:3.17%
controls:1.12%
cases:1.99%
controls:0.15%
—
—
cases:0.87%
controls:0.07%
cases:4.96%
controls:1.00%
cases:8.86%
controls:3.63%
51
472
1557
15606
51
180
1557
15898
32
24
1576
16054
—
14
12
1587
16040
76
156
1455
15497
115
500
1183
13258
Office Visit
OMOP4822458 [581477]
2.0e-01
1.0e+00
2.7e+00
—
2.3e+00
1.7e+00
9.5e-01
cases:10.57%
controls:8.83%
cases:6.09%
controls:2.31%
cases:3.79%
controls:0.27%
—
—
cases:3.31%
controls:0.33%
cases:10.58%
controls:2.13%
cases:14.71%
controls:6.23%
170
1419
1438
14659
98
371
1510
15707
61
44
1547
16034
—
53
53
1548
15999
162
334
1369
15319
191
857
1107
12901
Ultrasound examination of groin and abdominal wall
JA1AE [2001304364]
—
2.8e+00
—
—
—
3.2e+00
2.6e+00
—
—
cases:0.62%
controls:0.04%
—
—
—
—
—
—
cases:0.78%
controls:0.03%
cases:1.77%
controls:0.13%
—
10
6
1598
16072
—
—
—
12
5
1519
15648
23
18
1275
13740
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
2.6e-01
1.7e+00
2.8e+00
1.0e+50
1.9e+00
1.2e+00
9.9e-01
cases:1.49%
controls:1.15%
cases:2.43%
controls:0.45%
cases:1.55%
controls:0.09%
cases:0.31%
controls:0.00%
cases:0.50%
controls:0.07%
cases:1.57%
controls:0.47%
cases:3.47%
controls:1.32%
24
185
1584
15893
39
73
1569
16005
25
15
1583
16063
5
0
1603
16078
8
12
1593
16040
24
74
1507
15579
45
181
1253
13577
Abdominal ultrasound examination
JN3AE [2001305555]
-2.7e-01
1.8e+00
2.4e+00
—
—
2.2e+00
2.2e+00
cases:1.18%
controls:1.55%
cases:2.74%
controls:0.45%
cases:0.56%
controls:0.05%
—
—
—
—
cases:4.31%
controls:0.52%
cases:12.87%
controls:1.62%
19
249
1589
15829
44
72
1564
16006
9
8
1599
16070
—
—
66
81
1465
15572
167
223
1131
13535
Other and unspecified abdominal pain
R10.4 [45568113]
3.6e-01
1.4e+00
3.2e+00
—
2.4e+00
7.2e-01
4.8e-01
cases:6.41%
controls:4.55%
cases:5.78%
controls:1.52%
cases:2.99%
controls:0.12%
—
—
cases:1.19%
controls:0.11%
cases:2.94%
controls:1.46%
cases:8.63%
controls:5.52%
103
731
1505
15347
93
244
1515
15834
48
20
1560
16058
—
19
17
1582
16035
45
228
1486
15425
112
759
1186
12999
Inpatient Visit
IP [9201]
1.3e-01
8.8e-01
3.1e+00
—
2.8e+00
1.3e+00
5.7e-01
cases:6.72%
controls:5.92%
cases:6.28%
controls:2.71%
cases:5.85%
controls:0.29%
—
—
cases:5.93%
controls:0.39%
cases:9.27%
controls:2.81%
cases:15.95%
controls:9.68%
108
952
1500
15126
101
436
1507
15642
94
47
1514
16031
—
95
62
1506
15990
142
440
1389
15213
207
1332
1091
12426
Bacteria identified in Isolate by Culture
43409-2 [3042936]
-2.7e-01
9.9e-01
2.7e+00
—
2.7e+00
1.4e+00
7.8e-01
cases:1.87%
controls:2.43%
cases:2.80%
controls:1.06%
cases:1.87%
controls:0.12%
—
—
cases:1.31%
controls:0.09%
cases:3.53%
controls:0.93%
cases:6.93%
controls:3.31%
30
390
1578
15688
45
170
1563
15908
30
20
1578
16058
—
21
15
1580
16037
54
145
1477
15508
90
456
1208
13302
General anaesthesia
WX402 [2001310806]
3.6e-01
1.3e+00
4.0e+00
1.0e+50
1.7e+00
8.0e-01
7.0e-01
cases:2.24%
controls:1.58%
cases:3.23%
controls:0.89%
cases:3.92%
controls:0.07%
cases:0.37%
controls:0.00%
cases:0.50%
controls:0.09%
cases:2.16%
controls:0.98%
cases:6.93%
controls:3.58%
36
254
1572
15824
52
143
1556
15935
63
12
1545
16066
6
0
1602
16078
8
15
1593
16037
33
153
1498
15500
90
492
1208
13266
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
5.4e-02
9.4e-01
2.9e+00
1.0e+50
2.2e+00
1.4e+00
9.8e-01
cases:1.93%
controls:1.83%
cases:1.87%
controls:0.73%
cases:1.74%
controls:0.09%
cases:0.50%
controls:0.00%
cases:0.75%
controls:0.09%
cases:3.27%
controls:0.79%
cases:6.78%
controls:2.66%
31
294
1577
15784
30
118
1578
15960
28
15
1580
16063
8
0
1600
16078
12
14
1589
16038
50
124
1481
15529
88
366
1210
13392
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.1e-02
4.7e-01
2.1e+00
2.7e+00
1.9e+00
7.8e-01
4.4e-01
cases:24.13%
controls:23.39%
cases:29.73%
controls:20.87%
cases:28.92%
controls:4.64%
cases:3.86%
controls:0.28%
cases:23.92%
controls:4.30%
cases:38.47%
controls:22.33%
cases:50.69%
controls:39.78%
388
3760
1220
12318
478
3356
1130
12722
465
746
1143
15332
62
45
1546
16033
383
690
1218
15362
589
3495
942
12158
658
5473
640
8285
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
6.1e-01
2.1e+00
—
—
—
3.8e+00
2.6e+00
cases:0.44%
controls:0.24%
cases:0.44%
controls:0.06%
—
—
—
—
—
—
cases:1.37%
controls:0.03%
cases:2.70%
controls:0.21%
7
38
1601
16040
7
9
1601
16069
—
—
—
21
5
1510
15648
35
29
1263
13729
enoxaparin; parenteral
B01AB05 [21600976]
7.3e-02
6.5e-01
2.6e+00
—
2.7e+00
1.6e+00
8.8e-01
cases:5.78%
controls:5.40%
cases:3.48%
controls:1.84%
cases:3.17%
controls:0.24%
—
—
cases:3.31%
controls:0.24%
cases:7.25%
controls:1.58%
cases:11.56%
controls:5.13%
93
868
1515
15210
56
296
1552
15782
51
39
1557
16039
—
53
38
1548
16014
111
248
1420
15405
150
706
1148
13052
Supplier / Service Provider
OMOP5117446 [33004]
-9.3e-01
-4.6e-01
1.2e+00
—
3.2e+00
2.8e+00
2.6e+00
cases:12.31%
controls:26.18%
cases:5.78%
controls:8.87%
cases:3.11%
controls:0.96%
—
—
cases:2.81%
controls:0.12%
cases:8.82%
controls:0.61%
cases:17.10%
controls:1.49%
198
4210
1410
11868
93
1426
1515
14652
50
155
1558
15923
—
45
19
1556
16033
135
95
1396
15558
222
205
1076
13553
Benign neoplasm: Parotid gland
D11.0 [45571596]
1.4e+00
4.0e+00
—
1.0e+50
—
2.7e+00
1.7e+00
cases:0.62%
controls:0.16%
cases:1.99%
controls:0.04%
—
—
cases:0.37%
controls:0.00%
—
—
cases:0.65%
controls:0.04%
cases:0.62%
controls:0.12%
10
26
1598
16052
32
6
1576
16072
—
6
0
1602
16078
—
10
7
1521
15646
8
16
1290
13742
Infiltration anesthesia
WX110 [2001310767]
1.4e-01
6.3e-01
2.7e+00
3.0e+00
1.2e+00
4.4e-01
4.1e-01
cases:19.22%
controls:17.20%
cases:12.56%
controls:7.08%
cases:10.57%
controls:0.80%
cases:1.24%
controls:0.06%
cases:2.37%
controls:0.75%
cases:10.19%
controls:6.78%
cases:27.73%
controls:20.24%
309
2766
1299
13312
202
1138
1406
14940
170
129
1438
15949
20
10
1588
16068
38
121
1563
15931
156
1062
1375
14591
360
2784
938
10974
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2.5e-01
1.7e+00
3.2e+00
—
1.9e+00
7.5e-01
7.9e-01
cases:1.80%
controls:1.41%
cases:3.42%
controls:0.65%
cases:3.36%
controls:0.14%
—
—
cases:1.00%
controls:0.16%
cases:1.63%
controls:0.78%
cases:4.55%
controls:2.12%
29
226
1579
15852
55
104
1553
15974
54
23
1554
16055
—
16
25
1585
16027
25
122
1506
15531
59
291
1239
13467
Granulocytes [#/volume] in Blood
30394-1 [3035715]
4.0e-01
1.1e+00
—
—
3.4e+00
2.6e+00
2.3e+00
cases:0.62%
controls:0.42%
cases:0.37%
controls:0.13%
—
—
—
—
cases:1.06%
controls:0.04%
cases:1.24%
controls:0.09%
cases:1.69%
controls:0.17%
10
67
1598
16011
6
21
1602
16057
—
—
17
6
1584
16046
19
14
1512
15639
22
24
1276
13734
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
1.3e+00
3.8e+00
—
—
—
2.0e+00
1.2e+00
cases:1.24%
controls:0.35%
cases:5.29%
controls:0.13%
—
—
—
—
—
—
cases:0.59%
controls:0.08%
cases:1.46%
controls:0.44%
20
57
1588
16021
85
21
1523
16057
—
—
—
9
12
1522
15641
19
60
1279
13698
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-8.1e-02
3.6e-01
2.2e+00
2.9e+00
1.9e+00
7.0e-01
2.6e-01
cases:31.28%
controls:33.05%
cases:33.58%
controls:26.05%
cases:30.72%
controls:4.77%
cases:4.04%
controls:0.24%
cases:24.92%
controls:4.65%
cases:43.24%
controls:27.54%
cases:56.86%
controls:50.30%
503
5314
1105
10764
540
4189
1068
11889
494
767
1114
15311
65
39
1543
16039
399
747
1202
15305
662
4311
869
11342
738
6920
560
6838
Adjuvant radiotherapy
WF003 [2001310702]
7.4e-02
—
-1.0e+50
—
2.6e+00
3.4e+00
2.3e+00
cases:0.44%
controls:0.40%
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.44%
controls:0.03%
cases:2.68%
controls:0.10%
cases:1.31%
controls:0.14%
7
65
1601
16013
—
0
5
1608
16073
—
7
5
1594
16047
41
15
1490
15638
17
19
1281
13739
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
3.7e-01
1.0e+00
—
—
3.3e+00
2.7e+00
2.2e+00
cases:0.68%
controls:0.47%
cases:0.37%
controls:0.14%
—
—
—
—
cases:1.19%
controls:0.04%
cases:1.44%
controls:0.10%
cases:1.93%
controls:0.22%
11
76
1597
16002
6
22
1602
16056
—
—
19
7
1582
16045
22
16
1509
15637
25
30
1273
13728
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
2.8e-01
7.4e-01
2.1e+00
—
2.2e+00
1.9e+00
1.2e+00
cases:3.23%
controls:2.47%
cases:1.62%
controls:0.78%
cases:0.87%
controls:0.11%
—
—
cases:0.94%
controls:0.11%
cases:5.09%
controls:0.83%
cases:9.40%
controls:3.04%
52
397
1556
15681
26
125
1582
15953
14
17
1594
16061
—
15
17
1586
16035
78
130
1453
15523
122
418
1176
13340
Scheduled procedure
ZXD10 [2001311387]
7.9e-02
1.1e+00
3.2e+00
—
1.6e+00
1.2e+00
9.2e-01
cases:7.34%
controls:6.82%
cases:5.47%
controls:1.82%
cases:6.34%
controls:0.27%
—
—
cases:0.81%
controls:0.16%
cases:4.18%
controls:1.36%
cases:8.47%
controls:3.55%
118
1096
1490
14982
88
292
1520
15786
102
43
1506
16035
—
13
26
1588
16026
64
213
1467
15440
110
488
1188
13270
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-1.8e-02
1.2e+00
3.2e+00
—
2.2e+00
9.4e-01
5.0e-01
cases:8.08%
controls:8.22%
cases:10.63%
controls:3.63%
cases:11.69%
controls:0.52%
—
—
cases:4.50%
controls:0.51%
cases:8.10%
controls:3.32%
cases:17.49%
controls:11.35%
130
1321
1478
14757
171
583
1437
15495
188
83
1420
15995
—
72
82
1529
15970
124
519
1407
15134
227
1561
1071
12197
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
1.5e-01
1.7e+00
3.3e+00
1.0e+50
3.0e+00
6.7e-01
7.5e-01
cases:0.68%
controls:0.59%
cases:1.31%
controls:0.24%
cases:1.18%
controls:0.04%
cases:0.31%
controls:0.00%
cases:0.62%
controls:0.03%
cases:0.52%
controls:0.27%
cases:1.46%
controls:0.70%
11
95
1597
15983
21
39
1587
16039
19
7
1589
16071
5
0
1603
16078
10
5
1591
16047
8
42
1523
15611
19
96
1279
13662
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-7.3e-02
4.0e-01
2.1e+00
2.8e+00
1.8e+00
6.7e-01
2.5e-01
cases:33.71%
controls:35.36%
cases:39.24%
controls:30.30%
cases:36.13%
controls:6.65%
cases:5.97%
controls:0.39%
cases:29.67%
controls:6.37%
cases:47.68%
controls:31.83%
cases:59.17%
controls:53.14%
542
5685
1066
10393
631
4871
977
11207
581
1069
1027
15009
96
62
1512
16016
475
1023
1126
15029
730
4983
801
10670
768
7311
530
6447
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
2.4e-01
1.7e+00
3.5e+00
—
2.8e+00
1.9e-01
3.1e-01
cases:0.87%
controls:0.68%
cases:1.62%
controls:0.30%
cases:1.55%
controls:0.05%
—
—
cases:0.62%
controls:0.04%
cases:0.46%
controls:0.38%
cases:1.46%
controls:1.08%
14
110
1594
15968
26
48
1582
16030
25
8
1583
16070
—
10
6
1591
16046
7
59
1524
15594
19
148
1279
13610
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
2.4e-01
1.7e+00
3.5e+00
—
2.8e+00
1.9e-01
3.1e-01
cases:0.87%
controls:0.68%
cases:1.62%
controls:0.30%
cases:1.55%
controls:0.05%
—
—
cases:0.62%
controls:0.04%
cases:0.46%
controls:0.38%
cases:1.46%
controls:1.08%
14
110
1594
15968
26
48
1582
16030
25
8
1583
16070
—
10
6
1591
16046
7
59
1524
15594
19
148
1279
13610
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2.4e-01
1.7e+00
3.5e+00
—
2.8e+00
1.9e-01
3.1e-01
cases:0.87%
controls:0.68%
cases:1.62%
controls:0.30%
cases:1.55%
controls:0.05%
—
—
cases:0.62%
controls:0.04%
cases:0.46%
controls:0.38%
cases:1.46%
controls:1.08%
14
110
1594
15968
26
48
1582
16030
25
8
1583
16070
—
10
6
1591
16046
7
59
1524
15594
19
148
1279
13610
dexamethasone; oral, parenteral
H02AB02 [21602730]
1.1e-01
3.8e-01
1.3e+00
1.0e+50
3.4e+00
2.2e+00
1.0e+00
cases:2.55%
controls:2.30%
cases:1.62%
controls:1.11%
cases:0.75%
controls:0.20%
cases:0.31%
controls:0.00%
cases:4.31%
controls:0.14%
cases:7.45%
controls:0.91%
cases:8.47%
controls:3.21%
41
370
1567
15708
26
178
1582
15900
12
32
1596
16046
5
0
1603
16078
69
23
1532
16029
114
142
1417
15511
110
441
1188
13317
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-1.6e-01
9.5e-01
2.7e+00
—
2.3e+00
1.2e+00
8.4e-01
cases:4.23%
controls:4.94%
cases:6.16%
controls:2.46%
cases:5.91%
controls:0.42%
—
—
cases:2.94%
controls:0.32%
cases:6.99%
controls:2.22%
cases:13.94%
controls:6.54%
68
795
1540
15283
99
396
1509
15682
95
67
1513
16011
—
47
51
1554
16001
107
347
1424
15306
181
900
1117
12858
Emergency Medicine
93 [38004510]
-7.7e-02
4.9e-01
1.8e+00
3.1e+00
1.4e+00
8.3e-01
2.4e-01
cases:11.88%
controls:12.71%
cases:10.82%
controls:6.93%
cases:5.85%
controls:0.98%
cases:1.12%
controls:0.05%
cases:4.18%
controls:1.05%
cases:16.07%
controls:7.70%
cases:27.50%
controls:22.90%
191
2043
1417
14035
174
1114
1434
14964
94
158
1514
15920
18
8
1590
16070
67
169
1534
15883
246
1206
1285
14447
357
3151
941
10607
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
5.1e-01
1.5e+00
3.4e+00
—
—
1.8e+00
1.2e+00
cases:0.87%
controls:0.52%
cases:1.37%
controls:0.31%
cases:1.12%
controls:0.04%
—
—
—
—
cases:1.05%
controls:0.17%
cases:2.47%
controls:0.76%
14
84
1594
15994
22
50
1586
16028
18
6
1590
16072
—
—
16
27
1515
15626
32
104
1266
13654
Thorax X-ray examination
GD1AA [2001303617]
2.4e-02
7.6e-01
2.2e+00
—
2.2e+00
1.6e+00
1.1e+00
cases:9.58%
controls:9.37%
cases:7.71%
controls:3.76%
cases:3.79%
controls:0.42%
—
—
cases:3.81%
controls:0.42%
cases:14.44%
controls:3.44%
cases:27.04%
controls:11.10%
154
1507
1454
14571
124
605
1484
15473
61
68
1547
16010
—
61
68
1540
15984
221
539
1310
15114
351
1527
947
12231
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
4.2e-01
1.8e+00
1.9e+00
—
2.6e+00
1.4e+00
7.7e-01
cases:0.31%
controls:0.21%
cases:0.62%
controls:0.10%
cases:0.44%
controls:0.06%
—
—
cases:1.00%
controls:0.07%
cases:0.78%
controls:0.20%
cases:1.08%
controls:0.50%
5
33
1603
16045
10
16
1598
16062
7
10
1601
16068
—
16
12
1585
16040
12
31
1519
15622
14
69
1284
13689
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-8.3e-02
3.6e-01
2.2e+00
2.9e+00
1.8e+00
5.2e-01
1.9e-01
cases:31.34%
controls:33.16%
cases:34.58%
controls:26.88%
cases:32.40%
controls:5.26%
cases:5.16%
controls:0.30%
cases:25.11%
controls:5.08%
cases:39.65%
controls:28.14%
cases:54.85%
controls:50.15%
504
5331
1104
10747
556
4322
1052
11756
521
845
1087
15233
83
49
1525
16029
402
815
1199
15237
607
4404
924
11249
712
6900
586
6858
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2.6e-01
1.7e+00
3.2e+00
—
2.8e+00
2.4e-03
3.6e-01
cases:0.87%
controls:0.67%
cases:1.55%
controls:0.28%
cases:1.24%
controls:0.05%
—
—
cases:0.50%
controls:0.03%
cases:0.33%
controls:0.33%
cases:1.31%
controls:0.92%
14
108
1594
15970
25
45
1583
16033
20
8
1588
16070
—
8
5
1593
16047
5
51
1526
15602
17
126
1281
13632
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2.4e-01
1.6e+00
3.3e+00
—
2.8e+00
2.6e-01
3.3e-01
cases:0.81%
controls:0.63%
cases:1.43%
controls:0.29%
cases:1.31%
controls:0.05%
—
—
cases:0.62%
controls:0.04%
cases:0.46%
controls:0.35%
cases:1.31%
controls:0.94%
13
102
1595
15976
23
47
1585
16031
21
8
1587
16070
—
10
6
1591
16046
7
55
1524
15598
17
130
1281
13628
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
1.8e-01
6.1e-01
1.6e+00
2.3e+00
1.8e+00
8.9e-01
5.0e-01
cases:6.59%
controls:5.55%
cases:5.35%
controls:2.98%
cases:2.74%
controls:0.57%
cases:0.37%
controls:0.04%
cases:2.44%
controls:0.42%
cases:7.77%
controls:3.34%
cases:15.49%
controls:9.98%
106
892
1502
15186
86
479
1522
15599
44
91
1564
15987
6
6
1602
16072
39
68
1562
15984
119
523
1412
15130
201
1373
1097
12385
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-7.9e-02
3.6e-01
2.1e+00
2.8e+00
1.8e+00
5.1e-01
1.8e-01
cases:31.65%
controls:33.38%
cases:34.83%
controls:27.22%
cases:32.46%
controls:5.39%
cases:5.16%
controls:0.33%
cases:25.30%
controls:5.16%
cases:39.84%
controls:28.54%
cases:55.16%
controls:50.56%
509
5367
1099
10711
560
4377
1048
11701
522
866
1086
15212
83
53
1525
16025
405
828
1196
15224
610
4467
921
11186
716
6956
582
6802
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
4.8e-01
4.8e-01
—
—
3.0e+00
2.7e+00
1.9e+00
cases:0.37%
controls:0.23%
cases:0.31%
controls:0.19%
—
—
—
—
cases:0.87%
controls:0.04%
cases:2.68%
controls:0.19%
cases:3.00%
controls:0.46%
6
37
1602
16041
5
31
1603
16047
—
—
14
7
1587
16045
41
29
1490
15624
39
63
1259
13695
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-2.4e-01
4.2e-01
2.2e+00
2.6e+00
1.6e+00
7.0e-01
1.3e-01
cases:6.28%
controls:7.84%
cases:5.91%
controls:3.96%
cases:4.73%
controls:0.52%
cases:0.50%
controls:0.04%
cases:3.06%
controls:0.60%
cases:7.38%
controls:3.81%
cases:13.79%
controls:12.32%
101
1261
1507
14817
95
637
1513
15441
76
84
1532
15994
8
6
1600
16072
49
97
1552
15955
113
596
1418
15057
179
1695
1119
12063
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
-3.5e-02
9.5e-01
3.0e+00
—
1.9e+00
1.1e+00
6.4e-01
cases:4.04%
controls:4.18%
cases:4.42%
controls:1.75%
cases:4.60%
controls:0.23%
—
—
cases:1.44%
controls:0.22%
cases:4.64%
controls:1.64%
cases:9.55%
controls:5.27%
65
672
1543
15406
71
281
1537
15797
74
37
1534
16041
—
23
35
1578
16017
71
256
1460
15397
124
725
1174
13033
Other and unspecified hydronephrosis
N13.3 [45553432]
—
1.8e+00
3.1e+00
—
—
2.7e+00
9.5e-01
—
—
cases:0.75%
controls:0.12%
cases:0.81%
controls:0.04%
—
—
—
—
cases:1.44%
controls:0.10%
cases:0.62%
controls:0.24%
—
12
19
1596
16059
13
6
1595
16072
—
—
22
16
1509
15637
8
33
1290
13725
Platelets [#/volume] in Blood
26515-7 [3007461]
-5.2e-02
3.8e-01
2.0e+00
2.9e+00
1.7e+00
6.1e-01
1.9e-01
cases:35.76%
controls:36.95%
cases:40.98%
controls:32.11%
cases:36.50%
controls:7.48%
cases:7.46%
controls:0.45%
cases:30.36%
controls:7.08%
cases:47.94%
controls:33.39%
cases:59.55%
controls:54.91%
575
5941
1033
10137
659
5163
949
10915
587
1202
1021
14876
120
73
1488
16005
486
1136
1115
14916
734
5227
797
10426
773
7555
525
6203
MCH [Entitic mass]
28539-5 [3035941]
-4.6e-02
3.9e-01
2.0e+00
2.9e+00
1.7e+00
6.1e-01
1.9e-01
cases:35.88%
controls:36.95%
cases:41.04%
controls:32.14%
cases:36.50%
controls:7.48%
cases:7.46%
controls:0.45%
cases:30.29%
controls:7.09%
cases:47.94%
controls:33.42%
cases:59.55%
controls:54.96%
577
5941
1031
10137
660
5167
948
10911
587
1203
1021
14875
120
73
1488
16005
485
1138
1116
14914
734
5232
797
10421
773
7562
525
6196
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-4.4e-02
3.8e-01
2.0e+00
2.9e+00
1.7e+00
6.0e-01
1.9e-01
cases:36.01%
controls:37.02%
cases:41.04%
controls:32.19%
cases:36.50%
controls:7.48%
cases:7.46%
controls:0.45%
cases:30.23%
controls:7.10%
cases:47.94%
controls:33.46%
cases:59.55%
controls:54.99%
579
5952
1029
10126
660
5175
948
10903
587
1203
1021
14875
120
73
1488
16005
484
1140
1117
14912
734
5238
797
10415
773
7565
525
6193
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-4.4e-02
3.9e-01
2.0e+00
2.9e+00
1.7e+00
6.0e-01
1.9e-01
cases:36.01%
controls:37.02%
cases:41.11%
controls:32.20%
cases:36.50%
controls:7.48%
cases:7.46%
controls:0.46%
cases:30.29%
controls:7.12%
cases:47.94%
controls:33.48%
cases:59.55%
controls:54.99%
579
5952
1029
10126
661
5177
947
10901
587
1203
1021
14875
120
74
1488
16004
485
1143
1116
14909
734
5240
797
10413
773
7565
525
6193
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-4.6e-02
3.9e-01
2.0e+00
2.9e+00
1.7e+00
6.0e-01
1.9e-01
cases:35.95%
controls:37.01%
cases:41.17%
controls:32.17%
cases:36.50%
controls:7.50%
cases:7.46%
controls:0.46%
cases:30.23%
controls:7.12%
cases:47.94%
controls:33.48%
cases:59.55%
controls:54.98%
578
5950
1030
10128
662
5173
946
10905
587
1206
1021
14872
120
74
1488
16004
484
1143
1117
14909
734
5241
797
10412
773
7564
525
6194
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
—
—
—
—
—
4.0e+00
3.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.76%
controls:0.03%
cases:3.08%
controls:0.09%
—
—
—
—
—
27
5
1504
15648
40
13
1258
13745
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-4.0e-02
3.8e-01
2.0e+00
2.9e+00
1.7e+00
6.1e-01
1.9e-01
cases:36.13%
controls:37.06%
cases:41.11%
controls:32.24%
cases:36.50%
controls:7.50%
cases:7.46%
controls:0.46%
cases:30.29%
controls:7.14%
cases:48.01%
controls:33.51%
cases:59.63%
controls:55.03%
581
5958
1027
10120
661
5183
947
10895
587
1206
1021
14872
120
74
1488
16004
485
1146
1116
14906
735
5245
796
10408
774
7571
524
6187
Anaemia, unspecified
D64.9 [45600610]
-3.0e-02
1.2e+00
2.4e+00
—
2.1e+00
1.1e+00
6.6e-01
cases:1.24%
controls:1.28%
cases:2.05%
controls:0.60%
cases:0.81%
controls:0.07%
—
—
cases:0.75%
controls:0.09%
cases:1.83%
controls:0.59%
cases:3.39%
controls:1.78%
20
206
1588
15872
33
97
1575
15981
13
12
1595
16066
—
12
15
1589
16037
28
92
1503
15561
44
245
1254
13513
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-4.7e-02
3.9e-01
2.0e+00
2.8e+00
1.7e+00
6.0e-01
1.9e-01
cases:35.95%
controls:37.04%
cases:41.23%
controls:32.21%
cases:36.57%
controls:7.52%
cases:7.40%
controls:0.47%
cases:30.36%
controls:7.14%
cases:47.94%
controls:33.47%
cases:59.55%
controls:55.02%
578
5956
1030
10122
663
5179
945
10899
588
1209
1020
14869
119
75
1489
16003
486
1146
1115
14906
734
5239
797
10414
773
7570
525
6188
Dentistry
C5 [903277]
3.2e-01
6.8e-01
1.8e+00
—
2.5e+00
2.1e+00
1.1e+00
cases:2.80%
controls:2.04%
cases:1.49%
controls:0.76%
cases:0.62%
controls:0.11%
—
—
cases:1.50%
controls:0.12%
cases:5.09%
controls:0.66%
cases:5.86%
controls:1.99%
45
328
1563
15750
24
122
1584
15956
10
17
1598
16061
—
24
20
1577
16032
78
103
1453
15550
76
274
1222
13484
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
5.3e-01
2.8e+00
—
1.0e+50
—
2.5e+00
2.2e+00
cases:0.50%
controls:0.29%
cases:1.18%
controls:0.07%
—
—
cases:0.93%
controls:0.00%
—
—
cases:1.50%
controls:0.12%
cases:2.16%
controls:0.25%
8
47
1600
16031
19
12
1589
16066
—
15
0
1593
16078
—
23
19
1508
15634
28
34
1270
13724
Clinic/Center
261Q00000X [38004207]
-3.8e-01
3.6e-01
—
—
3.2e+00
2.5e+00
1.7e+00
cases:0.56%
controls:0.81%
cases:0.44%
controls:0.30%
—
—
—
—
cases:1.94%
controls:0.08%
cases:3.46%
controls:0.28%
cases:3.00%
controls:0.54%
9
131
1599
15947
7
49
1601
16029
—
—
31
13
1570
16039
53
44
1478
15609
39
74
1259
13684
Other specified special examinations
Z01.8 [45581003]
8.2e-03
1.2e+00
2.9e+00
—
1.9e+00
8.7e-01
6.2e-01
cases:3.11%
controls:3.08%
cases:3.11%
controls:0.93%
cases:1.43%
controls:0.08%
—
—
cases:0.56%
controls:0.09%
cases:2.02%
controls:0.86%
cases:6.01%
controls:3.33%
50
496
1558
15582
50
150
1558
15928
23
13
1585
16065
—
9
14
1592
16038
31
134
1500
15519
78
458
1220
13300
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
1.9e-01
1.6e+00
3.2e+00
1.0e+50
2.7e+00
4.2e-01
5.4e-01
cases:0.75%
controls:0.62%
cases:1.31%
controls:0.26%
cases:1.31%
controls:0.06%
cases:0.31%
controls:0.00%
cases:0.62%
controls:0.04%
cases:0.52%
controls:0.34%
cases:1.46%
controls:0.86%
12
99
1596
15979
21
42
1587
16036
21
9
1587
16069
5
0
1603
16078
10
7
1591
16045
8
54
1523
15599
19
118
1279
13640
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
3.1e-01
2.5e+00
—
1.0e+50
—
2.6e+00
2.3e+00
cases:0.37%
controls:0.27%
cases:0.93%
controls:0.07%
—
—
cases:0.93%
controls:0.00%
—
—
cases:1.31%
controls:0.10%
cases:2.16%
controls:0.21%
6
44
1602
16034
15
12
1593
16066
—
15
0
1593
16078
—
20
16
1511
15637
28
29
1270
13729
Subcutaneous
ZX112 [2001311492]
5.5e-01
—
—
—
—
4.3e+00
3.1e+00
cases:0.31%
controls:0.18%
—
—
—
—
—
—
—
—
cases:3.59%
controls:0.05%
cases:3.85%
controls:0.17%
5
29
1603
16049
—
—
—
—
55
8
1476
15645
50
24
1248
13734
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-2.3e-01
9.0e-01
2.4e+00
—
2.4e+00
1.1e+00
6.2e-01
cases:2.24%
controls:2.81%
cases:2.61%
controls:1.08%
cases:1.74%
controls:0.16%
—
—
cases:0.87%
controls:0.08%
cases:2.74%
controls:0.95%
cases:7.09%
controls:3.95%
36
452
1572
15626
42
174
1566
15904
28
25
1580
16053
—
14
13
1587
16039
42
148
1489
15505
92
543
1206
13215
More than one and less than three hours
ZXE10 [2001311401]
1.3e-01
1.1e+00
3.1e+00
—
1.8e+00
6.6e-01
7.8e-01
cases:7.15%
controls:6.33%
cases:4.48%
controls:1.57%
cases:3.79%
controls:0.18%
—
—
cases:0.81%
controls:0.14%
cases:2.42%
controls:1.26%
cases:7.55%
controls:3.60%
115
1018
1493
15060
72
252
1536
15826
61
29
1547
16049
—
13
22
1588
16030
37
198
1494
15455
98
495
1200
13263
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
6.7e-01
2.8e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.56%
controls:0.29%
cases:1.18%
controls:0.07%
—
—
cases:1.06%
controls:0.00%
—
—
cases:1.44%
controls:0.12%
cases:2.08%
controls:0.25%
9
46
1599
16032
19
12
1589
16066
—
17
0
1591
16078
—
22
19
1509
15634
27
35
1271
13723
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.8e-02
9.2e-01
2.9e+00
—
1.9e+00
1.1e+00
6.4e-01
cases:6.28%
controls:5.89%
cases:6.28%
controls:2.61%
cases:6.41%
controls:0.39%
—
—
cases:2.12%
controls:0.34%
cases:6.21%
controls:2.21%
cases:12.94%
controls:7.25%
101
947
1507
15131
101
420
1507
15658
103
63
1505
16015
—
34
54
1567
15998
95
346
1436
15307
168
997
1130
12761
One hour or less
ZXE00 [2001311394]
2.4e-01
1.5e+00
3.7e+00
—
1.3e+00
1.2e+00
9.6e-01
cases:8.02%
controls:6.45%
cases:7.03%
controls:1.69%
cases:7.77%
controls:0.22%
—
—
cases:0.62%
controls:0.17%
cases:4.38%
controls:1.39%
cases:9.32%
controls:3.77%
129
1037
1479
15041
113
271
1495
15807
125
35
1483
16043
—
10
28
1591
16024
67
217
1464
15436
121
519
1177
13239
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
3.6e-01
1.7e+00
2.8e+00
—
—
1.4e+00
1.3e+00
cases:0.62%
controls:0.44%
cases:0.81%
controls:0.14%
cases:0.50%
controls:0.03%
—
—
—
—
cases:0.78%
controls:0.19%
cases:2.23%
controls:0.63%
10
70
1598
16008
13
23
1595
16055
8
5
1600
16073
—
—
12
30
1519
15623
29
87
1269
13671
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
-3.7e-01
5.0e-01
2.2e+00
—
2.3e+00
1.8e+00
9.4e-01
cases:0.87%
controls:1.26%
cases:1.24%
controls:0.76%
cases:0.87%
controls:0.10%
—
—
cases:1.19%
controls:0.12%
cases:4.31%
controls:0.73%
cases:7.78%
controls:3.20%
14
202
1594
15876
20
122
1588
15956
14
16
1594
16062
—
19
20
1582
16032
66
114
1465
15539
101
440
1197
13318
Extensive abdominal CT
JN3BD [2001305556]
2.8e-01
1.4e+00
2.8e+00
—
1.9e+00
2.0e+00
9.5e-01
cases:1.74%
controls:1.32%
cases:1.49%
controls:0.36%
cases:0.81%
controls:0.05%
—
—
cases:0.37%
controls:0.06%
cases:1.89%
controls:0.26%
cases:2.70%
controls:1.06%
28
212
1580
15866
24
58
1584
16020
13
8
1595
16070
—
6
9
1595
16043
29
41
1502
15612
35
146
1263
13612
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 [3014037]
—
—
—
1.0e+50
—
3.8e+00
3.4e+00
—
—
—
—
—
—
cases:0.75%
controls:0.00%
—
—
cases:2.48%
controls:0.06%
cases:3.08%
controls:0.11%
—
—
—
12
0
1596
16078
—
38
9
1493
15644
40
15
1258
13743
Very extensive body CT
JN4CD [2001310902]
8.3e-01
2.3e+00
—
1.0e+50
—
3.1e+00
1.7e+00
cases:1.00%
controls:0.44%
cases:1.31%
controls:0.13%
—
—
cases:0.87%
controls:0.00%
—
—
cases:1.11%
controls:0.05%
cases:1.08%
controls:0.20%
16
70
1592
16008
21
21
1587
16057
—
14
0
1594
16078
—
17
8
1514
15645
14
27
1284
13731
Chronic myeloid leukaemia [CML], BCR/ABL-positive
C92.1 [45576367]
2.2e+00
2.1e+00
—
—
—
2.3e+00
2.6e+00
cases:0.37%
controls:0.04%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.69%
controls:0.05%
6
7
1602
16071
5
6
1603
16072
—
—
—
6
6
1525
15647
9
7
1289
13751
Tissue Pathology biopsy report
66121-5 [40768804]
-7.9e-03
1.1e+00
3.2e+00
—
1.4e+00
7.0e-01
6.1e-01
cases:7.84%
controls:7.89%
cases:9.64%
controls:3.35%
cases:7.03%
controls:0.30%
—
—
cases:1.44%
controls:0.36%
cases:5.42%
controls:2.77%
cases:15.64%
controls:9.15%
126
1269
1482
14809
155
538
1453
15540
113
48
1495
16030
—
23
58
1578
15994
83
434
1448
15219
203
1259
1095
12499
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.6e-01
6.1e-01
1.5e+00
2.2e+00
1.6e+00
7.5e-01
4.5e-01
cases:7.03%
controls:6.08%
cases:6.28%
controls:3.53%
cases:2.92%
controls:0.67%
cases:0.37%
controls:0.04%
cases:2.50%
controls:0.52%
cases:8.10%
controls:3.98%
cases:16.87%
controls:11.48%
113
977
1495
15101
101
567
1507
15511
47
107
1561
15971
6
7
1602
16071
40
84
1561
15968
124
623
1407
15030
219
1579
1079
12179
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.3e-03
1.1e+00
2.6e+00
—
1.6e+00
9.9e-01
8.3e-01
cases:4.73%
controls:4.72%
cases:4.04%
controls:1.45%
cases:1.68%
controls:0.13%
—
—
cases:0.94%
controls:0.19%
cases:3.59%
controls:1.36%
cases:10.09%
controls:4.69%
76
759
1532
15319
65
233
1543
15845
27
21
1581
16057
—
15
31
1586
16021
55
213
1476
15440
131
645
1167
13113
Multidisciplinary treatment meeting
WZC20 [2001310890]
9.1e-01
2.0e+00
—
—
—
3.0e+00
2.0e+00
cases:1.06%
controls:0.43%
cases:1.93%
controls:0.27%
—
—
—
—
—
—
cases:3.79%
controls:0.20%
cases:5.01%
controls:0.68%
17
69
1591
16009
31
44
1577
16034
—
—
—
58
31
1473
15622
65
94
1233
13664
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.2e-01
5.6e-01
1.1e+00
3.6e+00
6.3e-01
8.5e-01
8.4e-01
cases:7.59%
controls:6.77%
cases:5.29%
controls:3.10%
cases:1.49%
controls:0.52%
cases:1.18%
controls:0.03%
cases:1.06%
controls:0.57%
cases:6.47%
controls:2.86%
cases:16.26%
controls:7.72%
122
1089
1486
14989
85
499
1523
15579
24
84
1584
15994
19
5
1589
16073
17
91
1584
15961
99
448
1432
15205
211
1062
1087
12696
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
5.8e-01
1.6e+00
1.0e+50
—
—
3.6e+00
3.3e+00
cases:0.31%
controls:0.17%
cases:0.37%
controls:0.07%
cases:0.50%
controls:0.00%
—
—
—
—
cases:2.81%
controls:0.08%
cases:5.24%
controls:0.20%
5
28
1603
16050
6
12
1602
16066
8
0
1600
16078
—
—
43
12
1488
15641
68
28
1230
13730
prednisolone; oral, parenteral
H02AB06 [21602734]
1.3e-01
4.3e-01
1.4e+00
1.0e+50
2.8e+00
1.6e+00
6.9e-01
cases:12.87%
controls:11.45%
cases:7.77%
controls:5.18%
cases:3.73%
controls:0.93%
cases:1.37%
controls:0.00%
cases:14.37%
controls:1.05%
cases:22.14%
controls:5.47%
cases:22.27%
controls:12.59%
207
1841
1401
14237
125
833
1483
15245
60
150
1548
15928
22
0
1586
16078
230
169
1371
15883
339
856
1192
14797
289
1732
1009
12026
prednisolone
A07EA01 [21600653]
1.3e-01
4.3e-01
1.4e+00
1.0e+50
2.8e+00
1.6e+00
6.9e-01
cases:12.87%
controls:11.49%
cases:7.77%
controls:5.19%
cases:3.73%
controls:0.93%
cases:1.37%
controls:0.00%
cases:14.37%
controls:1.06%
cases:22.21%
controls:5.49%
cases:22.42%
controls:12.62%
207
1847
1401
14231
125
834
1483
15244
60
150
1548
15928
22
0
1586
16078
230
170
1371
15882
340
859
1191
14794
291
1736
1007
12022
Sedation and analgesia
WX002 [2001310758]
1.1e-01
1.1e+00
3.2e+00
1.0e+50
2.0e+00
6.5e-01
5.5e-01
cases:3.17%
controls:2.85%
cases:2.18%
controls:0.75%
cases:2.30%
controls:0.09%
cases:0.56%
controls:0.00%
cases:0.56%
controls:0.07%
cases:1.44%
controls:0.75%
cases:3.85%
controls:2.27%
51
458
1557
15620
35
121
1573
15957
37
15
1571
16063
9
0
1599
16078
9
12
1592
16040
22
118
1509
15535
50
312
1248
13446
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
-5.1e-01
5.5e-01
2.1e+00
—
2.2e+00
1.7e+00
8.9e-01
cases:0.75%
controls:1.23%
cases:1.31%
controls:0.76%
cases:0.87%
controls:0.11%
—
—
cases:1.12%
controls:0.13%
cases:4.05%
controls:0.75%
cases:7.78%
controls:3.34%
12
198
1596
15880
21
122
1587
15956
14
18
1594
16060
—
18
21
1583
16031
62
117
1469
15536
101
460
1197
13298
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
6.6e-01
1.1e+00
—
—
2.5e+00
2.7e+00
1.7e+00
cases:0.31%
controls:0.16%
cases:0.44%
controls:0.15%
—
—
—
—
cases:0.37%
controls:0.03%
cases:1.70%
controls:0.12%
cases:2.85%
controls:0.55%
5
26
1603
16052
7
24
1601
16054
—
—
6
5
1595
16047
26
19
1505
15634
37
76
1261
13682
nystatin; oral
A07AA02 [21600604]
1.6e-01
7.7e-01
—
—
3.1e+00
2.4e+00
1.3e+00
cases:1.18%
controls:1.01%
cases:0.75%
controls:0.35%
—
—
—
—
cases:1.12%
controls:0.05%
cases:3.98%
controls:0.37%
cases:3.78%
controls:1.09%
19
162
1589
15916
12
56
1596
16022
—
—
18
8
1583
16044
61
58
1470
15595
49
150
1249
13608
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.7e-01
4.0e-01
9.5e-01
2.3e+00
1.6e+00
9.2e-01
6.2e-01
cases:20.77%
controls:18.04%
cases:15.11%
controls:10.64%
cases:5.91%
controls:2.38%
cases:0.93%
controls:0.09%
cases:11.37%
controls:2.49%
cases:24.04%
controls:11.22%
cases:34.82%
controls:22.37%
334
2901
1274
13177
243
1710
1365
14368
95
383
1513
15695
15
15
1593
16063
182
400
1419
15652
368
1756
1163
13897
452
3077
846
10681
Neutrophils [#/volume] in Blood
26499-4 [3017732]
4.1e-01
8.3e-01
2.4e+00
—
1.9e+00
9.2e-01
6.8e-01
cases:1.62%
controls:1.08%
cases:1.80%
controls:0.80%
cases:1.31%
controls:0.12%
—
—
cases:1.12%
controls:0.16%
cases:2.02%
controls:0.82%
cases:6.47%
controls:3.38%
26
173
1582
15905
29
128
1579
15950
21
19
1587
16059
—
18
26
1583
16026
31
128
1500
15525
84
465
1214
13293
Teaching
WZC30 [2001310891]
7.0e-02
6.4e-01
1.8e+00
—
2.5e+00
1.5e+00
1.0e+00
cases:2.05%
controls:1.92%
cases:1.74%
controls:0.93%
cases:1.12%
controls:0.19%
—
—
cases:1.94%
controls:0.16%
cases:3.98%
controls:0.95%
cases:7.40%
controls:2.86%
33
308
1575
15770
28
149
1580
15929
18
30
1590
16048
—
31
26
1570
16026
61
148
1470
15505
96
393
1202
13365
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
-1.1e-02
1.4e+00
3.0e+00
—
2.4e+00
8.1e-01
1.7e-01
cases:1.18%
controls:1.19%
cases:1.06%
controls:0.27%
cases:1.18%
controls:0.06%
—
—
cases:0.62%
controls:0.06%
cases:0.78%
controls:0.35%
cases:1.39%
controls:1.18%
19
192
1589
15886
17
43
1591
16035
19
10
1589
16068
—
10
9
1591
16043
12
55
1519
15598
18
162
1280
13596
INR in Blood by Coagulation assay
34714-6 [3032080]
-6.9e-02
6.2e-01
1.5e+00
2.1e+00
1.1e+00
8.1e-01
6.3e-01
cases:10.01%
controls:10.65%
cases:11.13%
controls:6.31%
cases:9.02%
controls:2.21%
cases:1.18%
controls:0.15%
cases:6.12%
controls:2.09%
cases:13.13%
controls:6.28%
cases:24.96%
controls:15.00%
161
1712
1447
14366
179
1014
1429
15064
145
355
1463
15723
19
24
1589
16054
98
335
1503
15717
201
983
1330
14670
324
2064
974
11694
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.1e-01
2.7e-01
1.7e+00
2.9e+00
1.5e+00
4.2e-01
-5.7e-03
cases:24.75%
controls:26.86%
cases:26.55%
controls:21.69%
cases:21.95%
controls:5.08%
cases:5.10%
controls:0.30%
cases:18.30%
controls:4.60%
cases:30.63%
controls:22.55%
cases:40.14%
controls:40.27%
398
4319
1210
11759
427
3488
1181
12590
353
817
1255
15261
82
49
1526
16029
293
739
1308
15313
469
3529
1062
12124
521
5541
777
8217
Diffuse large B-cell lymphoma
C83.3 [45600549]
3.3e+00
—
1.0e+50
—
—
—
3.4e+00
cases:1.18%
controls:0.04%
—
—
cases:0.44%
controls:0.00%
—
—
—
—
—
—
cases:1.93%
controls:0.07%
19
7
1589
16071
—
7
0
1601
16078
—
—
—
25
9
1273
13749
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
-3.7e-01
4.8e-01
1.9e+00
—
2.2e+00
1.8e+00
8.9e-01
cases:1.37%
controls:1.96%
cases:1.74%
controls:1.09%
cases:1.12%
controls:0.17%
—
—
cases:1.37%
controls:0.16%
cases:6.40%
controls:1.12%
cases:10.09%
controls:4.40%
22
315
1586
15763
28
175
1580
15903
18
28
1590
16050
—
22
26
1579
16026
98
175
1433
15478
131
605
1167
13153
Active surveillance of a diagnosed cancer
XZZ00 [2001311159]
—
—
—
1.0e+50
—
3.4e+00
3.3e+00
—
—
—
—
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.37%
controls:0.04%
cases:4.93%
controls:0.20%
—
—
—
20
0
1588
16078
—
21
7
1510
15646
64
27
1234
13731
Palliative radiotherapy
WF004 [2001310703]
—
-1.0e+50
—
—
—
3.6e+00
3.0e+00
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:1.63%
controls:0.04%
cases:3.39%
controls:0.17%
—
0
10
1608
16068
—
—
—
25
7
1506
15646
44
23
1254
13735
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
-5.0e-02
5.6e-01
2.1e+00
1.0e+50
2.4e+00
8.9e-01
6.6e-01
cases:7.03%
controls:7.36%
cases:3.42%
controls:1.99%
cases:1.12%
controls:0.14%
cases:0.56%
controls:0.00%
cases:2.19%
controls:0.20%
cases:4.77%
controls:2.01%
cases:12.87%
controls:7.06%
113
1184
1495
14894
55
320
1553
15758
18
22
1590
16056
9
0
1599
16078
35
32
1566
16020
73
315
1458
15338
167
972
1131
12786
oxycodone; oral, parenteral
N02AA05 [21604260]
-1.7e-01
4.2e-01
1.6e+00
—
2.3e+00
1.7e+00
9.8e-01
cases:1.31%
controls:1.55%
cases:1.62%
controls:1.07%
cases:2.18%
controls:0.43%
—
—
cases:3.56%
controls:0.39%
cases:5.88%
controls:1.11%
cases:8.78%
controls:3.48%
21
249
1587
15829
26
172
1582
15906
35
69
1573
16009
—
57
62
1544
15990
90
174
1441
15479
114
479
1184
13279
Plastic And Reconstructive Surgery
24 [38004467]
7.4e-02
1.6e+00
2.7e+00
1.0e+50
1.5e+00
7.1e-01
4.3e-01
cases:2.86%
controls:2.66%
cases:4.98%
controls:1.04%
cases:3.30%
controls:0.22%
cases:0.87%
controls:0.00%
cases:0.75%
controls:0.16%
cases:2.02%
controls:1.01%
cases:4.78%
controls:3.16%
46
428
1562
15650
80
167
1528
15911
53
36
1555
16042
14
0
1594
16078
12
26
1589
16026
31
158
1500
15495
62
435
1236
13323
CBC panel - Blood by Automated count
58410-2 [40761511]
-3.5e-02
2.9e-01
1.5e+00
2.9e+00
1.4e+00
4.1e-01
1.2e-01
cases:30.53%
controls:31.29%
cases:27.30%
controls:21.91%
cases:16.60%
controls:4.08%
cases:3.79%
controls:0.22%
cases:14.93%
controls:4.09%
cases:30.11%
controls:22.23%
cases:46.07%
controls:43.15%
491
5031
1117
11047
439
3523
1169
12555
267
656
1341
15422
61
35
1547
16043
239
657
1362
15395
461
3479
1070
12174
598
5937
700
7821
Ultrsound examination of soft tissue not elsewhere classified
QX2XE [2001310033]
4.6e-01
2.0e+00
—
—
—
2.3e+00
2.2e+00
cases:0.37%
controls:0.24%
cases:0.62%
controls:0.09%
—
—
—
—
—
—
cases:0.85%
controls:0.08%
cases:2.62%
controls:0.29%
6
38
1602
16040
10
14
1598
16064
—
—
—
13
13
1518
15640
34
40
1264
13718
Case Management Agency
251B00000X [38004193]
7.9e-02
3.0e-01
1.0e+00
3.4e+00
1.3e+00
4.1e-01
2.4e-01
cases:63.62%
controls:61.77%
cases:62.75%
controls:55.51%
cases:44.40%
controls:22.63%
cases:30.41%
controls:1.38%
cases:51.59%
controls:22.41%
cases:67.60%
controls:58.12%
cases:80.74%
controls:76.80%
1023
9932
585
6146
1009
8925
599
7153
714
3639
894
12439
489
222
1119
15856
826
3597
775
12455
1035
9097
496
6556
1048
10566
250
3192
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
-4.0e-02
3.8e-01
1.3e+00
2.1e+00
1.6e+00
7.1e-01
3.3e-01
cases:14.30%
controls:14.80%
cases:11.50%
controls:8.17%
cases:5.04%
controls:1.39%
cases:0.68%
controls:0.08%
cases:5.18%
controls:1.13%
cases:15.61%
controls:8.33%
cases:28.12%
controls:22.01%
230
2380
1378
13698
185
1314
1423
14764
81
223
1527
15855
11
13
1597
16065
83
181
1518
15871
239
1304
1292
14349
365
3028
933
10730
Multiple cystostatic therapy of methastized malignancy
WD115 [2001310679]
1.6e+00
—
—
1.0e+50
—
4.1e+00
2.4e+00
cases:0.37%
controls:0.07%
—
—
—
—
cases:0.50%
controls:0.00%
—
—
cases:2.87%
controls:0.05%
cases:2.16%
controls:0.20%
6
12
1602
16066
—
—
8
0
1600
16078
—
44
8
1487
15645
28
28
1270
13730
CT examination of mouth and soft tissues of neck
EN1AD [2001302280]
—
—
—
1.0e+50
—
3.8e+00
2.7e+00
—
—
—
—
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.37%
controls:0.03%
cases:1.23%
controls:0.09%
—
—
—
7
0
1601
16078
—
21
5
1510
15648
16
12
1282
13746
pH of Specimen
17433-4 [3019225]
-1.6e-01
6.3e-01
3.2e+00
—
2.6e+00
6.2e-01
3.8e-01
cases:2.05%
controls:2.39%
cases:2.30%
controls:1.24%
cases:3.61%
controls:0.16%
—
—
cases:2.25%
controls:0.17%
cases:2.22%
controls:1.21%
cases:4.24%
controls:2.93%
33
384
1575
15694
37
199
1571
15879
58
25
1550
16053
—
36
28
1565
16024
34
189
1497
15464
55
403
1243
13355
Exploration of lymph nodes
PJA10 [2001309626]
2.5e+00
—
1.0e+50
1.0e+50
—
—
3.9e+00
cases:0.93%
controls:0.07%
—
—
cases:7.52%
controls:0.00%
cases:0.37%
controls:0.00%
—
—
—
—
cases:3.31%
controls:0.07%
15
12
1593
16066
—
121
0
1487
16078
6
0
1602
16078
—
—
43
10
1255
13748
Laboratory Visit
OMOP4822461 [32036]
-3.1e-02
2.7e-01
1.6e+00
2.8e+00
1.4e+00
3.7e-01
1.2e-01
cases:39.24%
controls:39.97%
cases:44.96%
controls:38.29%
cases:41.48%
controls:12.73%
cases:10.70%
controls:0.74%
cases:35.10%
controls:12.03%
cases:49.51%
controls:40.46%
cases:61.33%
controls:58.33%
631
6427
977
9651
723
6157
885
9921
667
2047
941
14031
172
119
1436
15959
562
1931
1039
14121
758
6333
773
9320
796
8025
502
5733
Other technic of radiotherapy
ZX090 [2001311480]
2.8e-01
-1.0e+50
—
—
—
3.7e+00
2.5e+00
cases:0.44%
controls:0.33%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:1.57%
controls:0.04%
cases:1.08%
controls:0.09%
7
53
1601
16025
0
15
1608
16063
—
—
—
24
6
1507
15647
14
12
1284
13746
ranitidine; oral, parenteral
A02BA02 [21600083]
5.3e-01
7.0e-01
1.9e+00
—
2.4e+00
1.4e+00
4.8e-01
cases:3.48%
controls:2.08%
cases:1.43%
controls:0.72%
cases:0.81%
controls:0.12%
—
—
cases:1.25%
controls:0.11%
cases:2.22%
controls:0.57%
cases:1.93%
controls:1.20%
56
334
1552
15744
23
115
1585
15963
13
19
1595
16059
—
20
18
1581
16034
34
90
1497
15563
25
165
1273
13593
ranitidine bismuth citrate; oral
A02BA07 [21600088]
5.3e-01
7.0e-01
1.9e+00
—
2.4e+00
1.4e+00
4.8e-01
cases:3.48%
controls:2.08%
cases:1.43%
controls:0.72%
cases:0.81%
controls:0.12%
—
—
cases:1.25%
controls:0.11%
cases:2.22%
controls:0.57%
cases:1.93%
controls:1.20%
56
334
1552
15744
23
115
1585
15963
13
19
1595
16059
—
20
18
1581
16034
34
90
1497
15563
25
165
1273
13593
Demanding cystostatic therapy of methastized malignancy
WD135 [2001310681]
2.3e+00
—
—
1.0e+50
—
—
3.9e+00
cases:0.50%
controls:0.05%
—
—
—
—
cases:0.44%
controls:0.00%
—
—
—
—
cases:3.24%
controls:0.07%
8
8
1600
16070
—
—
7
0
1601
16078
—
—
42
9
1256
13749
Essential (primary) hypertension
I10 [45591453]
-3.2e-02
9.1e-02
9.5e-01
4.0e+00
1.2e+00
2.5e-01
-1.0e-02
cases:20.77%
controls:21.30%
cases:11.82%
controls:10.90%
cases:4.48%
controls:1.77%
cases:4.91%
controls:0.09%
cases:6.12%
controls:1.86%
cases:13.85%
controls:11.12%
cases:27.66%
controls:27.87%
334
3425
1274
12653
190
1753
1418
14325
72
285
1536
15793
79
15
1529
16063
98
298
1503
15754
212
1740
1319
13913
359
3834
939
9924
Pulmonary Disease
29 [38004472]
4.1e-02
5.7e-01
1.4e+00
3.2e+00
5.6e-01
4.7e-01
5.0e-01
cases:10.14%
controls:9.77%
cases:8.77%
controls:5.14%
cases:3.67%
controls:0.97%
cases:1.24%
controls:0.05%
cases:1.62%
controls:0.93%
cases:8.16%
controls:5.25%
cases:16.95%
controls:11.06%
163
1571
1445
14507
141
827
1467
15251
59
156
1549
15922
20
8
1588
16070
26
150
1575
15902
125
821
1406
14832
220
1522
1078
12236
Thrombocytopenia, unspecified
D69.6 [45581327]
1.5e+00
2.3e+00
—
—
—
2.6e+00
2.0e+00
cases:0.62%
controls:0.14%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.65%
controls:0.05%
cases:1.54%
controls:0.20%
10
22
1598
16056
5
5
1603
16073
—
—
—
10
8
1521
15645
20
28
1278
13730
Intravenous general anesthesia
WX404 [2001310807]
-1.4e-01
7.2e-01
3.1e+00
—
1.5e+00
1.0e+00
1.2e+00
cases:2.74%
controls:3.15%
cases:1.87%
controls:0.92%
cases:2.18%
controls:0.10%
—
—
cases:0.37%
controls:0.09%
cases:1.24%
controls:0.44%
cases:4.31%
controls:1.35%
44
506
1564
15572
30
148
1578
15930
35
16
1573
16062
—
6
14
1595
16038
19
69
1512
15584
56
186
1242
13572
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
-2.6e-02
6.0e-01
2.1e+00
2.2e+00
1.2e+00
1.9e-01
1.2e-01
cases:12.87%
controls:13.17%
cases:11.01%
controls:6.36%
cases:6.65%
controls:0.86%
cases:0.44%
controls:0.05%
cases:2.75%
controls:0.88%
cases:7.64%
controls:6.43%
cases:20.80%
controls:18.84%
207
2118
1401
13960
177
1022
1431
15056
107
139
1501
15939
7
8
1601
16070
44
141
1557
15911
117
1006
1414
14647
270
2592
1028
11166
dexamethasone and antiinfectives
S02CA06 [21605178]
-5.9e-02
6.3e-01
—
—
3.1e+00
2.0e+00
8.8e-01
cases:0.93%
controls:0.99%
cases:0.75%
controls:0.40%
—
—
—
—
cases:0.69%
controls:0.03%
cases:3.07%
controls:0.41%
cases:3.24%
controls:1.37%
15
159
1593
15919
12
64
1596
16014
—
—
11
5
1590
16047
47
64
1484
15589
42
188
1256
13570
Simple therapy of methastized malignancy with biomodifiers
WD305 [2001310685]
—
—
—
—
—
2.9e+00
3.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.04%
cases:2.08%
controls:0.10%
—
—
—
—
—
11
6
1520
15647
27
14
1271
13744
B-cell lymphoma in marginal zone
C83.80 [2000501237]
1.8e+00
2.4e+00
—
—
—
—
3.5e+00
cases:0.31%
controls:0.05%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.04%
5
8
1603
16070
8
7
1600
16071
—
—
—
—
19
6
1279
13752
Generalized enlarged lymph nodes
R59.1 [45563318]
2.3e+00
—
—
1.0e+50
1.0e+50
—
3.6e+00
cases:1.06%
controls:0.11%
—
—
—
—
cases:1.18%
controls:0.00%
cases:1.56%
controls:0.00%
—
—
cases:1.62%
controls:0.04%
17
17
1591
16061
—
—
19
0
1589
16078
25
0
1576
16052
—
21
6
1277
13752
Image guided radiotherapy
ZX080 [2001311479]
8.2e-01
—
—
—
—
3.0e+00
2.9e+00
cases:0.31%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.04%
cases:0.92%
controls:0.05%
5
22
1603
16056
—
—
—
—
12
6
1519
15647
12
7
1286
13751
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
-3.0e-01
6.5e-01
1.5e+00
—
2.2e+00
9.2e-01
6.9e-01
cases:1.99%
controls:2.68%
cases:2.74%
controls:1.45%
cases:1.37%
controls:0.32%
—
—
cases:2.69%
controls:0.32%
cases:3.79%
controls:1.54%
cases:7.32%
controls:3.81%
32
431
1576
15647
44
233
1564
15845
22
51
1586
16027
—
43
51
1558
16001
58
241
1473
15412
95
524
1203
13234
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
9.6e-02
4.4e-01
1.4e+00
2.3e+00
1.3e+00
4.4e-01
1.5e-01
cases:9.89%
controls:9.07%
cases:8.64%
controls:5.75%
cases:3.61%
controls:0.93%
cases:0.44%
controls:0.04%
cases:3.06%
controls:0.85%
cases:9.41%
controls:6.26%
cases:20.88%
controls:18.45%
159
1458
1449
14620
139
925
1469
15153
58
149
1550
15929
7
7
1601
16071
49
137
1552
15915
144
980
1387
14673
271
2539
1027
11219
valaciclovir; oral
J05AB11 [21603137]
4.4e-01
-4.6e-01
—
—
2.4e+00
2.0e+00
1.4e+00
cases:2.67%
controls:1.74%
cases:0.44%
controls:0.69%
—
—
—
—
cases:1.19%
controls:0.11%
cases:5.03%
controls:0.70%
cases:8.01%
controls:2.07%
43
280
1565
15798
7
111
1601
15967
—
—
19
17
1582
16035
77
110
1454
15543
104
285
1194
13473
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
1.1e-01
4.4e-01
1.4e+00
2.3e+00
1.3e+00
4.3e-01
1.3e-01
cases:10.32%
controls:9.35%
cases:8.83%
controls:5.85%
cases:3.61%
controls:0.93%
cases:0.44%
controls:0.04%
cases:3.06%
controls:0.87%
cases:9.47%
controls:6.38%
cases:20.88%
controls:18.78%
166
1503
1442
14575
142
940
1466
15138
58
150
1550
15928
7
7
1601
16071
49
140
1552
15912
145
999
1386
14654
271
2584
1027
11174
Pharmacy visit
OMOP4822462 [581458]
2.4e-01
4.7e-01
5.6e-01
1.4e+00
9.9e-01
1.0e+00
1.5e+00
cases:95.02%
controls:93.76%
cases:91.29%
controls:86.75%
cases:65.05%
controls:51.57%
cases:9.58%
controls:2.66%
cases:73.77%
controls:51.14%
cases:94.91%
controls:87.17%
cases:99.08%
controls:96.16%
1528
15075
80
1003
1468
13947
140
2131
1046
8292
562
7786
154
428
1454
15650
1181
8209
420
7843
1453
13645
78
2008
1286
13230
12
528
Radical radiotherapy
WF002 [2001310701]
5.3e-01
—
—
—
—
4.0e+00
1.8e+00
cases:0.81%
controls:0.48%
—
—
—
—
—
—
—
—
cases:7.71%
controls:0.15%
cases:3.08%
controls:0.51%
13
77
1595
16001
—
—
—
—
118
24
1413
15629
40
70
1258
13688
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
-3.0e-01
-4.8e-02
1.0e+00
3.5e+00
1.3e+00
3.2e-01
-5.1e-03
cases:4.91%
controls:6.55%
cases:3.30%
controls:3.45%
cases:1.55%
controls:0.58%
cases:1.43%
controls:0.04%
cases:2.19%
controls:0.62%
cases:5.16%
controls:3.79%
cases:8.78%
controls:8.82%
79
1053
1529
15025
53
555
1555
15523
25
93
1583
15985
23
7
1585
16071
35
100
1566
15952
79
594
1452
15059
114
1214
1184
12544
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
8.6e-02
4.2e-01
1.3e+00
2.3e+00
1.3e+00
4.1e-01
1.4e-01
cases:10.26%
controls:9.50%
cases:8.77%
controls:5.93%
cases:3.54%
controls:0.95%
cases:0.44%
controls:0.04%
cases:3.06%
controls:0.87%
cases:9.34%
controls:6.43%
cases:21.11%
controls:18.80%
165
1527
1443
14551
141
954
1467
15124
57
152
1551
15926
7
7
1601
16071
49
139
1552
15913
143
1006
1388
14647
274
2587
1024
11171
Whole body extensive metabolic PET with CT
JN4JR [2001310913]
2.5e+00
—
—
1.0e+50
1.0e+50
—
3.2e+00
cases:0.62%
controls:0.05%
—
—
—
—
cases:0.56%
controls:0.00%
cases:0.62%
controls:0.00%
—
—
cases:1.08%
controls:0.04%
10
8
1598
16070
—
—
9
0
1599
16078
10
0
1591
16052
—
14
6
1284
13752
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
7.0e-01
2.6e+00
3.2e+00
—
—
3.6e-01
1.3e-01
cases:1.37%
controls:0.68%
cases:2.74%
controls:0.21%
cases:0.87%
controls:0.04%
—
—
—
—
cases:0.39%
controls:0.27%
cases:1.31%
controls:1.15%
22
110
1586
15968
44
34
1564
16044
14
6
1594
16072
—
—
6
43
1525
15610
17
158
1281
13600
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
1.6e-01
6.3e-01
1.6e+00
—
2.1e+00
9.8e-01
4.2e-01
cases:2.61%
controls:2.23%
cases:2.74%
controls:1.48%
cases:1.31%
controls:0.27%
—
—
cases:1.50%
controls:0.18%
cases:4.05%
controls:1.56%
cases:7.24%
controls:4.90%
42
359
1566
15719
44
238
1564
15840
21
44
1587
16034
—
24
29
1577
16023
62
244
1469
15409
94
674
1204
13084
clozapine; oral, parenteral
N05AH02 [21604542]
1.2e+00
1.1e+00
1.3e+00
—
1.1e+00
1.0e+00
8.3e-01
cases:1.06%
controls:0.33%
cases:1.00%
controls:0.33%
cases:1.00%
controls:0.26%
—
—
cases:0.81%
controls:0.28%
cases:0.91%
controls:0.33%
cases:0.85%
controls:0.37%
17
53
1591
16025
16
53
1592
16025
16
42
1592
16036
—
13
45
1588
16007
14
52
1517
15601
11
51
1287
13707
Pathology report gross observation
24419-4 [3002256]
1.8e-01
1.1e+00
2.9e+00
—
—
8.3e-01
8.3e-01
cases:2.67%
controls:2.24%
cases:2.55%
controls:0.83%
cases:1.93%
controls:0.11%
—
—
—
—
cases:1.63%
controls:0.72%
cases:5.86%
controls:2.64%
43
360
1565
15718
41
134
1567
15944
31
17
1577
16061
—
—
25
113
1506
15540
76
363
1222
13395
Thorax extensive CT-examination
GD1BD [2001303621]
-1.1e-01
2.3e+00
—
1.0e+50
—
1.9e+00
1.5e+00
cases:0.56%
controls:0.62%
cases:1.24%
controls:0.13%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.65%
controls:0.10%
cases:1.77%
controls:0.39%
9
100
1599
15978
20
21
1588
16057
—
5
0
1603
16078
—
10
15
1521
15638
23
54
1275
13704
Radiotherapy of metastasis
WF049 [2001310705]
—
-1.0e+50
—
—
—
2.8e+00
2.9e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:1.89%
controls:0.12%
cases:4.39%
controls:0.25%
—
0
16
1608
16062
—
—
—
29
19
1502
15634
57
35
1241
13723
Enlarged lymph nodes, unspecified
R59.9 [45563319]
2.3e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.3e+00
cases:0.56%
controls:0.06%
—
—
cases:4.66%
controls:0.00%
cases:0.50%
controls:0.00%
cases:0.50%
controls:0.00%
—
—
cases:1.00%
controls:0.04%
9
9
1599
16069
—
75
0
1533
16078
8
0
1600
16078
8
0
1593
16052
—
13
5
1285
13753
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
-6.0e-01
4.2e-01
2.1e+00
—
2.6e+00
9.1e-01
-1.2e-02
cases:0.75%
controls:1.36%
cases:1.00%
controls:0.65%
cases:0.62%
controls:0.07%
—
—
cases:0.56%
controls:0.04%
cases:1.44%
controls:0.58%
cases:3.08%
controls:3.12%
12
218
1596
15860
16
105
1592
15973
10
12
1598
16066
—
9
7
1592
16045
22
91
1509
15562
40
429
1258
13329
Osmolality of Urine
2695-5 [3026782]
2.4e-01
6.2e-01
1.8e+00
—
1.8e+00
7.5e-01
6.4e-01
cases:5.10%
controls:4.07%
cases:3.11%
controls:1.70%
cases:1.55%
controls:0.27%
—
—
cases:1.31%
controls:0.22%
cases:3.72%
controls:1.79%
cases:8.71%
controls:4.77%
82
655
1526
15423
50
274
1558
15804
25
44
1583
16034
—
21
35
1580
16017
57
280
1474
15373
113
656
1185
13102
Bronchial lavation
TGC00 [2001303585]
1.1e+00
—
—
—
—
3.5e+00
2.1e+00
cases:0.50%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.03%
cases:1.85%
controls:0.24%
8
27
1600
16051
—
—
—
—
16
5
1515
15648
24
33
1274
13725
General Practice
1 [38004446]
-7.0e-02
7.6e-02
9.2e-01
2.8e+00
1.5e+00
3.6e-01
2.3e-01
cases:12.50%
controls:13.29%
cases:6.09%
controls:5.67%
cases:2.05%
controls:0.83%
cases:1.12%
controls:0.07%
cases:3.25%
controls:0.78%
cases:8.16%
controls:5.85%
cases:20.18%
controls:16.69%
201
2137
1407
13941
98
912
1510
15166
33
133
1575
15945
18
11
1590
16067
52
125
1549
15927
125
916
1406
14737
262
2296
1036
11462
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.0e-02
3.7e-01
1.3e+00
1.6e+00
1.2e+00
5.7e-01
4.4e-01
cases:35.39%
controls:34.71%
cases:26.06%
controls:19.64%
cases:12.31%
controls:3.77%
cases:0.75%
controls:0.15%
cases:11.93%
controls:3.74%
cases:30.70%
controls:20.03%
cases:53.54%
controls:42.64%
569
5580
1039
10498
419
3157
1189
12921
198
606
1410
15472
12
24
1596
16054
191
600
1410
15452
470
3136
1061
12517
695
5866
603
7892
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
2.2e-01
5.7e-01
1.4e+00
—
1.7e+00
1.0e+00
8.5e-01
cases:9.39%
controls:7.71%
cases:3.86%
controls:2.21%
cases:0.93%
controls:0.22%
—
—
cases:0.81%
controls:0.16%
cases:5.88%
controls:2.25%
cases:16.41%
controls:7.74%
151
1239
1457
14839
62
355
1546
15723
15
36
1593
16042
—
13
25
1588
16027
90
352
1441
15301
213
1065
1085
12693
Bacteria [Presence] in Urine
87829-8 [36304419]
1.8e-01
5.6e-01
1.6e+00
—
1.8e+00
9.1e-01
5.7e-01
cases:5.53%
controls:4.68%
cases:4.17%
controls:2.43%
cases:2.11%
controls:0.44%
—
—
cases:2.12%
controls:0.36%
cases:6.14%
controls:2.57%
cases:12.79%
controls:7.68%
89
753
1519
15325
67
391
1541
15687
34
70
1574
16008
—
34
58
1567
15994
94
403
1437
15250
166
1056
1132
12702
Abdominal CT examination
JN3AD [2001305554]
1.3e-01
1.2e+00
3.1e+00
—
2.1e+00
1.2e+00
4.5e-01
cases:0.87%
controls:0.77%
cases:1.31%
controls:0.40%
cases:1.06%
controls:0.05%
—
—
cases:0.31%
controls:0.04%
cases:1.50%
controls:0.48%
cases:3.62%
controls:2.34%
14
123
1594
15955
21
65
1587
16013
17
8
1591
16070
—
5
6
1596
16046
23
75
1508
15578
47
322
1251
13436
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
1.3e-01
4.1e-01
1.2e+00
2.6e+00
1.1e+00
3.3e-01
1.3e-01
cases:9.14%
controls:8.12%
cases:6.84%
controls:4.64%
cases:2.24%
controls:0.70%
cases:0.44%
controls:0.03%
cases:2.12%
controls:0.69%
cases:6.60%
controls:4.83%
cases:15.64%
controls:14.00%
147
1305
1461
14773
110
746
1498
15332
36
112
1572
15966
7
5
1601
16073
34
111
1567
15941
101
756
1430
14897
203
1926
1095
11832
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.7e-01
5.9e-01
1.5e+00
—
1.8e+00
9.0e-01
5.7e-01
cases:5.60%
controls:4.78%
cases:4.54%
controls:2.56%
cases:2.18%
controls:0.47%
—
—
cases:2.12%
controls:0.37%
cases:6.47%
controls:2.72%
cases:13.79%
controls:8.29%
90
768
1518
15310
73
411
1535
15667
35
76
1573
16002
—
34
60
1567
15992
99
426
1432
15227
179
1141
1119
12617
Obstetrics / Gynecology
16 [38004461]
5.4e-02
5.9e-01
1.3e+00
2.9e+00
5.8e-01
5.1e-01
1.5e-01
cases:8.46%
controls:8.05%
cases:5.41%
controls:3.06%
cases:1.87%
controls:0.50%
cases:0.56%
controls:0.03%
cases:1.06%
controls:0.60%
cases:5.36%
controls:3.30%
cases:10.02%
controls:8.75%
136
1294
1472
14784
87
492
1521
15586
30
81
1578
15997
9
5
1599
16073
17
96
1584
15956
82
516
1449
15137
130
1204
1168
12554
Oxygen saturation in Arterial blood
2708-6 [3016502]
-4.9e-01
3.7e-01
2.0e+00
—
2.4e+00
8.6e-01
4.8e-02
cases:0.93%
controls:1.52%
cases:1.00%
controls:0.69%
cases:0.62%
controls:0.08%
—
—
cases:0.69%
controls:0.06%
cases:1.50%
controls:0.64%
cases:3.31%
controls:3.16%
15
244
1593
15834
16
111
1592
15967
10
13
1598
16065
—
11
10
1590
16042
23
100
1508
15553
43
435
1255
13323
Doppler ultrasound examination of heart
FM1DE [2001303299]
2.3e-01
7.2e-01
—
1.0e+50
2.7e+00
1.3e+00
1.3e+00
cases:1.99%
controls:1.59%
cases:1.24%
controls:0.61%
—
—
cases:0.68%
controls:0.00%
cases:1.00%
controls:0.07%
cases:2.22%
controls:0.59%
cases:5.24%
controls:1.50%
32
256
1576
15822
20
98
1588
15980
—
11
0
1597
16078
16
11
1585
16041
34
93
1497
15560
68
206
1230
13552
Spread to lymph node
OMOP4998263 [36768587]
—
1.7e+00
2.2e+00
—
—
1.4e+00
9.2e-01
—
—
cases:0.75%
controls:0.14%
cases:0.75%
controls:0.08%
—
—
—
—
cases:0.65%
controls:0.16%
cases:0.62%
controls:0.25%
—
12
23
1596
16055
12
13
1596
16065
—
—
10
25
1521
15628
8
34
1290
13724
Gastroenterology
10 [38004455]
3.4e-02
9.9e-01
1.6e+00
—
1.2e+00
8.1e-01
7.0e-01
cases:5.72%
controls:5.54%
cases:5.72%
controls:2.20%
cases:2.11%
controls:0.43%
—
—
cases:1.12%
controls:0.35%
cases:4.70%
controls:2.15%
cases:12.94%
controls:6.88%
92
891
1516
15187
92
353
1516
15725
34
69
1574
16009
—
18
56
1583
15996
72
336
1459
15317
168
947
1130
12811
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
—
—
—
—
—
3.0e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.04%
cases:1.93%
controls:0.20%
—
—
—
—
—
13
7
1518
15646
25
27
1273
13731
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
7.6e-02
5.1e-01
1.6e+00
—
1.8e+00
8.6e-01
4.5e-01
cases:7.40%
controls:6.90%
cases:5.91%
controls:3.65%
cases:2.99%
controls:0.60%
—
—
cases:2.69%
controls:0.45%
cases:8.49%
controls:3.76%
cases:16.18%
controls:10.95%
119
1109
1489
14969
95
587
1513
15491
48
96
1560
15982
—
43
73
1558
15979
130
589
1401
15064
210
1507
1088
12251
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
7.5e-01
1.4e+00
—
—
—
3.0e+00
2.3e+00
cases:0.44%
controls:0.21%
cases:0.31%
controls:0.07%
—
—
—
—
—
—
cases:1.24%
controls:0.06%
cases:1.93%
controls:0.20%
7
33
1601
16045
5
12
1603
16066
—
—
—
19
10
1512
15643
25
28
1273
13730
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
—
8.7e-01
—
—
—
2.8e+00
2.4e+00
—
—
cases:0.31%
controls:0.13%
—
—
—
—
—
—
cases:1.24%
controls:0.08%
cases:2.54%
controls:0.23%
—
5
21
1603
16057
—
—
—
19
12
1512
15641
33
32
1265
13726
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
—
7.4e-01
—
—
—
2.8e+00
2.4e+00
—
—
cases:0.31%
controls:0.15%
—
—
—
—
—
—
cases:1.18%
controls:0.07%
cases:2.77%
controls:0.27%
—
5
24
1603
16054
—
—
—
18
11
1513
15642
36
37
1262
13721
Laceration/cut
S18 [2002000983]
-7.4e-02
4.7e-01
2.6e+00
—
1.5e+00
5.8e-01
2.2e-01
cases:8.15%
controls:8.72%
cases:4.91%
controls:3.13%
cases:5.04%
controls:0.39%
—
—
cases:1.87%
controls:0.41%
cases:5.81%
controls:3.33%
cases:13.56%
controls:11.19%
131
1402
1477
14676
79
503
1529
15575
81
63
1527
16015
—
30
66
1571
15986
89
522
1442
15131
176
1540
1122
12218
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 [3029080]
1.2e+00
1.5e+00
—
—
—
3.0e+00
2.1e+00
cases:0.37%
controls:0.12%
cases:0.31%
controls:0.07%
—
—
—
—
—
—
cases:1.37%
controls:0.07%
cases:2.23%
controls:0.27%
6
19
1602
16059
5
11
1603
16067
—
—
—
21
11
1510
15642
29
37
1269
13721
Very extensive CT examination of mouth and soft tissues of neck
EN1BD [2001302281]
1.4e+00
2.2e+00
1.0e+50
1.0e+50
—
—
2.9e+00
cases:0.50%
controls:0.12%
cases:0.44%
controls:0.05%
cases:0.31%
controls:0.00%
cases:1.00%
controls:0.00%
—
—
—
—
cases:2.00%
controls:0.11%
8
20
1600
16058
7
8
1601
16070
5
0
1603
16078
16
0
1592
16078
—
—
26
15
1272
13743
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
-1.9e-02
4.3e-01
1.8e+00
—
1.8e+00
1.1e+00
4.4e-01
cases:6.16%
controls:6.27%
cases:2.92%
controls:1.93%
cases:0.93%
controls:0.16%
—
—
cases:1.00%
controls:0.17%
cases:5.03%
controls:1.80%
cases:9.17%
controls:6.08%
99
1008
1509
15070
47
310
1561
15768
15
25
1593
16053
—
16
27
1585
16025
77
281
1454
15372
119
836
1179
12922
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 [40764127]
—
—
—
—
—
2.7e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.03%
cases:1.46%
controls:0.13%
—
—
—
—
—
7
5
1524
15648
19
18
1279
13740
Leukocytes other/Leukocytes in Blood
26471-3 [3013727]
—
—
1.0e+50
—
—
3.2e+00
1.8e+00
—
—
—
—
cases:0.31%
controls:0.00%
—
—
—
—
cases:0.98%
controls:0.04%
cases:0.77%
controls:0.12%
—
—
5
0
1603
16078
—
—
15
6
1516
15647
10
17
1288
13741
Ultrasound examination of upper extremity veins
PH1AE [2001309445]
—
2.3e+00
—
—
—
3.1e+00
2.0e+00
—
—
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.85%
controls:0.04%
cases:0.92%
controls:0.13%
—
5
5
1603
16073
—
—
—
13
6
1518
15647
12
18
1286
13740
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 [3037875]
—
—
—
—
—
2.7e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.03%
cases:1.46%
controls:0.14%
—
—
—
—
—
7
5
1524
15648
19
19
1279
13739
Extensive CT examination of pelvis for dose design of radiotherapy
YL1BD [2001305594]
—
—
—
—
1.0e+50
3.5e+00
1.5e+00
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.00%
cases:1.05%
controls:0.03%
cases:0.69%
controls:0.15%
—
—
—
—
7
0
1594
16052
16
5
1515
15648
9
21
1289
13737
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-5.5e-03
4.0e-01
1.9e+00
—
1.8e+00
8.9e-01
4.4e-01
cases:6.16%
controls:6.19%
cases:4.60%
controls:3.12%
cases:3.23%
controls:0.49%
—
—
cases:3.19%
controls:0.57%
cases:6.99%
controls:3.00%
cases:13.87%
controls:9.41%
99
995
1509
15083
74
502
1534
15576
52
78
1556
16000
—
51
91
1550
15961
107
469
1424
15184
180
1294
1118
12464
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
—
8.4e-01
—
—
—
2.9e+00
2.1e+00
—
—
cases:0.37%
controls:0.16%
—
—
—
—
—
—
cases:1.89%
controls:0.10%
cases:2.85%
controls:0.37%
—
6
26
1602
16052
—
—
—
29
16
1502
15637
37
51
1261
13707
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
-6.9e-02
2.9e-01
—
—
2.7e+00
1.6e+00
7.3e-01
cases:0.44%
controls:0.47%
cases:0.37%
controls:0.28%
—
—
—
—
cases:0.62%
controls:0.04%
cases:1.50%
controls:0.31%
cases:3.00%
controls:1.47%
7
75
1601
16003
6
45
1602
16033
—
—
10
7
1591
16045
23
48
1508
15605
39
202
1259
13556
Left side
ZXA05 [2001311347]
3.1e-03
9.1e-01
3.5e+00
—
1.0e+00
7.0e-01
5.9e-01
cases:4.04%
controls:4.03%
cases:2.49%
controls:1.01%
cases:3.36%
controls:0.11%
—
—
cases:0.37%
controls:0.14%
cases:1.63%
controls:0.82%
cases:5.16%
controls:2.92%
65
648
1543
15430
40
163
1568
15915
54
17
1554
16061
—
6
22
1595
16030
25
128
1506
15525
67
402
1231
13356
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
—
—
—
—
—
2.5e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.06%
cases:1.85%
controls:0.16%
—
—
—
—
—
11
9
1520
15644
24
22
1274
13736
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
-2.2e-01
8.3e-01
1.9e+00
—
1.8e+00
1.3e+00
4.7e-01
cases:1.37%
controls:1.70%
cases:1.24%
controls:0.55%
cases:0.56%
controls:0.08%
—
—
cases:0.62%
controls:0.11%
cases:1.24%
controls:0.35%
cases:2.08%
controls:1.31%
22
273
1586
15805
20
88
1588
15990
9
13
1599
16065
—
10
17
1591
16035
19
55
1512
15598
27
180
1271
13578
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
2.2e-01
1.3e+00
—
—
—
1.8e+00
1.8e+00
cases:0.37%
controls:0.30%
cases:0.68%
controls:0.19%
—
—
—
—
—
—
cases:0.72%
controls:0.11%
cases:2.47%
controls:0.40%
6
48
1602
16030
11
30
1597
16048
—
—
—
11
18
1520
15635
32
55
1266
13703
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
1.8e-01
1.7e+00
3.3e+00
—
—
5.6e-01
7.7e-01
cases:0.68%
controls:0.57%
cases:1.24%
controls:0.22%
cases:1.12%
controls:0.04%
—
—
—
—
cases:0.46%
controls:0.26%
cases:1.46%
controls:0.68%
11
92
1597
15986
20
36
1588
16042
18
7
1590
16071
—
—
7
41
1524
15612
19
94
1279
13664
Localized swelling, mass and lump, head
R22.0 [45548955]
9.5e-01
3.7e+00
1.0e+50
1.0e+50
—
—
1.3e+00
cases:0.56%
controls:0.22%
cases:1.68%
controls:0.04%
cases:0.68%
controls:0.00%
cases:0.37%
controls:0.00%
—
—
—
—
cases:1.39%
controls:0.38%
9
35
1599
16043
27
7
1581
16071
11
0
1597
16078
6
0
1602
16078
—
—
18
52
1280
13706
cefalexin; oral
J01DB01 [21602870]
4.9e-02
6.7e-01
1.8e+00
1.9e+00
1.2e+00
8.5e-01
4.0e-01
cases:28.54%
controls:27.55%
cases:16.11%
controls:8.97%
cases:5.10%
controls:0.90%
cases:0.37%
controls:0.06%
cases:3.56%
controls:1.06%
cases:18.22%
controls:8.69%
cases:35.05%
controls:26.49%
459
4430
1149
11648
259
1442
1349
14636
82
145
1526
15933
6
9
1602
16069
57
170
1544
15882
279
1360
1252
14293
455
3644
843
10114
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
-1.7e-01
3.8e-01
2.1e+00
—
2.0e+00
8.2e-01
1.9e-01
cases:1.62%
controls:1.90%
cases:1.37%
controls:0.94%
cases:1.00%
controls:0.12%
—
—
cases:1.06%
controls:0.15%
cases:2.35%
controls:1.05%
cases:5.16%
controls:4.32%
26
306
1582
15772
22
151
1586
15927
16
20
1592
16058
—
17
24
1584
16028
36
164
1495
15489
67
594
1231
13164
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
-2.3e-01
1.8e-01
2.2e+00
—
2.0e+00
6.5e-01
2.3e-01
cases:3.05%
controls:3.79%
cases:2.18%
controls:1.82%
cases:2.36%
controls:0.27%
—
—
cases:2.06%
controls:0.27%
cases:3.66%
controls:1.94%
cases:7.63%
controls:6.16%
49
609
1559
15469
35
293
1573
15785
38
44
1570
16034
—
33
44
1568
16008
56
303
1475
15350
99
847
1199
12911
Reticulocyte production index
31111-8 [3000012]
9.6e-01
1.7e+00
—
—
—
2.9e+00
1.9e+00
cases:0.44%
controls:0.17%
cases:0.37%
controls:0.07%
—
—
—
—
—
—
cases:1.18%
controls:0.06%
cases:2.23%
controls:0.33%
7
27
1601
16051
6
11
1602
16067
—
—
—
18
10
1513
15643
29
45
1269
13713
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
4.7e-01
9.2e-01
—
—
2.4e+00
1.4e+00
9.8e-01
cases:0.75%
controls:0.47%
cases:0.62%
controls:0.25%
—
—
—
—
cases:0.50%
controls:0.04%
cases:1.44%
controls:0.34%
cases:3.00%
controls:1.15%
12
75
1596
16003
10
40
1598
16038
—
—
8
7
1593
16045
22
54
1509
15599
39
158
1259
13600
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 [3032699]
—
—
—
—
—
2.6e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:1.54%
controls:0.17%
—
—
—
—
—
8
6
1523
15647
20
23
1278
13735
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
-1.4e-01
8.2e-01
1.9e+00
—
2.1e+00
6.4e-01
4.3e-01
cases:2.49%
controls:2.85%
cases:2.24%
controls:1.00%
cases:0.93%
controls:0.14%
—
—
cases:1.12%
controls:0.14%
cases:1.44%
controls:0.77%
cases:4.85%
controls:3.20%
40
458
1568
15620
36
160
1572
15918
15
22
1593
16056
—
18
23
1583
16029
22
120
1509
15533
63
440
1235
13318
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
2.1e-01
5.6e-01
1.5e+00
—
1.3e+00
7.9e-01
6.0e-01
cases:4.73%
controls:3.87%
cases:2.92%
controls:1.70%
cases:1.49%
controls:0.32%
—
—
cases:1.00%
controls:0.27%
cases:4.05%
controls:1.87%
cases:9.63%
controls:5.52%
76
622
1532
15456
47
273
1561
15805
24
52
1584
16026
—
16
43
1585
16009
62
293
1469
15360
125
760
1173
12998
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
1.8e-01
1.7e+00
3.1e+00
—
—
5.3e-01
6.2e-01
cases:0.68%
controls:0.57%
cases:1.18%
controls:0.22%
cases:1.00%
controls:0.04%
—
—
—
—
cases:0.39%
controls:0.23%
cases:1.16%
controls:0.63%
11
92
1597
15986
19
36
1589
16042
16
7
1592
16071
—
—
6
36
1525
15617
15
86
1283
13672
pH of Arterial blood
2744-1 [3019977]
-3.2e-01
4.9e-01
1.8e+00
—
2.2e+00
8.0e-01
9.4e-02
cases:1.31%
controls:1.79%
cases:1.24%
controls:0.77%
cases:0.62%
controls:0.11%
—
—
cases:0.69%
controls:0.07%
cases:1.70%
controls:0.77%
cases:3.85%
controls:3.52%
21
287
1587
15791
20
123
1588
15955
10
17
1598
16061
—
11
12
1590
16040
26
120
1505
15533
50
484
1248
13274
Other CT eamination for dose design of radiotherapy
YX9AD [2001311065]
—
—
—
—
—
3.2e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.04%
cases:0.85%
controls:0.18%
—
—
—
—
—
17
7
1514
15646
11
25
1287
13733
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
—
1.2e+00
—
—
—
2.9e+00
1.9e+00
—
—
cases:0.62%
controls:0.19%
—
—
—
—
—
—
cases:2.48%
controls:0.14%
cases:3.62%
controls:0.57%
—
10
31
1598
16047
—
—
—
38
22
1493
15631
47
79
1251
13679
metronidazole; oral, rectal
P01AB01 [21604857]
1.1e-01
7.4e-01
1.3e+00
—
1.6e+00
7.1e-01
4.4e-01
cases:7.03%
controls:6.34%
cases:3.67%
controls:1.79%
cases:0.68%
controls:0.19%
—
—
cases:0.69%
controls:0.14%
cases:3.59%
controls:1.80%
cases:8.32%
controls:5.53%
113
1019
1495
15059
59
287
1549
15791
11
30
1597
16048
—
11
23
1590
16029
55
281
1476
15372
108
761
1190
12997
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
-1.2e-02
7.2e-01
2.2e+00
—
2.6e+00
7.8e-01
2.4e-01
cases:1.06%
controls:1.07%
cases:1.18%
controls:0.58%
cases:0.50%
controls:0.06%
—
—
cases:0.81%
controls:0.06%
cases:1.24%
controls:0.57%
cases:3.08%
controls:2.44%
17
172
1591
15906
19
93
1589
15985
8
9
1600
16069
—
13
10
1588
16042
19
90
1512
15563
40
336
1258
13422
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
7.7e-01
1.9e+00
2.8e+00
—
—
8.9e-01
4.3e-01
cases:1.06%
controls:0.49%
cases:1.62%
controls:0.24%
cases:0.62%
controls:0.04%
—
—
—
—
cases:0.59%
controls:0.24%
cases:1.00%
controls:0.65%
17
79
1591
15999
26
38
1582
16040
10
6
1598
16072
—
—
9
38
1522
15615
13
90
1285
13668

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
245
114
25.16
307.65
2.8
1.9
1050.47
1164.39
e6/l
0.50
223
100
519
135
56.22
307.65
1.7
1.2
—
—
—
0
0
693
862
13.35
307.65
1.4
1.4
—
—
—
0
0
781
1508
9.11
307.65
1.6
1.5
—
—
—
0
0
353
204
21.88
307.65
1.6
1.3
—
—
—
0
0
821
1677
8.94
307.65
1.6
1.6
—
—
—
0
0
737
1323
9.42
307.65
1.4
1.6
—
—
—
0
0
206
91
25.81
288.34
2.5
1.9
73.00
71.78
%
0.26
198
83
197
87
25.66
275.56
2.5
1.9
18.56
16.30
%
0.88
190
82
620
1436
6.39
272.16
1.9
1.4
—
—
—
0
0
296
303
11.74
265.42
1.6
1.6
—
—
—
0
0
552
1181
6.59
262.43
4.4
3.0
8.25
10.95
g/l
28.76
532
1088
1010
4091
4.93
216.99
5.1
2.9
320.74
350.88
umol/l
17.99
983
3541
140
55
27.78
203.61
1.2
1.1
—
—
—
0
0
170
107
17.64
202.28
2.6
1.9
30.04
37.27
%
3.66
170
107
148
76
21.34
193.59
2.9
2.1
598.01
600.33
e6/l
0.01
118
61
147
78
20.64
189.48
3.2
2.3
255.44
213.33
e6/l
0.72
124
67
1366
7586
6.25
181.97
10.9
6.3
0.58
0.60
e9/l
3.39
1245
6390
1366
7610
6.21
180.55
11.0
6.3
0.04
0.04
e9/l
1.68
1245
6413
1367
7716
6.08
174.98
11.2
6.4
1.69
1.91
e9/l
4.41
1260
6690
1297
7032
5.32
174.58
11.1
6.6
9.83
9.08
%
13.60
1272
6553
1294
7021
5.27
173.51
10.9
6.5
2.94
2.85
%
0.82
1270
6539
1289
7015
5.18
170.98
11.0
6.6
0.78
0.68
%
9.01
1266
6534
1371
7840
6.01
170.27
11.6
6.5
0.18
0.19
e9/l
3.64
1260
6738
1298
7129
5.21
169.33
11.0
6.6
26.82
26.78
%
0.04
1275
6726
145
98
16.16
165.81
3.7
2.9
32.79
38.78
%
1.87
108
53
1270
6995
4.84
161.39
10.6
6.5
56.79
57.87
%
2.58
1257
6647
114
49
24.96
159.96
2.5
1.7
40.86
31.76
%
2.47
114
49
1071
5270
4.08
158.97
9.5
6.3
—
—
—
0
0
391
949
5.12
154.64
2.7
1.9
0.89
1.48
g/l
6.00
369
868
1389
8523
5.55
144.30
24.6
10.0
3.47
4.19
e9/l
38.68
1297
7342
1351
8245
4.94
137.92
14.9
6.9
10.48
11.74
umol/l
6.27
1333
7873
96
39
26.11
137.35
2.5
2.2
38.67
27.35
%
4.81
89
34
95
40
25.17
134.10
2.4
2.1
7.41
8.58
%
0.24
87
33
184
270
7.56
121.62
1.4
1.3
—
—
—
0
0
169
244
7.62
113.16
1.3
1.4
115.78
162.06
au/ml
3.23
46
76
1202
7250
3.59
112.89
7.5
5.3
35.71
35.16
g/l
3.05
1156
6795
412
1412
3.58
98.34
6.5
4.5
0.82
0.89
%
0.27
222
452
66
26
26.43
95.14
2.1
1.9
0.08
0.20
e9/l
—
20
6
387
1342
3.48
89.95
6.6
4.6
0.19
0.11
%
1.11
197
383
387
1344
3.47
89.72
6.2
4.4
0.66
0.65
%
0.03
204
425
653
3072
2.89
89.37
9.6
5.0
—
—
—
0
0
377
1357
3.32
81.83
6.8
4.8
0.06
0.09
%
0.33
188
363
596
2806
2.78
79.67
6.0
3.3
0.81
0.82
mmol/l
1.79
577
2648
408
1613
3.05
74.84
3.4
2.8
69.42
69.15
e9/l
0.05
336
1194
475
2053
2.86
73.93
3.4
2.7
1.69
1.81
%
2.10
448
1837
134
257
5.60
67.27
4.2
4.1
2.35
1.45
%
0.93
126
235
1183
8179
2.68
66.64
9.5
7.6
1.22
1.21
mmol/l
5.99
1020
7044
998
6532
2.39
60.72
19.5
12.3
0.00
0.00
e9/l
0.21
845
5285
1084
7427
2.40
58.28
8.3
6.8
1.22
1.21
mmol/l
7.31
1049
6831
1393
10799
3.13
56.99
7.7
4.6
13.38
13.44
mm/h
0.05
1355
10030
885
5660
2.25
54.62
8.2
3.6
2.37
2.36
mmol/l
2.34
845
5077
1443
11494
3.44
54.60
20.6
8.8
81.38
80.34
u/l
0.43
1428
10872
804
5012
2.21
52.04
6.6
4.4
7.40
7.40
ph
1.74
605
3653
764
4676
2.20
51.68
7.1
4.6
—
—
—
0
0
136
333
4.37
50.90
1.2
1.3
—
—
—
0
0
306
1261
2.76
50.17
1.7
2.8
—
—
—
0
0
514
2756
2.27
47.33
2.4
1.5
1.69
2.63
g/l
30.63
406
1595
596
3426
2.17
45.90
5.0
3.1
2.47
2.46
mmol/l
0.94
577
3078
108
248
4.60
43.77
1.2
1.2
250.89
273.88
u/ml
0.33
70
129
383
1872
2.37
43.30
4.2
3.3
4.54
4.80
e9/l
0.21
336
1587
331
1536
2.45
41.89
3.0
3.0
63.75
66.38
g/l
7.59
317
1414
101
237
4.48
39.80
1.5
1.2
89.49
202.53
miu/ml
1.27
15
89
980
7060
1.99
38.16
3.7
2.9
—
—
estimate
—
0
0
1034
7629
1.99
37.08
14.1
17.0
1.20
1.29
inr
7.70
867
6363
105
269
4.11
36.88
2.6
2.2
0.92
0.89
%
0.17
83
195
702
4567
1.95
36.33
14.3
6.6
—
—
—
0
0
416
2295
2.10
33.88
6.1
5.8
1.00
1.04
mmol/l
2.12
398
2123
63
121
5.38
31.40
2.2
2.4
30.04
35.88
iu/ml
—
10
18
1150
9146
1.90
28.89
6.5
5.4
6.50
6.80
mmol/l
7.83
1119
8751
59
118
5.15
28.12
1.2
1.2
—
—
—
0
0
82
217
3.93
27.52
1.5
1.5
—
—
—
0
0
82
217
3.93
27.52
1.5
1.5
—
—
—
0
0
82
217
3.93
27.52
1.5
1.5
—
—
—
0
0
82
217
3.93
27.52
1.5
1.5
—
—
—
0
0
403
2354
1.95
27.17
1.9
2.1
—
—
—
0
0
104
327
3.33
26.99
4.2
3.0
57.65
59.03
%
0.48
104
327
70
167
4.34
26.98
5.0
4.2
57.52
56.56
%
0.12
65
147
812
5903
1.76
26.59
2.6
2.3
—
—
—
0
0
261
1311
2.18
26.50
8.2
4.0
1.23
1.23
mmol/l
1.43
251
1125
84
235
3.72
26.04
1.1
1.1
—
—
—
0
0
168
737
2.43
23.33
2.2
1.9
0.54
2.16
ug/l
1.81
151
659
576
3962
1.71
21.75
5.3
4.3
91.26
87.01
%
4.33
569
3883
697
5061
1.66
21.32
3.7
2.6
—
—
—
0
0
62
165
3.87
20.66
4.7
4.5
—
—
—
0
0
707
5226
1.63
19.66
3.9
3.6
35.47
84.33
e6/l
2.19
565
4032
628
4521
1.64
19.34
3.6
3.5
0.33
0.49
e6/l
1.11
490
3358
557
3912
1.65
18.80
1.5
1.3
—
—
—
0
0
76
250
3.14
18.32
2.1
2.8
—
—
—
0
0
334
2065
1.78
17.92
1.4
1.3
—
—
—
0
0
299
1794
1.82
17.72
5.0
2.7
6.73
8.25
umol/l
0.93
278
1616
391
2546
1.71
17.40
3.1
2.0
29.03
29.57
s
1.48
386
2470
755
5813
1.56
16.78
4.8
4.2
141.21
121.77
e6/l
0.12
577
4168
519
3666
1.61
16.69
2.8
2.8
5.20
5.29
e6/l
0.05
481
3351
36
78
4.70
15.68
2.2
1.7
—
—
—
0
0
27
49
5.59
14.32
1.4
1.3
—
—
—
0
0
67
240
2.87
13.96
1.1
1.1
—
—
—
0
0
26
28
9.42
12.98
1.4
1.5
—
—
—
0
0
146
774
1.97
12.50
1.6
2.7
3.30
3.73
g/l
3.88
136
707
146
775
1.97
12.45
1.6
2.7
7.41
7.41
g/l
0.01
136
707
146
775
1.97
12.45
1.6
2.7
4.05
4.20
g/l
1.38
136
708
683
5379
1.47
12.34
3.3
3.2
1429.49
1356.83
ng/l
0.21
611
4676
435
3126
1.54
12.29
3.3
3.0
505.26
532.89
mosm/kgh2o
2.04
399
2731
94
424
2.29
12.22
1.2
1.6
—
—
—
0
0
352
2421
1.58
12.06
2.0
2.7
24.10
22.22
%
0.89
336
2265
1475
13691
1.91
11.94
36.7
18.4
22.41
26.26
mg/l
4.76
1378
11461
19
13
14.77
11.79
1.3
2.8
—
—
—
0
0
371
2596
1.56
11.75
2.1
2.7
2.25
2.28
g/l
0.40
350
2409
109
541
2.09
11.19
2.5
4.1
7.42
7.41
ph
1.48
109
536
21
38
5.59
11.18
2.0
1.5
—
—
—
0
0
53
190
2.85
11.08
1.4
1.6
—
—
—
0
0
629
4956
1.44
10.96
3.6
3.4
—
—
—
0
0
133
731
1.89
10.23
1.6
2.7
3.09
2.98
g/l
0.67
123
664
619
4911
1.42
10.18
3.3
2.6
56.37
78.66
u/l
0.75
580
4519
383
2775
1.50
10.14
2.2
2.7
13.28
12.55
umol/l
0.95
364
2596
818
6817
1.41
10.13
2.5
2.5
78.57
79.07
nmol/l
0.20
752
6038
1240
11138
1.49
10.09
41.1
22.9
14.05
13.78
%
10.41
1233
10982
29
77
3.82
9.79
2.4
2.7
1660.21
1343.36
u/ml
0.28
29
77
1113
9818
1.43
9.75
5.9
5.1
266.10
1841.42
e6/l
1.95
20
146
21
29
7.32
9.22
1.0
1.1
—
—
—
0
0
273
1880
1.54
9.08
3.1
4.4
21.83
18.84
ug/l
0.11
214
1562
122
678
1.86
9.08
1.6
2.8
8.68
10.59
g/l
4.81
111
607
605
4859
1.39
8.97
6.3
3.3
30.09
34.82
u/l
1.98
576
4578
145
853
1.77
8.96
1.6
1.9
1.73
1.55
g/l
0.95
111
748
21
47
4.51
8.84
1.9
1.6
3093.33
4525.71
titre
—
6
7
125
712
1.82
8.61
1.3
1.2
—
—
—
0
0
734
6113
1.37
8.59
4.4
4.2
34.45
73.23
ng/l
1.64
612
4714
357
2645
1.45
8.24
3.7
3.3
2.42
2.15
e6/l
0.17
178
1317
49
199
2.51
8.11
1.4
1.4
—
—
—
0
0
21
51
4.16
8.00
1.4
1.2
20.95
28.61
%
0.55
21
46
421
3230
1.41
7.98
2.0
1.7
1.38
1.45
mg/l
0.15
348
2543
36
128
2.85
7.72
1.2
1.1
—
—
—
0
0
1122
10074
1.37
7.70
5.4
4.9
—
2.12
—
0
13
894
7767
1.34
7.54
4.7
4.2
0.00
0.00
estimate
-0.00
234
1640
250
1757
1.50
7.49
4.5
3.5
7.38
7.38
ph
0.26
139
1002
268
1912
1.48
7.46
1.7
1.5
—
—
—
0
0
68
334
2.08
7.25
2.8
4.9
3.72
2.69
mmol/l
2.18
55
233
38
144
2.68
7.25
1.6
1.4
0.27
0.40
g/l
1.69
29
106
38
144
2.68
7.25
1.6
1.4
5.14
7.04
g/l
1.94
32
105
38
144
2.68
7.25
1.6
1.4
1.82
2.88
g/l
3.17
32
107
68
335
2.08
7.20
2.8
4.9
5.04
5.08
kpa
0.16
68
330
68
335
2.08
7.20
2.8
4.9
8.92
8.47
kpa
0.83
68
330
227
1582
1.51
7.07
5.2
4.5
7.37
7.36
ph
0.71
194
1113
119
709
1.73
7.06
1.5
1.3
—
—
—
0
0
53
239
2.26
7.00
5.1
6.5
11.84
12.47
mg/l
0.50
47
222
898
7865
1.32
6.87
4.8
4.2
0.00
3.12
estimate
1.08
236
1684
238
1688
1.48
6.79
4.5
3.5
2.32
1.94
mmol/l
0.86
213
1457
37
144
2.61
6.72
1.6
1.4
—
—
—
0
0
218
1523
1.50
6.70
7.4
9.0
—
—
—
0
0
372
2874
1.38
6.61
3.5
3.2
0.88
1.08
e6/l
0.92
194
1557
544
4460
1.33
6.57
4.8
4.3
0.01
0.00
estimate
0.31
219
1516
40
164
2.48
6.54
1.1
1.3
—
—
—
0
0
900
7914
1.31
6.54
4.8
4.2
0.01
0.21
estimate
0.50
225
1572
731
6251
1.31
6.52
4.2
3.7
6.24
6.25
ph
0.12
394
3397
222
1568
1.48
6.46
6.3
7.1
9.20
10.42
mmol/l
1.84
216
1510
47
210
2.28
6.37
1.3
1.4
35098.73
120478.76
e6/l
1.01
22
119
516
4218
1.33
6.30
2.3
2.3
2.95
2.92
mg/l
0.11
462
3615
298
2244
1.40
6.13
1.3
1.3
—
—
—
0
0
51
240
2.16
6.12
1.5
1.4
1983.56
5361.04
e6/l
0.44
34
164
241
1748
1.45
6.11
4.5
3.5
5.84
5.84
kpa
0.01
232
1700
62
320
1.98
5.84
1.5
1.3
5.02
57.68
e6/l
1.21
44
230
62
322
1.96
5.74
1.7
1.3
148.40
580.73
e6/l
0.58
48
245
13
19
6.89
5.74
1.4
1.7
3.00
9.67
%
—
7
9
36
151
2.42
5.65
1.2
1.1
—
—
—
0
0
163
1113
1.52
5.59
4.9
8.5
25.46
24.96
mmol/l
0.95
163
1107
68
368
1.89
5.58
3.3
4.0
—
—
—
0
0
745
6477
1.28
5.53
3.2
3.1
272.89
144.63
ug/l
3.43
704
5966
173
1199
1.50
5.52
4.2
4.2
—
—
—
0
0
80
460
1.78
5.42
2.5
3.1
1.46
1.68
mg/l
1.31
75
414
18
53
3.42
5.31
1.3
1.3
10.34
112.58
ug/l
—
7
23
70
391
1.83
5.23
2.5
2.4
121.19
128.89
g/l
1.58
54
312
96
589
1.67
5.18
1.5
1.6
—
—
—
0
0
37
165
2.27
5.10
1.4
1.2
—
—
—
0
0
52
267
1.98
5.01
1.1
1.1
—
—
—
0
0
64
353
1.85
4.99
2.8
2.8
15.06
16.05
%
1.64
64
345
30
123
2.47
4.97
1.4
1.2
—
—
—
0
0
49
247
2.01
4.97
1.6
1.8
0.38
0.87
g/l
2.91
40
196
225
1675
1.40
4.91
1.9
2.2
0.20
0.21
g/l
1.36
210
1550
117
766
1.57
4.87
2.3
2.2
0.00
1.18
estimate
0.50
27
213
391
3175
1.31
4.81
4.2
4.1
479.77
379.18
ng/l
0.18
334
2649
8
7
11.48
4.78
1.0
1.0
—
—
—
0
0
197
1452
1.41
4.56
2.5
2.2
392.84
379.84
nmol/l
0.45
186
1331
63
361
1.78
4.38
3.1
3.1
90.83
89.10
%
1.18
63
348
40
197
2.06
4.35
1.4
1.4
—
—
—
0
0
7
7
10.04
4.01
1.0
1.0
—
—
—
0
0
7
7
10.04
4.01
1.0
1.0
—
—
—
0
0
7
7
10.04
4.01
1.0
1.0
—
—
—
0
0
7
7
10.04
4.01
1.0
1.0
—
—
—
0
0
14
36
3.91
3.99
1.1
1.2
7.16
3.76
mmol/l
—
8
25
99
655
1.54
3.98
2.1
3.8
29.60
59.70
mg/l
2.65
79
570
99
656
1.54
3.95
2.1
3.8
30.95
89.22
mg/l
1.64
79
573
50
276
1.84
3.95
1.7
1.9
1.69
1.65
mmol/l
0.09
50
267
47
256
1.86
3.88
2.4
2.9
—
—
—
0
0
102
686
1.52
3.81
2.8
3.6
119.80
5981.58
u/ml
0.86
86
600
14
38
3.71
3.79
1.2
1.5
—
—
—
0
0
653
5778
1.22
3.64
4.8
4.2
0.01
0.10
estimate
0.63
196
1361
13
36
3.63
3.49
1.0
1.2
1.80
1.71
mmol/l
—
8
23
466
3999
1.23
3.47
4.1
3.7
0.01
0.24
estimate
0.61
190
1298
103
710
1.48
3.45
3.1
2.7
—
—
—
0
0
1479
14320
1.40
3.40
35.3
22.3
139.74
139.68
mmol/l
0.41
1469
14045
16
59
2.73
3.32
1.2
1.1
—
70.29
%
—
0
7
67
425
1.60
3.27
3.2
3.3
8.40
7.92
kpa
1.75
67
412
1479
14343
1.38
3.14
35.6
22.5
3.99
3.99
mmol/l
0.38
1467
14046
50
302
1.68
2.98
1.6
1.2
—
—
—
0
0
24
114
2.12
2.95
1.2
1.2
2.02
2.04
mmol/l
0.07
24
105
962
8937
1.19
2.92
3.9
3.4
51.47
54.20
u/l
0.46
899
8275
192
1515
1.30
2.89
2.3
2.2
0.08
0.02
estimate
0.35
37
278
186
1462
1.31
2.88
3.5
2.9
4.53
4.43
kpa
0.25
179
1416
11
33
3.35
2.81
1.1
1.1
—
—
—
0
0
85
592
1.46
2.76
2.1
3.7
1.49
3.80
ratio
1.69
39
353
146
1119
1.34
2.71
4.2
3.9
7.43
7.42
ph
1.54
127
934
497
5588
0.84
2.66
3.4
3.5
39.01
46.61
mg/l
0.46
296
3575
31
543
0.56
2.64
1.0
1.1
—
—
—
0
0
59
386
1.55
2.59
2.8
3.5
393.24
1034.62
u/ml
0.40
53
362
191
1530
1.28
2.57
2.5
2.4
31.12
40.03
u/l
1.85
155
1284
1249
12994
0.83
2.54
4.3
4.6
1.32
1.30
mmol/l
0.45
1106
11753
11
38
2.91
2.41
1.6
1.1
—
—
—
0
0
23
117
1.98
2.41
1.9
1.8
3222.54
3795.39
u/l
0.06
11
41
544
4878
1.17
2.38
1.7
1.8
20.27
20.43
nmol/l
0.09
467
4058
28
154
1.83
2.34
2.0
1.3
—
—
—
0
0
1288
13334
0.83
2.29
6.5
7.2
39.83
40.05
mmol/mol
0.26
1184
12327
11
40
2.76
2.27
1.0
1.0
—
—
—
0
0
1312
13555
0.83
2.25
5.0
5.5
1.43
1.46
mmol/l
1.64
1168
12378
512
5680
0.86
2.24
4.2
4.2
6.55
8.61
mg/mmol
0.68
298
3522
46
296
1.57
2.21
1.5
1.3
28.82
28.72
iu/l
0.01
33
253
60
410
1.48
2.20
1.4
1.2
—
—
—
0
0
79
570
1.41
2.18
1.3
1.2
—
—
—
0
0
20
101
1.99
2.16
1.0
1.0
—
—
—
0
0
9
30
3.01
2.15
2.1
3.3
14.50
15.21
ml/dl
—
9
25
1352
13909
0.83
2.07
5.7
6.4
2.61
2.61
mmol/l
0.06
1216
12741
30
176
1.72
2.06
1.8
1.5
31.19
29.99
ng/l
0.05
30
176
0
58
0.00
2.04
0.0
1.3
—
118.95
—
0
41
232
1955
1.22
2.03
1.3
1.3
545.37
542.30
titre
0.01
41
452
218
1827
1.22
2.01
1.6
1.8
—
—
—
0
0
54
369
1.48
2.00
1.4
1.3
—
—
—
0
0
69
495
1.41
1.99
1.4
1.5
290.67
274.89
ug/g
0.30
43
301
519
5711
0.87
1.99
3.3
3.5
6.75
7.28
mmol/l
2.57
414
4776
215
1810
1.22
1.90
1.4
1.3
—
—
—
0
0
5
12
4.18
1.82
4.2
3.9
11.40
26.58
mg/mmol
—
5
12
1475
14438
1.25
1.78
24.8
13.4
25.07
25.73
u/l
1.03
1459
13970
27
435
0.61
1.76
1.4
1.7
—
—
—
0
0
103
809
1.29
1.69
2.3
3.5
4.38
4.45
pmol/l
0.38
96
721
1330
13653
0.85
1.65
5.0
5.6
4.54
4.53
mmol/l
0.12
1197
12561
62
454
1.38
1.63
2.2
3.3
2.62
2.00
index
0.22
34
238
238
2056
1.18
1.62
6.6
7.8
1.55
0.92
mmol/l
1.68
201
1699
572
6176
0.89
1.56
2.0
2.0
1.39
1.33
mmol/l
1.04
460
5059
12
57
2.11
1.55
1.0
1.2
158.58
220.59
iu/ml
0.47
12
57
76
583
1.32
1.50
1.0
1.1
—
128.00
—
0
12
238
2074
1.17
1.47
6.6
7.8
5.12
5.09
kpa
0.13
228
1995
238
2075
1.17
1.46
6.6
7.8
12.47
12.12
kpa
0.47
229
2000
95
757
1.27
1.43
2.1
2.0
—
—
—
0
0
39
547
0.71
1.36
1.8
1.6
0.33
0.33
mg/l
0.02
14
248
236
2071
1.16
1.34
6.7
7.8
7.43
7.41
ph
1.37
128
1132
130
1084
1.22
1.32
7.5
9.9
24.94
24.30
mmol/l
1.61
130
1065
42
300
1.41
1.32
1.3
1.2
72.33
37.47
u/l
0.78
37
256
120
1440
0.82
1.31
1.6
1.5
—
—
—
0
0
20
121
1.66
1.31
2.3
3.3
19.68
31.22
mg/l
0.39
13
96
1121
10819
1.12
1.29
4.4
4.4
15.18
14.99
pmol/l
1.89
1039
9783
213
1862
1.17
1.28
7.1
8.1
96.10
95.53
%
0.96
204
1806
8
35
2.29
1.27
1.1
1.1
—
—
—
0
0
10
49
2.05
1.22
1.0
1.3
—
—
—
0
0
1483
14595
1.20
1.22
43.7
24.6
82.32
80.60
umol/l
1.00
1476
14424
0
33
0.00
1.16
0.0
1.2
—
0.79
—
0
17
21
135
1.56
1.11
1.7
1.5
25.89
27.83
%
0.09
12
89
15
88
1.71
1.11
2.5
1.9
18.79
17.54
nmol/l
0.17
15
77
15
88
1.71
1.11
1.0
1.0
—
—
—
0
0
96
793
1.22
1.10
4.4
3.9
—
—
—
0
0
36
260
1.39
1.10
1.8
1.3
8.86
9.75
u/l
0.22
29
207
20
129
1.56
1.05
1.0
1.1
—
—
—
0
0
438
4711
0.90
1.05
3.6
3.5
—
—
—
0
0
160
1400
1.16
0.99
2.6
2.9
257.20
207.87
ng/l
0.66
145
1285
7
132
0.53
0.99
1.3
1.1
—
92.00
—
0
5
7
36
1.95
0.97
1.6
2.0
—
—
—
0
0
97
815
1.20
0.97
4.1
3.5
1.02
1.02
ratio
0.07
90
751
23
157
1.47
0.96
1.1
1.2
—
—
—
0
0
43
329
1.32
0.94
1.4
1.2
—
—
—
0
0
431
4019
1.10
0.93
3.7
3.3
0.00
0.02
0.50
11
109
24
167
1.44
0.92
1.2
1.1
—
—
—
0
0
60
483
1.25
0.91
6.1
5.9
1.11
1.34
mmol/l
2.18
53
422
25
176
1.43
0.91
1.1
1.3
—
—
nmol/l
—
0
0
314
2890
1.11
0.88
1.7
1.8
1211.26
1169.96
nmol/l
0.27
229
2154
13
79
1.65
0.88
2.5
2.7
—
—
—
0
0
370
3435
1.10
0.88
5.2
4.5
1.02
1.02
kg/l
0.59
274
2304
8
43
1.86
0.87
2.1
1.5
7.47
6.70
mmol/l
—
8
43
94
1103
0.84
0.87
1.2
1.2
—
—
—
0
0
6
114
0.52
0.83
1.0
1.8
—
—
—
0
0
362
3375
1.09
0.79
1.7
1.8
30208810.21
17424954.40
pmol/l
0.17
288
2749
179
1987
0.89
0.78
4.7
5.3
31.03
32.79
%
1.30
106
1260
71
837
0.84
0.72
1.2
1.2
45.64
141.63
u/ml
3.80
20
296
10
60
1.67
0.72
1.0
1.3
157.40
168.61
mmol/24h
—
10
60
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
101
881
1.16
0.70
1.2
1.4
65.20
56.44
au/ml
—
5
69
7
41
1.71
0.70
1.1
1.6
174.14
754.80
nmol/24h
—
7
41
9
59
1.53
0.68
1.9
1.6
—
—
—
0
0
17
119
1.43
0.67
1.1
1.2
0.43
0.62
u/ml
—
8
61
101
885
1.15
0.67
1.4
1.3
182.36
226.54
u/ml
0.22
78
819
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
67
570
1.18
0.64
2.5
3.3
215.58
272.84
mg/l
0.39
34
242
14
95
1.48
0.64
1.4
1.6
79.00
87.34
umol/l
0.64
14
95
5
29
1.73
0.64
2.4
2.2
2.60
2.60
%
—
5
29
0
20
0.00
0.60
0.0
1.2
—
819.70
—
0
7
14
198
0.70
0.60
1.4
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
3.4
—
21.18
—
0
5
60
703
0.85
0.60
1.7
1.8
3.34
3.50
mmol/l
0.40
40
529
12
174
0.69
0.59
1.2
1.2
—
—
—
0
0
8
53
1.51
0.58
1.4
2.3
13.69
180.01
ug/l
—
8
43
89
783
1.14
0.58
5.3
4.7
1.43
1.57
%
1.29
82
739
36
440
0.81
0.56
2.0
1.6
4908.62
13178.76
e6/l
2.72
26
312
5
89
0.56
0.56
3.8
1.5
—
—
—
0
0
8
122
0.65
0.54
1.0
1.0
—
1.00
u/ml
—
0
59
47
395
1.20
0.54
4.7
4.4
—
—
—
0
0
227
2434
0.92
0.53
1.2
1.3
14.98
13.55
u/ml
0.09
76
863
35
287
1.22
0.51
1.6
1.6
93.74
314.97
pmol/l
2.66
35
282
1485
14725
1.11
0.51
50.9
28.0
225.67
245.57
e9/l
25.24
1466
14396
1485
14728
1.11
0.49
50.7
28.0
4.32
4.43
e12/l
12.22
1461
14343
1485
14728
1.11
0.49
51.2
28.5
39.11
40.00
%
9.05
1480
14534
1485
14730
1.10
0.48
50.8
28.0
6.30
6.80
e9/l
15.81
1461
14346
11
76
1.45
0.48
1.1
1.7
40.64
39.27
g/l
0.29
11
76
131
1201
1.10
0.45
8.3
9.8
94.51
93.91
%
0.76
131
1193
11
77
1.43
0.45
2.8
1.5
14.46
7.69
ug/l
0.76
11
67
180
1676
1.08
0.45
2.2
2.3
128.55
143.74
ug/g
0.36
149
1333
708
7275
0.95
0.44
2.2
2.2
95.27
95.66
pmol/l
0.07
374
3807
24
295
0.81
0.42
1.3
1.2
0.90
0.91
g/l
0.08
24
295
8
57
1.41
0.42
1.3
1.3
14.90
14.02
g/l
—
8
45
15
114
1.32
0.40
1.1
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
176.57
—
0
7
23
186
1.24
0.40
1.7
1.6
61.57
64.26
%
0.13
14
124
8
60
1.33
0.40
1.3
1.1
1200.88
1515.33
miu/ml
—
8
60
0
18
0.00
0.40
0.0
1.2
—
0.02
—
0
18
0
18
0.00
0.40
0.0
1.2
—
1.83
—
0
18
0
19
0.00
0.39
0.0
2.7
—
0.64
—
0
19
70
779
0.89
0.38
1.3
1.3
—
—
—
0
0
34
398
0.85
0.38
3.0
3.5
0.90
0.83
nmol/l
0.13
27
327
20
161
1.25
0.37
1.3
1.3
—
—
—
0
0
296
3094
0.95
0.36
1.2
1.3
0.68
1.64
u/ml
3.02
56
780
40
347
1.16
0.36
1.4
1.3
64.29
59.73
mmol/l
0.29
34
273
108
997
1.09
0.35
1.2
1.3
—
—
—
0
0
48
425
1.13
0.33
1.2
1.2
—
98.06
—
0
36
246
2577
0.95
0.33
1.3
1.3
24.84
35.81
iu/ml
1.04
71
811
144
1350
1.07
0.33
3.3
3.9
78.54
91.20
ng/l
0.95
115
1167
6
90
0.67
0.32
1.2
1.2
121.83
137.74
nmol/l
—
6
90
14
110
1.28
0.31
1.9
2.6
14.35
16.23
%
1.66
14
110
117
1091
1.08
0.31
6.6
6.5
25.24
24.39
mmol/l
1.52
110
1042
140
1320
1.07
0.28
1.5
1.6
—
—
—
0
0
15
121
1.24
0.28
4.4
2.9
36.89
32.53
mg/l
—
9
90
14
112
1.25
0.28
2.4
1.7
114.19
103.69
ng/l
0.11
14
112
78
845
0.92
0.28
2.6
2.5
—
—
—
0
0
13
103
1.26
0.28
3.7
3.3
13.53
13.17
%
0.88
13
103
13
103
1.26
0.28
1.8
2.2
514.50
494.53
min
—
6
73
8
63
1.27
0.27
1.3
1.1
—
—
—
0
0
16
192
0.83
0.25
1.1
1.1
—
—
—
0
0
15
123
1.22
0.25
1.1
1.2
—
—
—
0
0
9
76
1.19
0.24
1.1
1.3
117.09
155.42
pmol/l
—
9
76
321
3311
0.96
0.24
3.1
3.4
0.73
0.77
ug/l
0.36
214
2268
6
85
0.70
0.24
1.0
1.0
—
—
—
0
0
77
717
1.08
0.23
5.8
4.9
0.93
0.87
%
0.55
70
674
1081
10918
0.97
0.22
43.5
24.3
331.40
331.71
g/l
0.55
1076
10861
151
1442
1.05
0.22
2.2
2.5
5.35
7.23
ug/l
0.43
132
1281
5
41
1.22
0.22
1.4
1.7
—
—
—
0
0
5
41
1.22
0.22
1.8
1.4
—
0.41
—
0
8
67
623
1.08
0.21
1.5
1.8
1.94
8.12
iu/ml
4.86
12
142
24
273
0.88
0.21
1.3
1.2
1.52
1.54
g/l
0.11
24
273
63
586
1.08
0.20
3.7
3.9
1.47
1.39
mmol/l
0.23
58
578
48
441
1.09
0.20
1.2
1.2
—
1493.08
—
0
13
125
1191
1.05
0.20
2.3
2.3
12.81
13.17
nmol/l
0.17
112
1065
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
48
1.25
0.20
1.5
1.7
—
—
—
0
0
125
1195
1.05
0.18
2.6
3.0
6.04
6.07
ph
0.14
90
845
20
175
1.14
0.18
1.1
1.1
—
—
—
0
0
39
358
1.09
0.17
1.7
1.9
7.40
20.25
iu/l
0.35
11
141
542
5510
0.98
0.17
5.1
5.8
2.35
2.86
ug/l
0.97
480
4958
16
138
1.16
0.17
2.6
2.3
708.29
618.50
ml
—
7
88
5
66
0.76
0.17
1.8
3.9
—
—
—
0
0
13
111
1.17
0.15
1.1
1.2
339.38
355.38
nmol/l
—
8
97
10
83
1.21
0.15
1.2
1.4
4.86
7.69
u/l
—
10
68
10
119
0.84
0.15
2.4
2.3
2.61
3.26
ug/l
—
10
113
11
129
0.85
0.14
1.2
1.1
113.55
106.40
pmol/l
0.12
11
129
514
5064
1.02
0.14
2.4
2.3
155.92
212.51
u/l
1.59
492
4782
15
131
1.15
0.14
1.9
2.3
—
—
—
0
0
10
118
0.85
0.14
1.2
1.3
—
—
—
0
0
8
96
0.83
0.13
1.1
1.6
—
—
—
0
0
35
325
1.08
0.13
3.9
4.0
37.20
28.80
mg/l
0.60
27
222
10
116
0.86
0.12
2.6
2.3
2.16
2.04
ug/l
—
10
99
13
115
1.13
0.10
2.1
2.4
8.38
9.08
mmol/l
0.28
13
115
14
125
1.12
0.10
1.0
1.3
—
—
—
0
0
37
349
1.06
0.10
1.1
1.1
—
—
—
0
0
17
186
0.91
0.09
1.1
1.8
—
—
—
0
0
6
55
1.09
0.09
1.0
2.2
0.59
0.61
mmol/l
—
6
55
5
60
0.83
0.08
1.4
1.2
1.06
1.06
ratio
—
5
51
7
65
1.08
0.08
38.4
30.0
75.57
121.04
ug/l
—
7
52
7
67
1.04
0.08
1.0
1.4
—
0.37
—
0
6
6
71
0.84
0.07
1.7
3.7
—
—
—
0
0
15
137
1.10
0.07
2.3
2.6
—
—
—
0
0
23
245
0.94
0.07
1.2
1.2
0.51
0.68
ratio
—
7
47
22
206
1.07
0.07
3.4
2.7
—
—
—
0
0
9
105
0.86
0.06
1.3
1.6
14.38
14.40
umol/l
—
9
98
22
233
0.94
0.05
1.0
1.1
1.67
1.55
g/l
0.66
22
215
14
129
1.09
0.05
2.0
1.9
—
—
—
0
0
42
435
0.96
0.05
10.9
11.8
—
—
—
0
0
19
201
0.94
0.04
1.1
2.3
—
—
—
0
0
19
199
0.95
0.03
1.1
1.8
—
—
—
0
0
10
93
1.08
0.02
1.7
3.2
1.60
0.87
index
—
10
93
1287
12883
0.99
0.02
5.5
5.5
2.02
2.00
mu/l
0.26
1196
11718
39
398
0.98
0.01
2.5
2.4
68.88
92.48
ug/min
0.31
17
233
50
493
1.01
0.01
1.6
1.6
11.71
18.17
u/ml
—
8
84
10
94
1.06
0.01
1.1
2.1
—
—
—
0
0
34
346
0.98
0.00
9.0
6.5
10.69
11.28
mmol/l
0.55
29
309
34
346
0.98
0.00
9.0
6.5
106.52
105.56
mmol/l
0.74
29
309
1361
13604
1.00
0.00
5.4
5.7
5.96
6.05
mmol/l
2.18
1228
12306
21
206
1.02
0.00
2.0
2.4
0.38
1.31
g/24h
2.25
14
119
25
246
1.02
0.00
1.5
1.7
—
—
—
0
0
17
168
1.01
0.00
1.5
1.1
—
—
—
0
0
19
188
1.01
0.00
1.2
1.2
2.00
5.06
u/ml
—
6
82
20
202
0.99
0.00
1.1
1.8
—
—
—
0
0
20
202
0.99
0.00
1.1
1.8
—
—
—
0
0
38
382
0.99
0.00
1.3
1.2
—
—
—
0
0
13
125
1.04
0.00
2.2
2.1
0.86
1.59
u/field
—
7
66
0
7
0.00
-0.00
0.0
1.4
—
0.53
—
0
7
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
17
170
1.00
-0.00
1.5
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
2.38
—
0
5
20
200
1.00
-0.00
1.1
1.6
—
—
—
0
0
6
69
0.87
-0.00
2.3
2.5
46.67
49.81
umol/l
—
6
58
0
6
0.00
-0.00
0.0
2.2
—
4.68
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
69
0.87
-0.00
1.7
1.4
24.67
30.32
umol/l
—
6
64
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
316.67
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
222.57
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.03
—
0
5
7
74
0.95
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
365.43
—
0
7
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.6
—
99.80
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_FOLLICULAR_LYMPHOMA – Follicular lymphoma, hilmo

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).